Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,retinoid binding (GO:0005501),-0.7794452235195818,-2.2438170129781914,0.0,0.0,0.0,9/22,13.37%,ALDH1A2;PTGDS;NR2F2;ABCA4;RBP4;RXRA;RBP1;RARA;CYP26B1
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),-0.5429169836761335,-2.006729821111114,0.0,0.020810345433461015,0.032,23/60,10.93%,ERBB4;NTRK3;FGFR2;EGFR;EPHA6;PDGFRB;EPHB1;NTRK2;NRP1;AXL;RYK;EPHA7;KIT;EFEMP1;CRIM1;ROR1;DDR1;PDGFRA;EPHB4;NRP2;EPHA3;EPHB2;IGF2R
prerank,cation channel activity (GO:0005261),-0.4925045104571534,-1.9971931821131366,0.0,0.01657120099331155,0.036,42/94,29.03%,TRPM3;SLC24A3;HCN1;NALCN;MCU;CACNA1D;PKD1;UNC80;ANXA2;TRPM6;TRPC5;SEC61A1;PIEZO2;KCNK5;TRPC1;KCNA1;SLC24A2;ANO1;KCNK10;ABCC9;TMEM63A;TMCO1;ANO6;TMEM63B;TMEM38A;KCNQ4;ANO10;KCNA2;GRIN1;MCOLN1;TRPC6;ANXA6;PANX1;CALHM5;KCNK9;TRPV2;CHRNA7;SLC24A4;TRPC3;CACNA1E;KCNK1;TMEM63C
prerank,retinoic acid binding (GO:0001972),-0.816746809985822,-1.9723912528157017,0.0,0.018498084829743123,0.055,4/12,13.37%,NR2F2;RXRA;RARA;CYP26B1
prerank,platelet-derived growth factor binding (GO:0048407),-0.8250934776685783,-1.9410511902406087,0.0,0.02150402361457638,0.077,7/11,6.59%,COL1A2;COL1A1;PDGFRB;COL3A1;COL5A1;COL6A1;PDGFRA
prerank,voltage-gated cation channel activity (GO:0022843),-0.4783558974012953,-1.9083222054707516,0.0,0.027361750477328365,0.111,40/97,28.78%,CACNA2D3;KCNQ3;KCNB2;CACNA1C;HCN1;KCNH7;KCNQ5;KCNMA1;CACNA1D;CACNB4;GRIN2B;KCNC2;KCND2;CACNA1B;KCNH5;KCNA1;CACNG7;CACNG4;OPRM1;KCNS3;KCNQ4;CACNG2;NCS1;KCNA2;KCNA6;GRIN2D;GRIN1;CACNA2D1;KCNC1;CACNG3;CACNG8;KCNC3;CACNB1;HCN2;KCNQ1;CACNA2D2;KCNQ2;LRRC38;CACNA1E;KCNK1
prerank,nucleotidyltransferase activity (GO:0016779),0.6891672868675793,1.7949870978907023,0.001890359168241966,0.8363506630908152,0.563,9/19,15.16%,THG1L;MOCS3;NUDT5;TENT4A;TERT;CRPPA;TUT7;PAPSS1;TUT4
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.5589116220773485,-1.7856372650513914,0.0,0.11908142109147135,0.461,13/32,28.10%,KCNQ3;KCNB2;KCNQ5;KCNC2;KCNA1;KCNS3;KCNQ4;KCNA2;KCNA6;KCNC1;KCNC3;KCNQ1;KCNQ2
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.4816203525336285,-1.7832662962068284,0.0,0.10737560178514953,0.47,20/60,10.73%,ERBB4;NTRK3;FGFR2;EGFR;EPHA6;PDGFRB;EPHB1;NTRK2;TGFBR2;AXL;RYK;EPHA7;KIT;ROR1;DDR1;PDGFRA;EPHB4;ACVR1;EPHA3;EPHB2
prerank,glycine binding (GO:0016594),-0.721172308131374,-1.7689453879143884,0.008281573498964804,0.11432844096160678,0.535,5/11,7.68%,GRIN2B;GLRB;SRR;GLRA3;GLRA1
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.7245209708100128,1.7392058393595153,0.016,0.8011687129394977,0.788,9/12,16.45%,CNOT2;CNOT7;PAN3;CNOT6;PAN2;CNOT1;CNOT6L;NOCT;PARN
prerank,solute:sodium symporter activity (GO:0015370),0.6135294860545859,1.7387932746971755,0.01001669449081803,0.5373783103281418,0.791,3/27,0.70%,SLC5A7;SLC4A4;SLC4A5
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.6860561038553993,1.731790458858224,0.007067137809187279,0.35110695568732625,0.821,7/16,6.58%,PTPRR;PTPRG;PTPRC;PTPRM;PTPRB;PTPRE;PTPRT
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.6860561038553993,1.731790458858224,0.007067137809187279,0.35110695568732625,0.821,7/16,6.58%,PTPRR;PTPRG;PTPRC;PTPRM;PTPRB;PTPRE;PTPRT
prerank,voltage-gated potassium channel activity (GO:0005249),-0.44168315425000215,-1.7164024226389922,0.0,0.18185929648241206,0.744,28/80,29.12%,KCNK2;KCNQ3;KCNB2;HCN1;KCNH7;KCNQ5;KCNMA1;KCNC2;KCND2;KCNH5;KCNJ2;KCNA1;KCNJ6;KCNJ13;KCNS3;KCNQ4;KCNJ10;KCNA2;KCNA6;KCNT1;KCNC1;KCNC3;HCN2;KCNQ1;KCNQ2;LRRC38;KCNK1;KCNJ12
prerank,calcium channel activity (GO:0005262),-0.42356058748197595,-1.681697969940126,0.0,0.23364342373022137,0.854,36/84,28.62%,CACNA2D3;SLC24A3;CACNA1C;STIM2;MCU;CACNA1D;CACNB4;PKD1;ANXA2;TRPC5;P2RX4;SEC61A1;CACNA1B;TRPC1;SLC24A2;CACNG7;TMCO1;CACNG4;OPRM1;CACNG2;NCS1;GRIN1;MCOLN1;TRPC6;CACNA2D1;ANXA6;PANX1;CACNG3;CACNG8;CACNB1;TRPV2;CHRNA7;CACNA2D2;SLC24A4;TRPC3;CACNA1E
prerank,gap junction channel activity (GO:0005243),-0.5738002651297724,-1.6617443264561338,0.013605442176870748,0.25935856438369004,0.905,5/22,11.14%,GJB6;GJC1;GJD3;GJA1;GJB2
prerank,R-SMAD binding (GO:0070412),-0.5968577626103936,-1.6538244288213726,0.012738853503184714,0.25710559251340076,0.916,8/18,16.22%,DDX5;LDLRAD4;SMAD3;SMAD4;SMAD6;RANBP3;PPM1A;JUN
prerank,alanine transmembrane transporter activity (GO:0022858),0.701755466416212,1.6509193788372156,0.014842300556586271,0.6910210040269337,0.975,4/12,5.75%,SLC7A8;SLC36A4;SLC3A2;SLC6A6
prerank,wide pore channel activity (GO:0022829),-0.5673252747446949,-1.6502329858097409,0.0091324200913242,0.24666865797519064,0.924,5/23,11.14%,GJB6;GJC1;GJD3;GJA1;GJB2
prerank,solute:anion antiporter activity (GO:0140323),-0.6438549969665898,-1.6466412721588302,0.012605042016806723,0.2374691640018273,0.93,6/14,19.78%,SLC7A11;SLC26A7;SLC26A2;SLC26A11;SLC4A2;SLC4A3
prerank,metalloendopeptidase activity (GO:0004222),-0.42963511446271396,-1.6404376152500197,0.003105590062111801,0.23606735601082335,0.939,28/76,21.05%,TRABD2B;NRDC;ADAMTS12;ADAMTSL3;ADAMTS2;THSD4;MMP16;ADAMTS6;ADAMTSL5;ADAMTS17;MMP14;ADAMTS9;ADAMTS5;ADAM19;NLN;ADAMTSL4;ADAMTS1;ADAMTS3;AFG3L2;MBTPS2;ADAMTS10;PITRM1;ADAMTS16;ADAMTS15;SPG7;ADAM33;ADAMTS20;MMP2
prerank,organic cation transmembrane transporter activity (GO:0015101),0.6696096382894748,1.6321908920750847,0.011472275334608031,0.7078379337858215,0.99,4/16,8.07%,SLC5A7;SLC7A8;SLC44A1;SLC25A26
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.5904343166776961,-1.628013594454463,0.009174311926605505,0.2514923444867282,0.952,7/18,17.04%,PDLIM5;ANXA2;BAIAP2L1;ANXA1;PDLIM1;S100A11;CDC42EP1
prerank,potassium channel regulator activity (GO:0015459),-0.46210721293172374,-1.6270001301774937,0.005141388174807198,0.24047510278666057,0.953,15/49,13.02%,DPP6;KCNIP4;KCNIP1;WNK1;FLNA;KCNIP3;ENSA;AKAP9;ARPP19;WNK4;SGK1;DPP10;ABCC9;DLG1;WNK3
prerank,MAP-kinase scaffold activity (GO:0005078),-0.6911819758524311,-1.621814939385097,0.014141414141414142,0.23755435255038534,0.958,4/11,8.48%,KSR1;AKAP13;IQGAP1;MAP2K2
prerank,monocarboxylic acid binding (GO:0033293),-0.5934679308315104,-1.6048962320174973,0.008733624454148471,0.26348209579365356,0.979,6/18,13.37%,NR2F2;PSAP;NAPEPLD;RXRA;RARA;CYP26B1
prerank,estrogen receptor binding (GO:0030331),0.5478359038789107,1.5981155785897334,0.011570247933884297,0.8373526806584161,1.0,11/32,10.70%,DCAF1;ARID5A;LEF1;RERG;DDX54;SRARP;CCDC62;PHB2;TACC1;WBP2;ESR1
prerank,poly(A) binding (GO:0008143),-0.5523632701609906,-1.5917849315478303,0.02511415525114155,0.2816003092385002,0.986,7/21,7.51%,RBMS1;TIA1;KHDRBS1;KHDRBS2;HNRNPDL;ELAVL4;DDX1
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.4623481154348825,-1.5911931574129998,0.0025974025974025974,0.26990387410670647,0.987,16/42,17.15%,LRRC4C;CNTN4;PDLIM5;CNTN6;NTNG1;ANXA2;DSCAM;JAM3;PALLD;BAIAP2L1;ANXA1;SIRPA;PDLIM1;S100A11;CDC42EP1;NEXN
prerank,leak channel activity (GO:0022840),-0.5840180854802657,-1.5902216981659854,0.008908685968819599,0.26043091712744326,0.988,4/18,10.23%,KCNK2;NALCN;KCNK5;KCNK10
prerank,ion channel activity (GO:0005216),-0.40891777547458547,-1.5879101697188591,0.006622516556291391,0.2548785594639866,0.989,33/80,28.43%,TRPM3;GABRB1;NALCN;GRIA4;GRIA2;GRID2;GRIN2B;UNC80;TRPM6;PIEZO2;GRID1;TRPC1;ABCC9;TMEM63A;GRIK4;TMEM63B;TMEM120B;GRIK1;GRIK3;MCUB;GRIN2D;GRIN1;TMEM120A;MCOLN1;TRPC6;ANXA6;CALHM5;TRPV2;CHRNA7;GRIA1;LRRC8A;TMC4;TMC6
prerank,metallopeptidase activity (GO:0008237),-0.3842873333873208,-1.5848445427280466,0.0,0.2516664441086552,0.991,37/113,21.06%,TRABD2B;NRDC;ADAMTS12;ADAMTSL3;ADAMTS2;THSD4;ADAM12;ADAM23;MMP16;PAPPA;ADAMTS6;ADAMTSL5;ADAMTS17;MMP14;ADAMTS9;RNPEP;ADAMTS5;ADAM19;NLN;ANPEP;ADAMTSL4;ADAMTS1;ADAMTS3;AFG3L2;MBTPS2;ADAMTS10;LAP3;ACE;PITRM1;ADAMTS16;ADAMTS15;COPS5;SPG7;ADAM33;ADAMTS20;MMP2;MYSM1
prerank,phosphatase binding (GO:0019902),-0.3879542721876036,-1.5800749923227082,0.0,0.2511026082537486,0.991,44/105,21.43%,MAGI2;EGFR;SMAD3;IQGAP1;AP3B1;JAK1;MAPK14;DLG4;SYTL2;CTNNB1;WNK1;PXN;VCP;MYO16;CRY2;ELL;STAT6;CDKN1B;DLG3;MAP3K5;TP53;CRY1;IKBKE;KIF3A;VRK3;DLG1;SIRPA;RACK1;PTK2;MTMR9;PPME1;MTMR4;NFATC2;TRAF2;FBXL2;TSC2;SNX3;CNST;SHOC2;MET;PPP6R3;PIK3R1;ITGA1;SH3RF2
prerank,acid-thiol ligase activity (GO:0016878),-0.6306047271188218,-1.5679604538106522,0.02591792656587473,0.26599560870917655,0.994,6/13,27.25%,ACSL1;ACSS3;ACSS2;AASDH;AACS;ACSS1
prerank,poly-purine tract binding (GO:0070717),-0.4987971289742772,-1.5489296229531082,0.03009259259259259,0.2985706504550726,0.998,13/27,23.03%,RBMS1;TIA1;KHDRBS1;KHDRBS2;HNRNPDL;ELAVL4;DDX1;DAZAP1;ATXN1;PABPC4;RBMS3;PABPC1;EIF4A3
prerank,adenylate cyclase binding (GO:0008179),-0.6757452371370535,-1.5470551431728439,0.030927835051546393,0.2925408329324462,0.998,4/10,2.67%,ADCY5;AKAP6;AKAP12;ADCY2
prerank,voltage-gated calcium channel activity (GO:0005245),-0.4607448641820278,-1.5463704185662897,0.017902813299232736,0.28433097890384323,0.998,17/37,28.62%,CACNA2D3;CACNA1C;CACNA1D;CACNB4;CACNA1B;CACNG7;CACNA1G;CACNG4;OPRM1;CACNG2;NCS1;CACNA2D1;CACNG3;CACNG8;CACNB1;CACNA2D2;CACNA1E
prerank,CoA-ligase activity (GO:0016405),-0.6004214333397895,-1.5425287132787915,0.02832244008714597,0.28392322542103704,0.999,3/14,6.20%,ACSL1;ACSS3;ACSS2
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.5432163840578851,-1.5388059632423374,0.03773584905660377,0.28350482745897315,0.999,8/21,9.47%,ARFGEF2;AKAP6;WASF2;PRRC1;WASF1;AKAP9;EZR;PRKACA
prerank,damaged DNA binding (GO:0003684),0.4829331543118549,1.5173880045859258,0.031879194630872486,1.0,1.0,14/44,12.66%,ERCC3;RAD18;PNKP;ERCC4;RAD1;XRCC1;EP300;TDG;DCLRE1B;CREBBP;APTX;RPS3;MPG;NBN
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.661952901426635,-1.5148060002041897,0.04294478527607362,0.33208967064608913,0.999,3/10,7.48%,SLC6A13;SLC6A1;SLC6A12
prerank,ATPase activator activity (GO:0001671),-0.5411182265056825,-1.5024088188791478,0.04157043879907621,0.3553400486595875,1.0,7/20,9.45%,TOR1AIP2;ATP1B1;DNAJC24;ATP1B3;DNAJC19;TOR1AIP1;ATP1B2
prerank,potassium:proton antiporter activity (GO:0015386),0.6656178092872268,1.4947515430451657,0.05384615384615385,1.0,1.0,3/10,6.87%,SLC9A7;SLC9A6;SLC9A8
prerank,GTP binding (GO:0005525),0.392158481192035,1.4943214717688766,0.006622516556291391,1.0,1.0,35/172,12.90%,PCK1;THG1L;RAC2;ARF5;RALB;RAP2A;EEF1A1;ARL5C;ARL4D;RERG;NRAS;TUBB;NME1;ATL1;GBP3;RAB7A;RRAD;RAB11B;RALA;GBP4;RAB6A;RAB14;RANBP17;ARL5B;ARF1;RHOQ;MFHAS1;DRG2;RHOG;GNAI1;RAB22A;LANCL2;RAP2C;RIT1;RRAGC
prerank,deoxyribonuclease activity (GO:0004536),0.6189614745837104,1.488534850130532,0.054003724394785846,1.0,1.0,5/14,5.53%,ZRANB3;NME1;MAP1S;ERCC4;APLF
prerank,chloride channel regulator activity (GO:0017081),-0.564256269040274,-1.480941839839077,0.055793991416309016,0.4050419931826967,1.0,8/14,26.53%,WNK1;STX8;WNK4;SGK1;WNK3;STX1A;VAMP8;CHRNA7
prerank,hexosaminidase activity (GO:0015929),-0.601186138277442,-1.480213527250003,0.05421686746987952,0.3959746283866887,1.0,7/12,29.51%,CEMIP;HEXA;CEMIP2;HEXB;HEXD;HYAL1;NAGA
prerank,translation elongation factor activity (GO:0003746),0.6059837660044781,1.4791002937847604,0.06296296296296296,1.0,1.0,6/14,13.47%,EIF5AL1;EIF5A;EEF1A1;TSFM;GTPBP2;EEF1B2
prerank,cAMP response element binding (GO:0035497),-0.6136801109375758,-1.4780818610655375,0.06827309236947791,0.3909907693827292,1.0,7/10,29.06%,CREB5;ATF7;CREB3L2;E4F1;JUN;CREB3L1;HMGA2
prerank,phospholipase inhibitor activity (GO:0004859),-0.6252673089520684,-1.4760990899126185,0.05742574257425743,0.3864517656371663,1.0,4/10,12.41%,ANXA2;ANXA4;ANXA1;ANXA5
prerank,acetylcholine receptor activity (GO:0015464),0.5402702064783526,1.474671229268933,0.06315789473684211,1.0,1.0,1/22,0.01%,HRH4
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.4513958319287584,-1.4744313970934155,0.028423772609819122,0.38081153481230795,1.0,14/34,18.15%,IQGAP1;OGT;ADAP2;ZFYVE16;CYTH3;PLEKHB2;GAB2;HIP1R;FCHSD2;COMMD1;DAPP1;IQGAP2;MYO1B;ARAP3
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.6158918961438715,-1.4727271344133186,0.05416666666666667,0.37574234810415713,1.0,2/11,1.56%,ITPR1;RYR3
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.47377564823889756,-1.4680014026916217,0.045023696682464455,0.379379928810006,1.0,13/27,27.69%,SLC22A8;SLC26A7;SLC39A14;SLC26A2;ANKH;ANO1;SLC39A8;SLC22A6;SLC26A11;SLC5A5;SLC25A30;SLC25A11;LRRC8A
prerank,metal ion binding (GO:0046872),0.3552775096043013,1.4658322976657059,0.0,1.0,1.0,81/477,13.08%,PCK1;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E;THG1L;EFHD2;SPOCK2;LCP1;MAP2K7;GCLC;SNRK;CSGALNACT1;EML1;RAP2A;SLC25A24;OXSR1;CABYR;ASTN2;CETN3;PPP3CB;ADGRL3;NUCB2;MEX3B;LTBP4;NUDT5;ATP2A2;NUDT12;NME1;ITSN1;CDH2;APOE;EFHD1;MMP12;ESYT2;SDF4;RASGRP3;CIB1;TDG;RET;MCTP2;SIK3;CALM3;SELP;CDH12;UBA2;RCN2;AIF1L;DXO;EXD2;NIM1K;S100A16;TRPM4;SRPK2;PAPOLA;NLK;MCTP1;PGP;PAM;GNAI1;ACER3;PPP3CA;PRNP;PPP3R1;ADPRH;MICU3;IDS;AGRN;POSTN;LETM1;HSPE1;SLC25A12;NEK6;CDH5;MAPK12;RRAGC;GSS
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.5715639585383693,-1.4657455934591428,0.04535637149028078,0.37684342458211806,1.0,10/13,24.41%,GLRB;GABRA2;GLRA3;GABRG2;GLRA1;GABRA5;GABRG3;GABRA4;GABRG1;GABRA1
prerank,peptide N-acetyltransferase activity (GO:0034212),0.6378948926578424,1.4653066115559756,0.07584830339321358,1.0,1.0,4/10,18.45%,NAA25;NAA80;NAA15;NAA50
prerank,neurexin family protein binding (GO:0042043),-0.6169510811067827,-1.460486316694611,0.057971014492753624,0.38189941413033623,1.0,6/10,26.00%,SYTL2;NLGN2;NLGN1;SYTL5;NLGN3;SYTL4
prerank,ligand-gated anion channel activity (GO:0099095),-0.5353800459915872,-1.45991575698184,0.06103286384976526,0.37445483935890517,1.0,11/17,24.41%,GABRB1;GLRB;GABRA2;GLRA3;GABRG2;GLRA1;GABRA5;GABRG3;GABRA4;GABRG1;GABRA1
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.4802249082067465,1.4568159416079025,0.05333333333333334,1.0,1.0,15/34,16.45%,REXO2;CNOT2;USB1;CNOT7;EXOSC9;XRN2;EXD2;PAN3;CNOT6;PAN2;CNOT1;CNOT6L;NOCT;ERI2;PARN
prerank,potassium channel activity (GO:0005267),-0.36779941669913957,-1.4510982278659679,0.01929260450160772,0.38915345960572095,1.0,23/89,20.76%,KCNK2;KCNQ3;KCNB2;HCN1;KCNH7;KCNQ5;KCNMA1;KCNC2;KCND2;KCNH5;KCNK5;KCNA1;KCNK10;ABCC9;GRIK4;TMEM38A;KCNS3;KCNQ4;KCNA2;KCNA6;GRIK1;GRIK3;KCNT1
prerank,outward rectifier potassium channel activity (GO:0015271),-0.6023487685055948,-1.4507049333357693,0.053763440860215055,0.3816737992180422,1.0,2/11,2.01%,KCNK2;KCND2
prerank,RNA polymerase II complex binding (GO:0000993),-0.460130302141348,-1.4458355993355871,0.05721393034825871,0.3857539445479144,1.0,16/32,27.44%,ELP4;WAC;RPRD1B;ERCC5;CDC73;ELP2;BRD4;WDR43;PAF1;SMYD2;RTRAF;PCIF1;GTF2B;SUPT4H1;ZNF326;SCAF1
prerank,protein tyrosine kinase activity (GO:0004713),-0.3523005116006865,-1.4415169520257358,0.013937282229965157,0.3892546210071336,1.0,25/108,10.73%,ERBB4;NTRK3;FGFR2;EGFR;EPHA6;PDGFRB;EPHB1;NTRK2;JAK1;AXL;RYK;FER;EPHA7;KIT;ROR1;TEC;DDR1;HIPK3;PDGFRA;FRK;EPHB4;EPHA3;CSK;HIPK1;EPHB2
prerank,phospholipase C activity (GO:0004629),-0.48153263035542104,-1.4406694550935344,0.045023696682464455,0.3835993152576067,1.0,10/25,19.38%,PLCE1;EDNRA;PDIA3;CHRM3;PLCD3;PLCB3;PLCH1;PLCL1;PLCD1;BDKRB2
prerank,zinc ion binding (GO:0008270),0.36132016677511536,1.4403597446443215,0.0070838252656434475,1.0,1.0,61/293,15.26%,MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E;LVRN;ARIH1;TRIM28;SOD1;TAB2;SHANK3;MYRIP;TRIM8;DUSP12;BIRC2;NUDT12;PHF5A;CA2;SIRT3;MMP12;MME;QPCTL;HPF1;KDM2A;CHMP1A;ZNF205;BMI1;ZNF3;TET3;WDFY1;TAB3;MDM2;ESCO1;MYCBP2;ZDHHC15;NQO2;RBSN;PAM;ACER3;TNKS;RNF11;CHD3;HHIP;CZIB;USP33;CSRP1;ZKSCAN5;PGGT1B;KDM5C;GRIN2A;GCH1;PHF8;QPCT;MT2A;S100A13;PTGR2;CRIP2;CLIP1
prerank,tropomyosin binding (GO:0005523),-0.5438611453531537,-1.4377835495952782,0.06047516198704104,0.3828178655515339,1.0,2/16,2.45%,CALD1;TMOD2
prerank,potassium ion leak channel activity (GO:0022841),-0.5521524818954027,-1.4331166374020041,0.04782608695652174,0.3862608669289131,1.0,3/15,10.23%,KCNK2;KCNK5;KCNK10
prerank,tRNA binding (GO:0000049),0.46205197976491796,1.4276240555633744,0.07424960505529225,1.0,1.0,11/43,16.41%,THG1L;EEF1A1;EIF2A;FARS2;YARS2;ELP1;TRMT10B;TERT;PTCD1;SSB;NSUN6
prerank,general transcription initiation factor binding (GO:0140296),0.5178065697354393,1.4266652888080293,0.08576329331046312,1.0,1.0,12/25,15.76%,RUVBL2;PSMC1;DRAP1;RUVBL1;RELA;PSMC2;ESR1;GTF2A2;TBP;THRA;DR1;TAF1
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.5744101567036985,1.4252774364845837,0.10567514677103718,1.0,1.0,1/14,0.03%,CAPN8
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.5707046627377853,-1.4244975891569023,0.06695464362850972,0.4002211839185168,1.0,4/13,4.63%,BMP6;BMP5;BMP7;BMP4
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.6013164041232916,-1.4244515400435886,0.08008213552361396,0.39280072350139666,1.0,4/10,6.00%,CACNA1C;CACNA1D;CACNB4;CACNA1B
prerank,glutathione transferase activity (GO:0004364),-0.47159753691749184,-1.422868437605469,0.051643192488262914,0.38923053495917814,1.0,14/23,40.20%,GSTT1;GSTZ1;GSTT2;PTGES;GSTA4;GSTM1;HPGDS;MGST1;GSTA3;GSTM2;MGST3;GSTM5;LANCL1;GSTO1
prerank,transmitter-gated ion channel activity (GO:0022824),-0.46031243089507135,-1.4227083591879628,0.07692307692307693,0.38253198605871064,1.0,17/29,24.41%,GABRB1;GRIA4;GRIA2;GRID2;GABRA2;GLRA3;GRID1;GABRG2;GRIK4;GABRA5;GABRG3;GABRA4;GRIK1;GRIK3;GRIN2D;GABRG1;GABRA1
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.5894475220937506,-1.4162043979681063,0.08548707753479125,0.3919075271462206,1.0,8/11,32.61%,ITPR1;TRPC5;TRPC1;ITPR2;RPH3A;TRPC6;TRPC3;TRPC7
prerank,pyrophosphatase activity (GO:0016462),0.445788347356161,1.416170834158326,0.045234248788368334,1.0,1.0,9/50,10.75%,NUDT14;BNIPL;NUDT11;FITM2;NUDT5;PLPP1;DXO;PRUNE1;DDX3X
prerank,GABA receptor activity (GO:0016917),-0.4865978365237603,-1.4159804273012413,0.06807511737089202,0.3854173332618189,1.0,10/21,24.41%,GABRB1;GABRA2;GABRG2;GABBR2;GABRA5;GABRG3;GABRA4;GPR156;GABRG1;GABRA1
prerank,protease binding (GO:0002020),-0.3507018041942685,-1.4114919578824645,0.026143790849673203,0.38923717938620034,1.0,27/99,12.29%,COL1A2;SLC2A13;TIMP3;COL1A1;CFLAR;TIMP2;NTRK2;COL3A1;PSAP;ANXA2;STIM1;ATP9A;F3;VCP;DPP4;LDLR;ADAMTSL4;BIN1;CCBE1;DVL3;FAP;GSK3B;FN1;UBC;TP53;SRI;ECM1
prerank,ligand-gated calcium channel activity (GO:0099604),-0.5079433169326104,-1.410837404663166,0.07339449541284404,0.38420757336522604,1.0,4/19,4.77%,ITPR1;GRIN2B;RYR3;P2RX4
prerank,cysteine-type peptidase activity (GO:0008234),-0.3676275416730161,-1.410461626595903,0.021538461538461538,0.37878682456571905,1.0,40/73,28.80%,USP40;USP29;CAPN2;MALT1;USP13;USP11;PDIA3;LGMN;OTULIN;CTSO;USP50;USP38;USP34;USP20;USP7;USP10;USP16;USP1;CASP7;CTSZ;USP42;USP5;OTULINL;CASP2;USP35;USP49;GGH;USP46;USP2;CASP3;CASP9;ATG4D;OTUD7B;USP24;CTSK;SFRP1;CTSF;CTSC;CTSB;UCHL1
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.5978491994082307,1.4029678311179825,0.10261194029850747,1.0,1.0,1/12,1.01%,GPR52
prerank,dynactin binding (GO:0034452),-0.5606122434653408,-1.4001053009504518,0.07584830339321358,0.3986754245836543,1.0,5/12,14.77%,BICD1;MAPT;HTT;GSK3B;BICDL1
prerank,BMP receptor binding (GO:0070700),-0.5707075514194615,-1.3993520970359428,0.08823529411764706,0.394389611037366,1.0,4/12,4.63%,BMP6;BMP5;BMP7;BMP4
prerank,guanyl ribonucleotide binding (GO:0032561),0.3611662683299287,1.3958242525803783,0.014230271668822769,1.0,1.0,37/196,12.90%,PCK1;THG1L;RAC2;ARF5;RALB;RAP2A;EEF1A1;ARL5C;ARL4D;RERG;RAB5C;NRAS;TUBB;NME1;ATL1;GBP3;RAB7A;RRAD;RAB11B;RALA;GBP4;RAB6A;RAB14;RANBP17;ARL5B;ARF1;RHOQ;MFHAS1;DRG2;RHOG;GNAI1;RAB5B;RAB22A;LANCL2;RAP2C;RIT1;RRAGC
prerank,5'-3' RNA polymerase activity (GO:0034062),0.49188640736577244,1.3905903888200506,0.08774834437086093,1.0,1.0,7/27,13.62%,POLR2J;POLR2B;POLR1C;POLR1D;TERT;POLR3F;POLR3B
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),-0.5746801373217643,-1.3886729696968454,0.09959349593495935,0.41391299934013503,1.0,1/11,0.75%,HCN1
prerank,RNA polymerase core enzyme binding (GO:0043175),-0.43713649050918063,-1.3882919415634682,0.06852791878172589,0.4084933518115051,1.0,15/33,26.37%,ELP4;WAC;RPRD1B;ERCC5;CDC73;ELP2;WDR43;PAF1;SMYD2;RTRAF;SPTY2D1;GTF2B;ERBB2;SUPT4H1;ZNF326
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.5083807868035477,-1.3832848067881123,0.11512415349887133,0.40751841427949237,1.0,6/17,10.73%,EPHA6;EPHB1;EPHA7;EPHB4;EPHA3;EPHB2
prerank,ephrin receptor activity (GO:0005003),-0.5083807868035477,-1.3832848067881123,0.11512415349887133,0.40751841427949237,1.0,6/17,10.73%,EPHA6;EPHB1;EPHA7;EPHB4;EPHA3;EPHB2
prerank,solute:proton symporter activity (GO:0015295),-0.51433319720545,-1.381925256214277,0.09302325581395349,0.4050079748497209,1.0,10/16,36.69%,SLC2A13;SLC25A3;SLC39A8;CTNS;SLC15A4;SLC11A2;SLC2A10;SLC36A1;SLC17A5;SLC2A9
prerank,peptidase inhibitor activity (GO:0030414),-0.4279116146314305,-1.3797194657452383,0.07124681933842239,0.40425456157794315,1.0,8/33,18.21%,TIMP2;TFPI;GPC3;PSMF1;ITIH2;RENBP;CAST;SERPIND1
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.5874215245576566,1.3770365134571287,0.1311787072243346,1.0,1.0,3/13,10.10%,EBP;ECH1;IDI1
prerank,sodium:proton antiporter activity (GO:0015385),0.5965497118814677,1.3744010524963606,0.1171003717472119,1.0,1.0,3/11,6.87%,SLC9A7;SLC9A6;SLC9A8
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.4849040138405165,1.373115514012806,0.09212730318257957,1.0,1.0,4/27,2.55%,POLR2J;POLR2B;POLR1C;POLR1D
prerank,chloride channel activity (GO:0005254),-0.3710003384698911,-1.3709368818194567,0.0425531914893617,0.4202114759466737,1.0,22/59,27.07%,GABRB1;GLRB;GABRA2;ANO3;CLIC4;SLC26A7;GLRA3;GABRG2;GLRA1;CLCN6;ANO1;CLCN2;ANO6;GABRA5;GABRG3;GABRA4;GABRG1;TTYH3;GABRA1;TTYH1;FXYD1;SLC1A4
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.4616544176691727,1.3698633853048219,0.09328968903436989,1.0,1.0,14/37,17.49%,FARS2;GARS1;YARS2;IARS1;LARS2;HARS1;NARS2;RARS2;EARS2;WARS2;LARS1;HARS2;WARS1;IARS2
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.46260039967815886,1.3677285217754984,0.0773109243697479,1.0,1.0,10/32,18.21%,SLC7A8;SLC1A1;SLC36A4;SLC3A2;SLC6A6;SFXN1;SLC38A5;SLC25A38;SLC7A5;SLC43A2
prerank,adrenergic receptor binding (GO:0031690),-0.5072558443000712,-1.3666149251329012,0.1,0.4246466598727905,1.0,3/16,6.22%,MAGI2;DLG4;ARRDC3
prerank,O-acyltransferase activity (GO:0008374),0.47196468947923265,1.3662863971973074,0.10899653979238755,1.0,1.0,6/30,7.89%,GPAM;LPCAT2;SOAT1;LPCAT3;GPAT4;MBOAT1
prerank,G protein-coupled amine receptor activity (GO:0008227),0.5072633908970907,1.360917904913803,0.10344827586206896,1.0,1.0,3/22,6.76%,HRH4;HTR1F;HTR2A
prerank,serotonin receptor activity (GO:0099589),0.5072633908970907,1.360917904913803,0.10344827586206896,1.0,1.0,3/22,6.76%,HRH4;HTR1F;HTR2A
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.5072633908970907,1.360917904913803,0.10344827586206896,1.0,1.0,3/22,6.76%,HRH4;HTR1F;HTR2A
prerank,ephrin receptor binding (GO:0046875),0.5121196929442756,1.3570856385927872,0.1099476439790576,1.0,1.0,6/21,9.34%,CBL;PIK3CG;SRC;FYN;EFNA1;LYN
prerank,cell adhesion mediator activity (GO:0098631),-0.4535994624167649,-1.3568703284330808,0.1021377672209026,0.44191859524154803,1.0,7/24,7.13%,LRRC4C;CNTN4;CNTN6;NTNG1;DSCAM;JAM3;PALLD
prerank,rRNA binding (GO:0019843),0.44059199288006257,1.3546975666174148,0.0688,0.9913293802130749,1.0,11/42,11.45%,RPL23;FASTKD2;MRPL18;RPS14;RPL5;EMG1;RPLP0;NGRN;MDM2;RPS9;RPS3
prerank,anion:anion antiporter activity (GO:0015301),-0.5007681593232511,-1.3525778448606227,0.10444444444444445,0.4457685181931413,1.0,8/17,31.21%,SLC26A7;SLC26A2;SLC26A11;SLC4A2;SLC19A1;SLC4A3;SLC25A11;SLC25A5
prerank,death receptor activity (GO:0005035),0.5890965033017835,1.3522051840290117,0.14198782961460446,0.9779450734842806,1.0,6/11,20.85%,TNFRSF10B;TNFRSF1B;TNFRSF19;TNFRSF1A;TNFRSF11A;FAS
prerank,insulin-like growth factor binding (GO:0005520),-0.5122123647030592,-1.351934107171467,0.1101123595505618,0.44116665326825716,1.0,6/15,15.83%,IGFBP2;IGFBP5;IGFBP6;IGF2R;IGFBP4;ITGB4
prerank,ligand-gated ion channel activity (GO:0015276),-0.43092572224579806,-1.3496159442741313,0.09319899244332494,0.44118869721884796,1.0,5/30,1.54%,GABRB1;GRIA4;GRIA2;GRID2;GRIN2B
prerank,GDP binding (GO:0019003),0.40913860264413915,1.3483900450894335,0.07177814029363784,0.9721562721359411,1.0,20/63,17.83%,RALB;RAP2A;RERG;RAB5C;NRAS;RAB7A;RAB11B;RALA;RAB14;GNAI1;RAB5B;RAB22A;RAP2C;RIT1;RRAGC;MIEF1;ARF6;MRAS;RAB28;RAB27A
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.3273355857427241,-1.3470088490960705,0.03793103448275862,0.4420579822187862,1.0,33/100,22.13%,PLA2G4A;IQGAP1;OGT;ADAP2;MAPT;WIPI1;SNX21;GAP43;PLEKHA8;CLVS2;ZFYVE16;CYTH3;OSBP;PLEKHB2;OSBPL5;GAB2;HIP1R;RNF34;FCHSD2;COMMD1;DAPP1;IQGAP2;MYO1B;ARAP3;SNX3;BBS5;ARFIP2;SNX11;SAP30L;GSDMD;OSBPL8;ATG2A;RPH3A
prerank,ligand-gated channel activity (GO:0022834),-0.43215020503130336,-1.3435239295699277,0.09653465346534654,0.44506452949325204,1.0,5/29,1.54%,GABRB1;GRIA4;GRIA2;GRID2;GRIN2B
prerank,magnesium ion binding (GO:0000287),0.3640726699627056,1.3406162092815672,0.04946524064171123,0.9901874798511366,1.0,26/135,13.08%,PCK1;THG1L;MAP2K7;GCLC;SNRK;RAP2A;OXSR1;NUDT5;NUDT12;NME1;TDG;SIK3;UBA2;DXO;EXD2;NIM1K;SRPK2;PAPOLA;NLK;PGP;GNAI1;ADPRH;NEK6;MAPK12;RRAGC;GSS
prerank,transition metal ion binding (GO:0046914),0.33009993414890226,1.3388439972058899,0.012387387387387387,0.9745177521344389,1.0,77/397,15.26%,PCK1;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E;LVRN;RNF7;ARIH1;TRIM28;GYG1;SOD1;TAB2;SHANK3;MYRIP;TRIM8;DUSP12;BIRC2;NUDT12;PHF5A;CA2;SIRT3;MMP12;MME;QPCTL;FBXL5;HPF1;KDM3A;KDM2A;CHMP1A;ZNF205;PIM1;ISCU;BMI1;ZNF3;TET3;WDFY1;TAB3;SOD2;MDM2;ESCO1;MYCBP2;EXD2;PARK7;ZDHHC15;NQO2;PAPOLA;RBSN;PAM;NOS3;MGAT5;ACER3;TNKS;PRNP;CUTC;RNF11;CHD3;HHIP;CZIB;USP33;CSRP1;ZKSCAN5;PGGT1B;KDM5C;GRIN2A;GCH1;PHF8;QPCT;MT2A;IMPA1;S100A13;PTGR2;CRIP2;CLIP1
prerank,GABA-A receptor activity (GO:0004890),-0.48054453380531337,-1.3388042065822847,0.10180995475113122,0.45060553881933507,1.0,8/18,24.41%,GABRB1;GABRA2;GABRG2;GABRA5;GABRG3;GABRA4;GABRG1;GABRA1
prerank,TBP-class protein binding (GO:0017025),0.5087846053161494,1.3379235011125177,0.13274336283185842,0.955810708711127,1.0,10/21,15.76%,RUVBL2;PSMC1;DRAP1;RUVBL1;PSMC2;ESR1;GTF2A2;THRA;DR1;TAF1
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",-0.3478794964772973,-1.3378525273536241,0.05263157894736842,0.44720009406905425,1.0,26/72,22.39%,SVIL;GSN;ADAP2;TULP3;SNAP91;ANXA2;SYTL2;FRMPD4;SNX21;GSDME;KCNJ2;ACTN2;HIP1R;SYT7;COMMD1;EXOC1;PLCD1;TWF2;MYO1B;SNX18;GSDMD;FZD7;VILL;PFN2;RPH3A;AMER1
prerank,glucuronosyltransferase activity (GO:0015020),0.5220050776085247,1.336975075477458,0.1316793893129771,0.9376975827852978,1.0,3/19,9.31%,CSGALNACT1;EXT2;B3GAT2
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.568268641838037,1.3338753924772404,0.1393596986817326,0.9306179902257261,1.0,4/12,12.51%,SLC9A7;SLC9A6;SLC9A8;LETM1
prerank,semaphorin receptor activity (GO:0017154),-0.5555324194500271,-1.3331481979428614,0.13211382113821138,0.4531591746463574,1.0,8/11,27.02%,PLXNA2;NRP1;NRP2;PLXND1;PLXNB2;PLXNC1;PLXNB1;PLXNA1
prerank,water transmembrane transporter activity (GO:0005372),-0.5638731402207726,-1.3300911389520271,0.14799154334038056,0.45505288681168077,1.0,3/11,24.54%,PDPN;AQP4;AQP11
prerank,retinoid X receptor binding (GO:0046965),0.5705823827312803,1.3288970277823038,0.15098039215686274,0.9337386735499572,1.0,3/11,10.21%,ARID5A;NR4A2;TACC1
prerank,symporter activity (GO:0015293),0.5854283681091152,1.3251986349269096,0.1793372319688109,0.9313369802644709,1.0,1/10,0.69%,SLC4A4
prerank,lipase activator activity (GO:0060229),0.5850962542839468,1.3245467916214,0.15625,0.9147113412759456,1.0,2/10,4.96%,SRC;FYN
prerank,calcium-release channel activity (GO:0015278),-0.483925185396582,-1.3210100863454428,0.1244343891402715,0.4730000255963405,1.0,5/17,22.61%,ITPR1;RYR3;TPCN1;ITPR2;MCOLN1
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.40628653651206925,-1.3207358254622925,0.08923884514435695,0.4680212850025327,1.0,16/35,16.60%,MPPED2;PLCE1;PLCXD3;ENPP1;PDIA3;NAPEPLD;TDP2;ENPP6;SMPD3;PLCB3;PDE11A;PLD3;GPLD1;PLCL1;ENPP3;APEX2
prerank,sterol transfer activity (GO:0120015),-0.4933341978434599,-1.31936297223201,0.1388888888888889,0.4657394309994661,1.0,7/17,18.89%,GRAMD1B;GRAMD1C;OSBP;ABCA1;STARD5;GRAMD1A;MTTP
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),-0.32472278970398566,-1.31503325688797,0.054140127388535034,0.47098546344777503,1.0,31/91,23.20%,SVIL;GSN;ADAP2;TULP3;SNAP91;ANXA2;SYTL2;MAPT;FRMPD4;WIPI1;SNX21;GSDME;KCNJ2;CLVS2;ACTN2;HIP1R;SYT7;COMMD1;EXOC1;PLCD1;TWF2;MYO1B;SNX3;SNX18;GSDMD;FZD7;VILL;PFN2;RPH3A;AMER1;SH3PXD2B
prerank,ubiquitin-specific protease binding (GO:1990381),0.4965929172599466,1.3146886687994122,0.13123844731977818,0.9426071643019315,1.0,5/19,10.15%,DERL2;SPATA2;RAD23A;PARK7;RHBDD2
prerank,nucleoside-triphosphatase activity (GO:0017111),0.33201637427136643,1.3143955641859584,0.03523693803159174,0.9245467649205686,1.0,49/248,13.07%,RAC2;DYNC1I1;RALB;DNM3;ABCB10;RAP2A;EEF1A1;PIN1;RUVBL2;GNAQ;RERG;RAB5C;NRAS;ATL1;GBP3;RAB7A;RAB43;RAB11B;RALA;GNB1;VWA8;GBP4;RAB6B;HBS1L;IFT22;RAB6A;RUVBL1;RAB14;GNA12;DNAJC27;GNA11;KIF15;RAB1A;KIF2A;RHOQ;DDX3X;EFTUD2;DRG2;RHOG;GNAI1;RAB5B;RAB22A;RAP2C;TBC1D24;EFL1;CHD3;RIT1;RRAGC;MYO1E
prerank,kinesin binding (GO:0019894),0.4643845508278852,1.3134387181484166,0.13321492007104796,0.9102409381438278,1.0,8/27,14.63%,CLSTN1;ACTB;KIFAP3;KIF1B;AP1G1;NEK6;AP1AR;ARHGEF10
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.4084189545725898,1.31250563314745,0.11235955056179775,0.8966320399576803,1.0,18/49,18.08%,ZRANB3;ABRAXAS1;RAD18;TNFAIP3;TAB2;UBL7;TAB3;SPRTN;RAD23A;UBQLN1;TNIP2;BRCC3;MINDY2;UBQLN4;UFD1;UBQLN2;RAD23B;AGAP3
prerank,AMP binding (GO:0016208),-0.5460942954561966,-1.307606093324757,0.16049382716049382,0.48470422867112195,1.0,4/11,6.20%,PRKAG2;MPPED2;PRKAG1;ACSS2
prerank,metal ion:proton antiporter activity (GO:0051139),0.5500624417360283,1.3053465625990013,0.1450381679389313,0.9127397670679127,1.0,4/13,12.51%,SLC9A7;SLC9A6;SLC9A8;LETM1
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.526744099794213,-1.3038531187169178,0.13390928725701945,0.4881692982721381,1.0,8/12,20.00%,TGFBR3;TGFBR1;TGFBR2;ACVR1;LTBP1;BMPR1B;BMPR1A;BMPR2
prerank,syntaxin-1 binding (GO:0017075),-0.43629561243933174,-1.2993859989859702,0.10297482837528604,0.49411945993127765,1.0,10/22,25.86%,SNAP25;STXBP5;UNC13C;UNC13B;SNPH;VAMP2;STXBP1;DAPK1;CPLX1;SYP
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.46396167600194904,-1.2941888649945765,0.152317880794702,0.5021021349596041,1.0,5/18,8.64%,TGFBR3;SMAD3;TGFBR1;TGFBR2;SMAD6
prerank,phospholipase activator activity (GO:0016004),0.5765987222753806,1.2931119409731298,0.1867704280155642,0.9533212266659601,1.0,2/10,4.96%,SRC;FYN
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.5605162839779669,-1.2921039873586568,0.15450643776824036,0.5016436389537852,1.0,8/10,38.20%,PML;FAN1;DNAJB2;ANKRD13D;ANKRD13B;LAPTM5;FAAP20;IDE
prerank,N-acyltransferase activity (GO:0016410),0.43702941132739404,1.2920373644851224,0.14457831325301204,0.9406277114256256,1.0,7/32,12.94%,CERS1;CERS4;PLAAT3;EP300;SIRT1;ESCO1;NAA80
prerank,galactosyltransferase activity (GO:0008378),-0.5321186829576009,-1.2913944782915203,0.17418032786885246,0.4979710127951334,1.0,8/11,35.59%,A4GALT;B4GALT1;B4GALT6;B4GALT4;B4GALT7;B4GALT3;B4GALT2;B4GALT5
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.4570900351830071,-1.2911037478632272,0.1462882096069869,0.49324838285023825,1.0,9/18,20.00%,TGFBR3;TGFBR1;TGFBR2;ACVR1;LTBP1;ACVR1B;BMPR1B;BMPR1A;BMPR2
prerank,adenylyltransferase activity (GO:0070566),0.48156961604499143,1.2893332511170439,0.17271157167530224,0.9358596669646543,1.0,10/21,21.55%,GPHN;FLAD1;TENT4A;PAPOLA;NMNAT1;SELENOO;PAPOLG;COASY;MTPAP;TENT2
prerank,FAD binding (GO:0071949),-0.4329980391252098,-1.2886709543181516,0.13452914798206278,0.49406977117267703,1.0,13/24,26.95%,MICAL2;DDO;MICAL3;CRY2;MTHFR;CRY1;SQOR;PRODH;QSOX1;KDM1B;MTRR;MICAL1;SQLE
prerank,GABA receptor binding (GO:0050811),-0.5394116949447887,-1.2886675996558812,0.16666666666666666,0.4887820560052688,1.0,3/11,7.26%,ARFGEF2;PLCL2;TRAK1
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",-0.42628799941056283,-1.2875587449990615,0.12322274881516587,0.48612819341462565,1.0,12/25,30.89%,MICAL2;CYP27A1;MICAL3;MSMO1;CYP26B1;FMO2;FMO5;MTRR;MICAL1;SQLE;NOS1;POR
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.5538651678087944,1.286450299357556,0.17857142857142858,0.9325281553571787,1.0,4/11,15.51%,RDH13;RDH11;RDH14;AKR1A1
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.4939458099949237,-1.2795340819616112,0.1575492341356674,0.5004462134004583,1.0,5/14,3.48%,SPOCK3;TIMP3;SPOCK1;TIMP2;COL4A3
prerank,cation transmembrane transporter activity (GO:0008324),0.3990435004938594,1.279500115620267,0.11801242236024845,0.9472883223609057,1.0,12/48,17.43%,SLC7A8;SLC1A1;SLC36A4;SLC39A1;SLC3A2;SLC6A6;SLC25A2;SFXN1;SLC38A5;SLC66A1;SLC25A38;SLC7A5
prerank,cGMP binding (GO:0030553),-0.5286845647285484,-1.2787888819896278,0.17695473251028807,0.4968951693197925,1.0,4/11,25.95%,PDE5A;PDE11A;RAPGEF2;PDE2A
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.4320789208415523,-1.2773442862237954,0.16179775280898875,0.49534819943564695,1.0,8/23,19.38%,PLCE1;EDNRA;CHRM3;PLCD3;PLCB3;PLCH1;PLCD1;BDKRB2
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.5444848714231026,1.2768564761983898,0.2112676056338028,0.9427012527998392,1.0,4/11,18.45%,NAA25;NAA80;NAA15;NAA50
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.3103041821828588,1.2758721528199148,0.02844141069397042,0.9310240470641338,1.0,80/431,13.44%,PCK1;THG1L;RAC2;ARF5;SNRK;PPIP5K2;RALB;RAP2A;EEF1A1;HSPA8;OXSR1;HSPA4L;ARL5C;ARL4D;PNKP;NEK11;RPS6KA4;RERG;PYGL;NRAS;TUBB;RPS6KA5;NME1;ATL1;GBP3;RAB7A;MLKL;RRAD;RAB11B;RALA;PEX1;TDG;YARS2;MTHFS;GBP4;PRPS1L1;PRPS1;ABCF1;SIK3;CDK11B;LONP1;PIM1;HARS1;UBA2;RAB6A;PEAK1;RAB14;SYN3;MINK1;RANBP17;ACVRL1;LATS2;ARL5B;ARF1;RHOQ;NIM1K;MFHAS1;SRPK2;PAPOLA;NLK;P2RX7;DRG2;RHOG;GNAI1;OLA1;PNPLA8;MAP4K4;RAB22A;LANCL2;PRKCI;MYO9B;RAP2C;NEK6;ABCF2;RIT1;RRAGC;GSS;NDUFA13;TLK2;PPP5C
prerank,MAP kinase kinase activity (GO:0004708),0.5069468481455163,1.2740812367230083,0.16923076923076924,0.9234412747290692,1.0,4/15,6.51%,MAP2K7;MAP2K5;MAP3K9;PAK3
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.36149089535484946,-1.2725524744363461,0.10991957104557641,0.502055482206236,1.0,16/48,24.68%,TRPM3;NALCN;UNC80;TRPM6;SLC41A1;PIEZO2;SLC12A2;TRPC1;ABCC9;SLC12A6;SLC12A4;MCOLN1;TRPC6;SLC12A7;DMAC2L;CALHM5
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.5206872430420247,-1.2721717146152771,0.16777041942604856,0.49811698884334793,1.0,8/12,24.41%,GABRB1;GABRA2;GABRG2;GABRA5;GABRG3;GABRA4;GABRG1;GABRA1
prerank,phospholipase binding (GO:0043274),0.52589385625728,1.269242349840634,0.20076481835564053,0.9299762156664945,1.0,3/13,6.82%,SRC;FYN;SYK
prerank,chloride channel inhibitor activity (GO:0019869),-0.558187417110087,-1.2691394257083617,0.18275154004106775,0.5007315950381277,1.0,6/10,23.79%,WNK1;STX8;WNK4;WNK3;STX1A;VAMP8
prerank,semaphorin receptor binding (GO:0030215),0.46904318173024107,1.2687786675364943,0.16753022452504318,0.9165412711966612,1.0,6/23,9.12%,SEMA6A;SEMA6D;SEMA7A;SEMA3C;SEMA6B;SEMA4C
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.5168166319155862,1.2661431667875203,0.17100371747211895,0.9129493393696331,1.0,2/14,0.88%,ALDH1L1;AASS
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",-0.41005079895137436,-1.2660623076354605,0.13189448441247004,0.5036607255623127,1.0,10/25,26.16%,ADAP2;PLEKHA2;GAB2;HIP1R;FCHSD2;COMMD1;DAPP1;ARAP3;AKT1;HIP1
prerank,calcium ion transmembrane transporter activity (GO:0015085),-0.3566897647678514,-1.2624240551163746,0.13450292397660818,0.5080285907805862,1.0,10/55,9.44%,SLC24A3;ITPR1;MCU;CACNA1D;PKD1;ANXA2;TRPC5;SEC61A1;TRPC1;SLC24A2
prerank,regulatory RNA binding (GO:0061980),-0.37365917675353194,-1.2620754488521668,0.11864406779661017,0.5038146465916383,1.0,11/38,14.71%,ZC3H7A;PUM1;ZC3H7B;PUM2;HNRNPA2B1;AGO3;HNRNPA1;RBM4;DDX21;DICER1;ZNF346
prerank,endopeptidase activity (GO:0004175),-0.2724132744302614,-1.2610376059323192,0.01744186046511628,0.5016493846316035,1.0,78/257,22.96%,TRABD2B;NRDC;ADAMTS12;ADAMTSL3;ADAMTS2;THSD4;USP40;USP29;PCSK2;PCSK5;MMP16;ADAMTS6;ADAMTSL5;MALT1;ADAMTS17;USP13;BACE2;MMP14;ADAMTS9;F3;RHBDL3;ADAMTS5;ADAM19;USP11;PDIA3;RHBDD1;DPP4;HTRA3;NLN;TPP2;PSMA2;ADAMTSL4;ADAMTS1;BACE1;PSMA6;LGMN;CLPP;FAP;PREP;PSMA1;ADAMTS3;CTSO;PIK3IP1;USP38;USP34;PCSK6;AFG3L2;USP20;DDI2;PSMA5;MBTPS2;ADAMTS10;USP7;USP10;USP16;USP1;CASP7;CTSZ;PSMB3;ACE;PITRM1;USP42;USP5;ADAMTS16;ADAMTS15;SPG7;ADAM33;CASP2;ADAMTS20;MMP2;USP35;RHBDF1;USP49;USP46;USP2;CASP3;KLK2;CASP9
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.5495369530681591,1.2606221740966819,0.21146245059288538,0.9218844378207613,1.0,4/11,10.86%,PRMT3;FBXO11;PRMT9;CARM1
prerank,ATPase binding (GO:0051117),-0.3285892717203004,-1.2571611161328307,0.0896358543417367,0.5058785770343559,1.0,18/71,11.27%,ANK2;SLC2A13;EGFR;SNTA1;TMTC4;TOR1AIP2;ATP1B1;ATP6V1E1;ATP1B3;PTPN3;TRPC1;EZR;TOR1AIP1;ZNHIT6;ATP1B2;CLPP;TCIRG1;ATP6V0A4
prerank,motor activity (GO:0003774),0.3778893988724347,1.255460797003539,0.13535031847133758,0.9303037269640528,1.0,15/60,15.44%,DYNC1I1;KIF18A;PIN1;DNAH3;KIF1B;KIF15;STARD9;KIF2A;KIF13A;MYO1E;KIF3B;KIF6;APPBP2;DYNC1I2;MYH9
prerank,cysteine-type endopeptidase activity (GO:0004197),-0.32537195793673895,-1.2554018085045557,0.07692307692307693,0.5057524726150876,1.0,41/78,28.80%,CFLAR;USP40;USP29;CAPN2;MALT1;USP13;USP11;PDIA3;LGMN;CASP12;CTSO;USP38;USP34;USP20;USP7;USP10;USP16;USP1;CASP7;CTSZ;USP42;USP5;CAPN15;CASP2;USP35;USP49;CAPN1;USP46;USP2;CASP3;CASP9;USP24;CTSK;CAPN10;CAPN5;SFRP1;CTSF;CTSC;CTSB;GPAA1;UCHL1
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.5343694781687851,-1.2543299394625924,0.18619246861924685,0.503456929113248,1.0,9/10,44.26%,B4GALT1;B4GALT6;B3GALT5;B3GALT1;B4GALT7;B3GALT2;B4GALT5;A3GALT2;B3GALT6
prerank,GTPase activity (GO:0003924),0.32715561034623775,1.2535201792315036,0.0858257477243173,0.9250489156047309,1.0,39/192,12.90%,RAC2;RALB;DNM3;RAP2A;EEF1A1;GNAQ;RERG;RAB5C;NRAS;ATL1;GBP3;RAB7A;RAB43;RAB11B;RALA;GNB1;GBP4;RAB6B;HBS1L;IFT22;RAB6A;RAB14;GNA12;DNAJC27;GNA11;RAB1A;RHOQ;DDX3X;EFTUD2;DRG2;RHOG;GNAI1;RAB5B;RAB22A;RAP2C;TBC1D24;EFL1;RIT1;RRAGC
prerank,miRNA binding (GO:0035198),-0.39548740977018715,-1.2531760663923075,0.14414414414414414,0.501567862623139,1.0,10/30,14.71%,ZC3H7A;PUM1;ZC3H7B;PUM2;HNRNPA2B1;AGO3;HNRNPA1;RBM4;DDX21;ZNF346
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.5580328948103644,1.2486510284218495,0.21183206106870228,0.9329087196050756,1.0,7/10,19.51%,TNFAIP3;YOD1;DESI2;OTUD5;OTUD4;ATXN3;STAMBP
prerank,anion channel activity (GO:0005253),-0.334522241296198,-1.2444201317750134,0.09785932721712538,0.5178190948326028,1.0,12/61,7.68%,GABRB1;GLRB;GABRA2;ANO3;CLIC4;LRRC8D;SLC26A7;LRRC8B;VDAC1;GLRA3;GABRG2;GLRA1
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.3673396843022392,1.2432013238606323,0.15501519756838905,0.9431261868449744,1.0,17/69,16.54%,CERS1;ZDHHC17;CERS4;ZDHHC13;PLAAT3;SOAT1;EP300;LPCAT3;ZDHHC14;ESCO1;ZDHHC15;CREBBP;ZDHHC9;ZDHHC7;NAA15;MBOAT7;ELP3
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.5312400264094621,-1.2427038724156347,0.2024793388429752,0.517368310081878,1.0,7/10,24.41%,GABRA2;GABRG2;GABRA5;GABRG3;GABRA4;GABRG1;GABRA1
prerank,nuclear receptor binding (GO:0016922),0.3426713237332719,1.2397877810386133,0.1251778093883357,0.9445554621228459,1.0,29/111,14.60%,DCAF1;ARID5A;NR4A2;GAS2L1;LEF1;RERG;DDX54;SRARP;CCDC62;PHB2;KDM3A;EP300;MED12;ACTN4;SIRT1;GTF2H1;PKN1;PARK7;RNF6;BUD31;TACC1;WBP2;ESR1;MED4;JMJD1C;YWHAH;NCOA7;BAZ2A;CNOT1
prerank,Wnt-activated receptor activity (GO:0042813),-0.47480491836845085,-1.2394096231505456,0.19599109131403117,0.5207065061336418,1.0,6/15,10.32%,PKD1;FZD6;RYK;ROR1;LRP5;FZD2
prerank,exonuclease activity (GO:0004527),0.3964853434511006,1.2391651207577006,0.16984126984126985,0.9336157500070426,1.0,12/46,13.09%,AEN;REXO2;RAD1;APLF;DCLRE1B;CNOT7;EXOSC9;XRN2;DXO;EXD2;EXOSC1;CNOT6
prerank,poly(U) RNA binding (GO:0008266),-0.43856995075050786,-1.2375438645832277,0.1973392461197339,0.520465087676143,1.0,8/20,22.72%,RBMS1;HNRNPH1;KHDRBS1;DAZAP1;ATXN1;PABPC4;RBMS3;PABPC1
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.4689312006409514,-1.2372848301621322,0.19661733615221988,0.5166470075484172,1.0,5/15,23.17%,SLC26A7;SLC26A2;SLC39A8;SLC4A3;SLC4A8
prerank,pre-mRNA binding (GO:0036002),-0.39359616818751975,-1.236624461009287,0.15945330296127563,0.5137072307926579,1.0,9/28,16.87%,CELF2;DDX5;CELF4;SRSF6;RNPC3;HNRNPA1;RBM4;SLU7;RBM7
prerank,insulin-like growth factor I binding (GO:0031994),-0.49520258763048774,-1.2361741492213243,0.1870824053452116,0.5103360218544837,1.0,5/13,15.83%,IGFBP2;IGFBP5;IGFBP6;IGFBP4;ITGB4
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.4031061415136029,-1.2338341734000238,0.16267942583732056,0.5116773583373826,1.0,12/27,23.17%,ITPR1;SLC41A1;MRS2;SLC12A2;KCNA1;SLC9B2;MAGT1;ITPR2;SLC11A2;CNNM2;ATP2B3;SLC4A8
prerank,U6 snRNA binding (GO:0017070),0.5004574274405955,1.2294390057906588,0.21772639691714837,0.9630947518637896,1.0,2/14,1.25%,EIF5A;RBM22
prerank,protein tyrosine kinase activator activity (GO:0030296),-0.44597104821771677,-1.226981472062467,0.19693654266958424,0.523924655853531,1.0,4/19,6.19%,GRM5;EFNA5;ABI1;ERCC6
prerank,tRNA methyltransferase activity (GO:0008175),0.48292445048166355,1.2259369471400268,0.2034548944337812,0.965110704578825,1.0,4/16,11.86%,BCDIN3D;THUMPD2;METTL2B;METTL2A
prerank,active ion transmembrane transporter activity (GO:0022853),-0.3663265853815161,-1.2257549925487865,0.15513126491646778,0.5222475718642996,1.0,12/37,18.19%,SLCO3A1;SLC22A8;SLC16A7;CYB5A;UQCRH;SLC22A4;COX8A;SLC22A6;UQCRC1;NDUFA4;COX7A2L;COX6A1
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),-0.34236764712772483,-1.224883882423326,0.16666666666666666,0.5199574590352006,1.0,16/55,18.79%,SLC16A12;SLC6A13;SLC13A3;SLC7A2;PDPN;SLC16A7;SLC7A14;SLC6A12;SLC22A4;SLC25A32;SLC38A11;SLC16A11;SLC19A1;SLC16A2;SLC38A7;SLC16A9
prerank,chemorepellent activity (GO:0045499),0.4420195357876795,1.2211808857420148,0.21554770318021202,0.9729590581403933,1.0,6/25,9.12%,SEMA6A;SEMA6D;SEMA7A;SEMA3C;SEMA6B;SEMA4C
prerank,filamin binding (GO:0031005),-0.5102089259353062,-1.2210878927277733,0.24696356275303644,0.5244881458574926,1.0,8/11,38.21%,DPYSL3;SYNPO2;CEACAM1;FBLIM1;CRMP1;MICALL2;RFLNA;RFLNB
prerank,CXCR chemokine receptor binding (GO:0045236),0.5328436108278615,1.2193458678587756,0.23941068139963168,0.9684034622889112,1.0,1/11,2.31%,CXCL12
prerank,calcium-dependent phospholipid binding (GO:0005544),-0.33875483721674987,-1.2162197711184624,0.15489130434782608,0.5320683635480761,1.0,15/49,14.39%,ANXA3;PLA2G4A;CPNE8;PCLO;ANXA2;ANXA4;SYT9;ESYT1;ANXA1;SYT12;SYT11;ANXA5;SYT4;CPNE2;SYT7
prerank,cholesterol transfer activity (GO:0120020),-0.4587715673359377,-1.2145722486912953,0.2159090909090909,0.5318104623772307,1.0,6/16,18.89%,GRAMD1B;GRAMD1C;ABCA1;STARD5;GRAMD1A;MTTP
prerank,aspartic-type peptidase activity (GO:0070001),-0.5224002745139679,-1.2142931063393014,0.226215644820296,0.5281259615491751,1.0,4/10,13.80%,BACE2;BACE1;CTSD;DDI2
prerank,Tat protein binding (GO:0030957),0.532257670186085,1.214037029130703,0.26045627376425856,0.9784385596136698,1.0,6/10,19.00%,ACTB;MDFIC;GABARAPL1;SMARCA4;NPM1;SMARCB1
prerank,epidermal growth factor receptor binding (GO:0005154),-0.40216375569459006,-1.2109625515934488,0.20388349514563106,0.5322581495340452,1.0,9/25,15.59%,ERBB4;SNX2;SNX4;FER;EFEMP1;CNOT9;PLSCR1;GRB2;ARF4
prerank,WW domain binding (GO:0050699),0.4322850470898586,1.2101040904911196,0.1967799642218247,0.9824938119725415,1.0,7/26,20.35%,PRRG4;TCEAL9;DAZAP2;TNK2;NDFIP2;WBP11;LITAF
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.4000295862136308,-1.2096116490200226,0.2033096926713948,0.5313944829040306,1.0,12/26,23.69%,SLC16A12;SLC6A13;SLC6A1;SLC16A7;SLC6A12;SLC27A1;SLC16A11;SLC16A2;SLC5A6;SLC16A9;SLC16A4;SLC6A11
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.4634024472212439,-1.2094983657578628,0.2329059829059829,0.5274339842179039,1.0,1/15,1.27%,PLA2G4A
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.44782957013969527,-1.2058560552873858,0.23043478260869565,0.5321294540540376,1.0,9/17,30.06%,DPYD;TECR;BLVRA;BLVRB;LBR;SRD5A3;DECR2;DHCR24;PECR
prerank,phosphatidate phosphatase activity (GO:0008195),-0.47655215328615724,-1.1992415015864992,0.225531914893617,0.5432457578539551,1.0,9/13,31.20%,PLPPR1;PLPP3;PLPPR5;LPIN1;PLPPR4;LPIN2;PLPP5;LPIN3;PLPPR2
prerank,muscle alpha-actinin binding (GO:0051371),-0.4527291307250442,-1.1985060999343766,0.21841541755888652,0.540737378005112,1.0,7/15,22.22%,PDLIM5;PDLIM7;PALLD;SYNPO2;PDLIM1;PDLIM2;PDLIM4
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.4263948033006297,1.1982004761827563,0.20442930153321975,1.0,1.0,4/27,6.87%,SLC9A7;SLC3A2;SLC9A6;SLC9A8
prerank,protein tyrosine phosphatase activity (GO:0004725),0.3559836981603331,1.1976960664967735,0.18816388467374812,1.0,1.0,15/71,11.40%,PTPRR;PTPN18;PTPRG;PTPRJ;PTPRC;PTPRM;PTPRB;PTPRE;PTP4A2;PTPN12;PTPRT;EYA3;DUSP11;PGP;HACD2
prerank,transcription coregulator binding (GO:0001221),0.3753967776173407,1.1913053746530824,0.22135007849293564,1.0,1.0,16/50,13.37%,EZH2;RPL23;EED;HDAC3;UBE2I;CNOT2;PPARD;RELA;TERT;LMO2;ESR1;THRB;CTBP1;HDGF;NEK6;CTBP2
prerank,mRNA 3'-UTR binding (GO:0003730),-0.3099820559882787,-1.1903534646848029,0.1550632911392405,0.5558763424437951,1.0,25/79,20.14%,CELF2;DDX5;RBMS1;CPEB4;CPEB1;CPEB2;ELAVL2;PUM1;ELAVL4;YBX3;PUM2;HNRNPA2B1;SECISBP2;ELAVL3;TP53;RBM4;RPS7;DAZAP1;CSDC2;PABPC4;RNPS1;CIRBP;HNRNPA0;RBMS3;RNF40
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.4090066203935082,1.1903076057071313,0.22084805653710246,1.0,1.0,6/28,10.58%,MAP2K7;RPS6KA1;MAP2K5;MAP3K9;PAK3;PRKAA2
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.5017579613239669,1.189550259904497,0.2756052141527002,1.0,1.0,6/13,18.02%,PRKAR1A;GSK3A;PJA2;PKIA;RYR2;PRKAR2A
prerank,phosphatidylinositol kinase activity (GO:0052742),0.4852021298505521,1.188525214228085,0.22988505747126436,1.0,1.0,6/15,14.65%,PIK3CG;PIK3C2G;PIKFYVE;PI4KA;PIK3CD;PIK3C2A
prerank,alpha-actinin binding (GO:0051393),-0.3997287368557855,-1.186429992527322,0.22566371681415928,0.5613144996857452,1.0,8/24,13.61%,CACNA1C;PDLIM5;CACNA1D;PDLIM7;PALLD;SYNPO2;RARA;PDLIM1
prerank,clathrin adaptor activity (GO:0035615),-0.44825251646525,-1.1839534249944983,0.23842592592592593,0.5630617326939849,1.0,7/15,12.82%,DAB2;AP2B1;AP2A2;STON2;AP2A1;STON1;HIP1R
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.4001238340323304,1.1834690052964765,0.21783876500857632,1.0,1.0,12/33,16.45%,REXO2;USB1;CNOT7;EXOSC9;XRN2;EXD2;CNOT6;PAN2;CNOT6L;NOCT;ERI2;PARN
prerank,signaling receptor complex adaptor activity (GO:0030159),-0.3499339589980768,-1.182412672032022,0.2026315789473684,0.5623139621552741,1.0,2/38,0.16%,MAGI2;SORBS1
prerank,cyclic nucleotide binding (GO:0030551),-0.4076069916610181,-1.1782515111655376,0.23623853211009174,0.5685141341820259,1.0,6/21,15.76%,HCN1;PDE5A;PDE4B;PDE11A;SLC19A1;RAPGEF2
prerank,store-operated calcium channel activity (GO:0015279),-0.4990760224366501,-1.176899775316024,0.2524850894632207,0.5675829028592848,1.0,3/10,8.47%,STIM2;TRPC5;TRPC1
prerank,transcription corepressor binding (GO:0001222),0.418275550824466,1.1766305916172786,0.24061433447098976,1.0,1.0,9/27,13.37%,EZH2;EED;HDAC3;CNOT2;ESR1;CTBP1;HDGF;NEK6;CTBP2
prerank,death receptor binding (GO:0005123),-0.45365905383012317,-1.176295556247599,0.23423423423423423,0.5647101457513813,1.0,5/15,17.91%,EDA;CASP8AP2;MADD;NGF;TMBIM1
prerank,frizzled binding (GO:0005109),-0.3594047976734717,-1.1741940985414367,0.22772277227722773,0.5656008848284093,1.0,13/34,28.27%,WNT5B;RYK;RNF43;WNT4;DVL3;ZNRF3;WNT9A;LRP6;DVL1;FZD7;SFRP1;MYOC;FZD1
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.39398806444531914,-1.1704883831183617,0.22769953051643194,0.5702570825140193,1.0,5/21,32.10%,GRM5;CHRFAM7A;CHRNA7;GRIA1;CHRNB1
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.486365370598478,1.1648205627087254,0.2827324478178368,1.0,1.0,6/13,16.86%,PIK3CG;PIK3C2G;PIKFYVE;PIK3CD;PIK3C2A;PIP4K2A
prerank,RNA binding (GO:0003723),0.27078353184940573,1.164564882971942,0.03881511746680286,1.0,1.0,369/1321,19.43%,THG1L;LRRFIP1;SORBS2;MAZ;CMSS1;SNRPD2;ZC3H12D;RPS19BP1;ILF3;NCBP1;RPL30;EIF5A;UTP20;THUMPD1;RSRC2;SYNE1;KHDRBS3;RBM22;FAU;RALYL;TRIM28;RSL24D1;EEF1A1;UTP18;HSPA8;RPP25L;POLR2B;PATL2;MRPL23;RPL17;RPL23;EIF2S1;EIF2A;PRPF31;FASTKD2;RPL31;PRPF3;RPL3;SNRPD1;RPS21;HNRNPH2;DDX54;MANF;DDX10;PCBP1;LARP4B;NAP1L4;FLNB;FARS2;MEX3B;UBA1;PPIB;IFIT1;ZFP36L1;NUDT5;PHF5A;NME1;SLC3A2;GOT2;HNRNPAB;SF1;QKI;PRPF40A;PFN1;HNRNPK;YY1;SMG1;RBBP6;EIF3B;PPIG;METAP2;RPL35A;SEC23IP;FAM50A;MYO5A;SAMSN1;PSMC1;UBE2I;MYEF2;CPSF4;RPS14;NFX1;FXR1;YARS2;RTCA;CHTOP;RPL8;RPL5;SRSF10;SSBP1;ABCF1;CDK11B;POLR1G;SLC4A1AP;RO60;RBM20;MRPS12;RPS12;SFPQ;LONP1;ACTN4;RPS26;HNRNPC;RPL37A;TXN;GEMIN5;ZNF638;MAP4;CS;SMNDC1;PUS10;FAM120C;ADAR;ZFR;ELP1;FYTTD1;RARS2;YTHDC1;IMMT;RPL4;PYM1;TRMT10B;SRSF4;RBM34;SECISBP2L;TRIM25;MRPL20;EMG1;EIF4H;SNU13;XPO5;POP5;SARNP;DHX32;EXOSC9;RPLP0;NOVA2;SF3A1;NGRN;ARF1;PCID2;XRN2;BCLAF1;DXO;FBRSL1;PATL1;PARK7;SUCLG1;AKAP8L;ZMAT3;TARDBP;SYF2;U2AF1;RPS28;CPSF6;ASCC3;TSFM;TAF15;CCAR2;RPS24;DUSP11;FAM133B;TERT;EIF4G2;RRP7A;S100A16;BCCIP;RBM45;GLRX3;RPS9;SRPK2;NCBP3;DDX3X;RPL24;RPS23;EFTUD2;ADARB2;CISD2;RPL34;APTX;NGDN;DRG2;FAM32A;ERH;TDRD3;AGO4;MATR3;NANOS3;HELZ;RPS3;EIF4B;ANKHD1;RPS11;PA2G4;PTBP1;ZBED4;DDX27;HDGF;ACO1;ARCN1;RBM10;PCBP3;ZC3H14;ILF2;NUFIP2;MRPS15;G3BP2;FKBP4;MRPS24;CRKL;API5;HSPE1;SRFBP1;STRAP;HELB;NDUFV3;CHD3;TUT7;EXOSC1;RRP8;RNMT;PPHLN1;UTP11;HEATR6;ANKRD17;CSRP1;RBM26;DDX55;RPL23A;RPS15A;SRP9;PTCD1;RPL21;YBX1;RPL35;SRSF7;PURG;CAPRIN1;BAZ2A;HEATR1;TASOR;CNOT1;DCP1A;SCAF8;FUS;ATP5F1C;SNRPA;RBM4B;UCHL5;SSB;EIF5;PTCD2;TFAM;TUT4;LARP1B;PCDHGA9;MOV10;MRPS35;MRPS28;SF3B6;TCF20;HNRNPL;MYH9;TCERG1;NKAP;TRA2B;SLBP;PPP1R8;NOCT;ADARB1;TOP1;PRKRIP1;ANG;TUBA1B;TCP1;RSL1D1;TDRD7;ZCCHC17;UPF3B;PURB;EIF1AX;NAA15;ENDOV;U2AF2;DKC1;OTUD4;NSUN6;PARN;HARS2;ACAA2;KPNB1;PRKDC;SPATS2;N4BP1;LARP4;WDR33;SERPINH1;CALR;NONO;CKAP4;LSM1;STAU2;NPM1;STAT3;RPL19;URB1;ZC3H13;EIF2S2;SMG6;HNRNPF;SNRPA1;UBAP2;RPL38;YTHDC2;EIF3A;RANGAP1;RCC1L;DHX8;DCAF13;RPSA;RPL36;DDX23;LUC7L2;RPL26;TSNAX;SAFB;RPS8;SMG5;NUP42;HEXIM1;MYO18A;HDAC2;RPL15;RPL10;CCDC47;USP36;RDX;PDIA4;DDX60;ZYX;TRIM56;RPS2;RPL32;SNRPD3;ZNF106;RC3H1;NSRP1;EIF4G1;PRRC2C;NSUN2;MRPS9;CLUH;PRRC2B;TOP3B;YWHAE;MRPL13;DHX36;RPL27A;HNRNPM;TFRC;MTIF2;EIF3E;TRNT1;TFB1M;DHX35;DCP1B;NOP58;LARP1;AGFG1
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.36342518220431685,-1.1630161438439706,0.2438423645320197,0.5845195186578361,1.0,17/31,28.78%,HCN1;SLC12A2;KCNK5;KCNA1;KCNK10;ABCC9;SLC12A6;TMEM38A;KCNQ4;SLC12A4;SLC12A9;KCNA2;SLC12A7;KCNK9;SLC12A8;SLC12A5;KCNK1
prerank,carboxypeptidase activity (GO:0004180),-0.35904754708807457,-1.1605807650453182,0.21447721179624665,0.5859846434972062,1.0,9/35,16.94%,AEBP1;AGBL4;PEPD;AGBL3;SCPEP1;CPM;CTSA;NAALAD2;CTSZ
prerank,PDZ domain binding (GO:0030165),-0.31342279180806476,-1.1601162670594616,0.19653179190751446,0.5829930538473252,1.0,14/61,10.32%,TGFBR3;GRID2;PLEKHA2;SDC2;CXADR;ARHGAP29;DLG4;SRR;CRIM1;CIT;NLGN1;MAP2K2;SLC22A4;FZD2
prerank,actin binding (GO:0003779),-0.2685729603061879,-1.1566553477099495,0.11688311688311688,0.5873467603951007,1.0,56/170,23.32%,SORBS1;CALD1;MAP1B;PAWR;KCNMA1;PDLIM5;GSN;SYNE2;PARVA;MICAL2;PLEKHH2;LIMA1;PACRG;MOBP;MAPT;MACF1;TPM1;MTSS1;PDLIM7;MICAL3;FMN2;VCL;ARPC1A;COBL;TLN2;P4HB;PHACTR3;EZR;SMTN;SYNPO2;PHACTR2;VPS16;PDLIM1;MAP1A;PTK2;IQGAP2;ABL2;BCL7B;TWF2;PDLIM2;ADD2;CAPZB;SSH1;MYO1F;ALDOA;TMOD1;TMSB10;ADCY8;MYO19;DBNL;PFN2;PDLIM4;CAP1;GAS2L3;KLHL1;EMD
prerank,ubiquitin protein ligase binding (GO:0031625),0.28919436384646696,1.1500082155799345,0.1762545899632803,1.0,1.0,59/254,16.38%,PRKAR1A;RAD18;PRR5L;TRIB3;RALB;ARIH1;TRIM28;SLF1;MAP1LC3B;HSPA8;RPL23;SPOP;CCT2;RFFL;TUBB;YOD1;TNFRSF1B;WFS1;RALA;CDKN1A;TPI1;BAG1;RPL5;TRAF5;SMAD7;AXIN1;NDUFS2;MAGEC2;TRAF3;RELA;MDM2;AUP1;FBXO7;MFHAS1;NAE1;ERLIN2;GPI;NLK;SPOPL;PA2G4;ELOB;MID1;NEK6;CUL3;CHEK2;FAF1;NFKBIA;PSMD1;APC;RNF20;FANCL;UBE2G1;GABARAPL1;TUBA1B;TCP1;LAPTM4B;ABI2;DNM1L;SLF2
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.4109235568997587,1.149680740705323,0.28222996515679444,1.0,1.0,3/26,3.55%,CSGALNACT1;CHSY3;EXTL2
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.40498963167719104,1.1485748819817543,0.2651006711409396,1.0,1.0,5/29,5.60%,PRKAR1A;RPTOR;SPRED1;CDKN1A;CIB1
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.5180734906925443,1.1455878441766716,0.3209647495361781,1.0,1.0,3/11,6.74%,PFN1;BAG1;GRPEL2
prerank,adenyl nucleotide binding (GO:0030554),0.5180734906925443,1.1455878441766716,0.3209647495361781,1.0,1.0,3/11,6.74%,PFN1;BAG1;GRPEL2
prerank,microtubule motor activity (GO:0003777),0.35346990103789816,1.1451968567407242,0.26003210272873195,1.0,1.0,12/51,14.94%,DYNC1I1;KIF18A;DNAH3;KIF1B;KIF15;STARD9;KIF2A;KIF13A;KIF3B;KIF6;APPBP2;DYNC1I2
prerank,neuropeptide binding (GO:0042923),-0.42515575691629987,-1.1420831907730533,0.2899543378995434,0.6193058549139654,1.0,4/18,22.49%,SORL1;GPR37;OPRM1;GPR149
prerank,tubulin binding (GO:0015631),0.28284026024215814,1.1335730378700113,0.15936739659367397,1.0,1.0,66/295,16.62%,REEP1;ABRAXAS1;DYNC1I1;EML1;KIF18A;DNM3;TTLL1;GAS2L1;MAP1LC3B;ALMS1;CETN3;TTLL12;EML6;CLASP2;TUBGCP5;MAP1S;SGIP1;KIF1B;CCT5;FYN;DST;KRIT1;DIP2B;FGF13;CRIPT;ARHGEF7;DNAL1;CCDC88C;UXT;CLIP2;AGTPBP1;MAP4;DAG1;RAB11FIP5;TRPV4;TBCEL;REEP3;KIF15;STARD9;PRUNE1;PAK1;KIF2A;DDX3X;KIF13A;RMDN3;RPS3;MAP4K4;PRNP;MID1;AGBL5;RABGAP1;KIF3B;KIF6;TTLL7;APC;SPEF1;EFHC2;INO80;WHAMM;CLIP1;MTUS1;GABARAPL1;HOOK3;DNM1L;TUBGCP2;SETD2
prerank,endopeptidase inhibitor activity (GO:0004866),-0.28696945907829263,-1.1308400854078353,0.20689655172413793,0.644020778913995,1.0,12/82,11.70%,SPOCK3;TIMP3;SPOCK1;TIMP2;TFPI;ANXA2;COL4A3;ROCK1;BIN1;PSMF1;ITIH2;RENBP
prerank,DNA polymerase activity (GO:0034061),0.41406651962022734,1.1298346720960422,0.31046312178387653,1.0,1.0,5/22,10.31%,POLK;POLE;POLD3;POLA1;TERT
prerank,microtubule binding (GO:0008017),0.28914259506092516,1.1289575449519649,0.20486555697823303,1.0,1.0,41/222,14.13%,REEP1;ABRAXAS1;DYNC1I1;EML1;KIF18A;DNM3;GAS2L1;MAP1LC3B;ALMS1;CETN3;HAUS4;EML6;CLASP2;TUBGCP5;MAP1S;SGIP1;KIF1B;DST;KRIT1;FGF13;CRIPT;CCDC88C;UXT;CLIP2;CAMSAP2;MAP4;TRPV4;REEP3;KIF15;STARD9;KIF2A;KIF13A;RMDN3;RPS3;MAP4K4;PRNP;MID1;KIF3B;KIF6;APC;SPEF1
prerank,3'-5' exonuclease activity (GO:0008408),0.3576436752115588,1.1267576312345557,0.2959349593495935,1.0,1.0,14/45,16.45%,REXO2;RAD1;APLF;USB1;CNOT7;EXOSC9;XRN2;EXD2;CNOT6;PAN2;CNOT6L;NOCT;ERI2;PARN
prerank,tau protein binding (GO:0048156),0.36985528765772735,1.126721164891891,0.30016583747927034,1.0,1.0,8/40,6.87%,GSK3A;PIN1;ACTB;PPP2CA;APOE;FYN;EP300;PPP2CB
prerank,amyloid-beta binding (GO:0001540),-0.29181902982897007,-1.1245621324181028,0.2119205298013245,0.6556215609031413,1.0,19/79,13.38%,LRP1;GRIA4;GRIA2;GRIN2B;COL25A1;FZD6;PGRMC1;SORL1;CACNA1B;TM2D1;HSPG2;LDLR;NLGN1;BACE1;EPHB2;APBA1;VBP1;GSAP;PFDN2
prerank,GTPase regulator activity (GO:0030695),-0.24673952884331946,-1.1214693089340044,0.14210526315789473,0.6591368086721566,1.0,57/212,16.22%,RIMS1;RANBP3L;ARHGAP42;ALDH1A1;ADGRB3;CPEB2;IQGAP1;DOCK1;TBCK;ERRFI1;ARHGAP10;HACD3;ARHGEF10L;NRP1;DEPDC5;SGSM2;ARHGAP29;WASL;RGS7;GARNL3;ARHGAP32;ARHGAP28;RAB3GAP2;ARFGAP1;BCR;ARHGAP20;ELMOD1;TBC1D22B;NPRL3;TBC1D8B;RGS12;STARD13;ELMOD2;SMAP2;STXBP5;GPSM1;SEC23A;RANBP3;RP2;GMIP;ARHGAP22;GDI1;SIPA1;MTSS2;SIRPA;TBC1D10A;TBC1D13;RALBP1;GNB5;ELMOD3;TBC1D9B;RALGDS;IQGAP2;ARHGAP26;RAPGEF2;RGS20;JUN
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),-0.35516506794443425,-1.1212334262150128,0.2914572864321608,0.6552112878746046,1.0,14/33,26.93%,ELP4;WAC;RPRD1B;ERCC5;CDC73;ELP2;WDR43;PAF1;SMYD2;RTRAF;GTF2B;SUPT4H1;ZNF326;LLPH
prerank,metalloexopeptidase activity (GO:0008235),-0.30806313786286343,-1.1193380030114024,0.26525198938992045,0.6556352448312247,1.0,10/51,8.36%,CPQ;AEBP1;MMP16;AGBL4;PEPD;MMP14;RNPEP;TRHDE;ANPEP;AGBL3
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.4827247914260627,-1.1186547454220817,0.3199152542372881,0.6531127501212828,1.0,4/10,16.61%,DSE;GLCE;RENBP;DSEL
prerank,ATP binding (GO:0005524),0.28209076790116455,1.1176532307779414,0.22021660649819494,1.0,1.0,56/266,15.73%,THG1L;SNRK;PPIP5K2;HSPA8;OXSR1;HSPA4L;PNKP;NEK11;RPS6KA4;PYGL;RPS6KA5;NME1;MLKL;PEX1;TDG;YARS2;MTHFS;PRPS1L1;PRPS1;ABCF1;SIK3;CDK11B;LONP1;PIM1;HARS1;UBA2;PEAK1;SYN3;MINK1;ACVRL1;LATS2;NIM1K;SRPK2;PAPOLA;NLK;P2RX7;OLA1;PNPLA8;MAP4K4;LANCL2;PRKCI;MYO9B;NEK6;ABCF2;GSS;NDUFA13;TLK2;PPP5C;PTPA;ABCF3;TWF1;RRM1;MYH9;DYRK2;TOP1;CDKL5
prerank,DNA binding (GO:0003677),0.26614360307530105,1.1169841621761263,0.14118895966029724,1.0,1.0,132/694,16.22%,TBX4;LRRFIP1;IRX1;ERCC3;IMPDH1;CTCFL;RAD18;ILF3;CHCHD2;MECOM;SIM1;ARID5A;TFCP2;NR4A2;BANF1;ATF6;CTC1;TRIM28;LEF1;PNKP;KLF2;PCBP1;GTF3C1;PAX8;ZBTB33;ZMYM4;MAP1S;NR5A1;RLF;SIRT3;MMP12;MEIS1;ERCC4;RAD1;SOX2;SMARCA2;YY1;FLI1;USF2;EP300;RFX3;TDG;CARF;TBX1;GTF3C5;CALCOCO1;SSBP1;CEBPG;FOXF2;PPARD;PMS2;POLE;SFPQ;CDC45;LONP1;DRAP1;CLOCK;ZNF638;ZNF3;DCLRE1B;HEY2;ZBTB14;MLH1;PMS1;RELA;SOX13;SPRTN;RAD23A;PCID2;POLA1;BCLAF1;CENPC;HOXA7;RAD51B;PARK7;MSH3;TFAP4;ERG;TARDBP;ZKSCAN3;AIFM1;RYBP;TERT;ING2;HIC2;RBPJ;THRB;DDX3X;CREBBP;HP1BP3;APTX;APP;RPS3;TOP3A;POLR3F;HDGF;TIGD2;E2F3;ILF2;MPG;TAF4B;SP1;RNF11;NUP35;NBN;IRF2;CHD3;DDIT3;EPAS1;YBX1;HES1;GRHL1;BRIP1;INO80;TSHZ1;EZH1;TFAM;BCL6;FOXJ3;ELK4;TAF6L;TOP1;TAF1;ANG;SMARCA4;TCF7L1;TCF3;GTF3C2;PURB;TSHZ2;ZBTB18;ENDOV
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.46598689719269965,1.1169576829767809,0.32737030411449014,1.0,1.0,7/14,17.35%,YOD1;DESI2;USP15;OTUD5;USP9X;MINDY2;ATXN3
prerank,alkali metal ion binding (GO:0031420),-0.44036963120077127,-1.1167406531929516,0.33043478260869563,0.6536144123882818,1.0,3/13,7.54%,ATP1A2;HDAC4;ATP1A1
prerank,I-SMAD binding (GO:0070411),-0.44638312840552236,-1.1147965368651327,0.3218390804597701,0.6541783385505306,1.0,6/13,14.47%,SMAD3;TGFBR1;CTNNB1;SMAD4;SMAD6;SMAD5
prerank,calcium channel inhibitor activity (GO:0019855),0.4800563729354723,1.1086199518853468,0.3532710280373832,1.0,1.0,1/11,0.32%,PHPT1
prerank,endonuclease activity (GO:0004519),0.34824106575177344,1.1066130077355587,0.29890453834115804,1.0,1.0,5/49,5.53%,ZRANB3;ZC3H12D;PNKP;ERCC4;APLF
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.4377875918958587,-1.1051403015527892,0.3456221198156682,0.6758037981589952,1.0,5/14,26.04%,SLC26A7;SLC26A2;SLC26A11;SLC25A30;SLC25A11
prerank,SUMO transferase activity (GO:0019789),0.44842108107702294,1.1047840110122495,0.34628378378378377,1.0,1.0,5/16,11.30%,TRIM28;UBE2I;MDM2;PIAS2;PIAS1
prerank,glutamate receptor activity (GO:0008066),-0.3939324722333248,-1.1038952999388627,0.28868360277136257,0.6746209221526988,1.0,5/19,6.89%,GRIA4;GRIA2;GRID2;GRM5;GRID1
prerank,beta-tubulin binding (GO:0048487),-0.3482044500984979,-1.1031812851018834,0.30170316301703165,0.6721846677762622,1.0,11/31,14.10%,EML4;GJB6;SMC3;PACRG;LRPPRC;PEX14;HTT;IFT74;ARL8A;PDCD5;TAOK1
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.3612578056596872,-1.1028950886162399,0.2913907284768212,0.6685789652072681,1.0,11/25,21.51%,PARP4;ZC3HAV1;PARP14;SIRT2;PARP6;PARP3;ART3;PARP1;SIRT5;PARP16;PARP2
prerank,protein serine/threonine kinase activity (GO:0004674),0.272647357387438,1.102833342845844,0.23205741626794257,1.0,1.0,75/334,16.72%,STK32A;MAP3K11;MAPK3;SNRK;GSK3A;OXSR1;MAP3K7;CDK19;PLK2;NEK11;RPS6KA1;RPS6KA4;CAMK1D;PRKCH;HIPK2;PRKD2;RPS6KA5;STK35;MAP3K9;PKN3;SMG1;SLK;MAP3K4;MAPK8;PAK3;SIK3;CSNK1G3;CDK11B;SYK;TRIO;SBK1;PIM1;PIKFYVE;MOK;MINK1;CDK4;ACVRL1;LATS2;CDKL4;NRBP1;PKN1;PAK1;NIM1K;ACVR2A;PRKAA2;SRPK2;NLK;NEK7;MAP4K4;MAST4;PRKCI;MAPK6;IKBKB;NEK6;MAPK12;CHUK;CHEK2;TLK2;BRD2;CSNK2A2;MAP3K10;BMP2K;DYRK2;ATR;TOP1;CAMK2G;CDKL5;TAF1;BRAF;CDK14;PTK2B;PIK3R4;RPS6KC1;PRKDC;WNK2
prerank,adenyl ribonucleotide binding (GO:0032559),0.27688034560808267,1.1024099818431061,0.23361144219308702,1.0,1.0,60/291,15.73%,THG1L;GCLC;SNRK;PPIP5K2;PDE4D;HSPA8;OXSR1;HSPA4L;PNKP;NEK11;RPS6KA4;PYGL;HMGCR;RPS6KA5;NME1;MLKL;PEX1;TDG;YARS2;MTHFS;PRPS1L1;PRPS1;ABCF1;SIK3;CDK11B;LONP1;PIM1;HARS1;UBA2;PEAK1;SYN3;MINK1;ACVRL1;LATS2;NIM1K;SRPK2;PAPOLA;NLK;P2RX7;OLA1;PNPLA8;MAP4K4;LANCL2;PRKCI;MYO9B;NEK6;ABCF2;GSS;NDUFA13;TLK2;PPP5C;MIEF1;PTPA;ABCF3;TWF1;RRM1;MYH9;DYRK2;TOP1;CDKL5
prerank,poly-pyrimidine tract binding (GO:0008187),-0.3740986202513006,-1.1009052650943931,0.2979683972911964,0.6689251349088998,1.0,8/23,22.72%,RBMS1;HNRNPH1;KHDRBS1;DAZAP1;ATXN1;PABPC4;RBMS3;PABPC1
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.2797675757219019,1.0993589814735756,0.24457831325301205,1.0,1.0,37/254,13.25%,SOX30;ATF3;CTCFL;MECOM;ONECUT1;TFCP2;NR4A2;ATF6;LEF1;ELK3;GABPA;SMAD1;PRDM15;RLF;PRDM4;MEIS1;MYBL2;YY1;VEZF1;CEBPG;FOXF2;CLOCK;RELA;MDM2;HOXA7;TFAP4;ERG;KLF6;RBPJ;ESR1;NFIC;E2F3;MZF1;SP1;SMARCD1;IRF2;DDIT3
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.3263317047248727,1.0992023175226588,0.3205317577548006,1.0,1.0,15/75,15.95%,IMPDH1;ABCC4;SPR;ME3;HMGCR;KDSR;KCNAB1;HSD17B11;NSDHL;RDH11;HSD17B4;RDH10;BDH2;AKR1A1;HPGD
prerank,flavin adenine dinucleotide binding (GO:0050660),-0.3046097396303712,-1.0989011416306114,0.27977839335180055,0.6698928252236194,1.0,15/53,16.03%,DPYD;MICAL2;AOX1;DDO;MICAL3;CRY2;XDH;DLD;MTHFR;CRY1;NOX4;KDM1A;SQOR;PRODH;QSOX1
prerank,retinoic acid receptor binding (GO:0042974),0.42393182337740803,1.0986079192467217,0.3427495291902072,1.0,1.0,4/17,10.21%,ARID5A;NR4A2;ACTN4;TACC1
prerank,GTPase inhibitor activity (GO:0005095),-0.439121738569645,-1.0980749317349052,0.35196687370600416,0.6680164787823333,1.0,7/13,29.78%,CPEB2;IQGAP1;IQGAP2;CDC42SE1;ARL2;RHOH;RTKN
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.3752191949608045,1.097358896035655,0.320695102685624,1.0,1.0,12/33,16.84%,ARIH1;DCUN1D4;UBA2;AUP1;UBE3D;PARK7;RPS3;RNF180;TCERG1;RNF125;DCUN1D1;DCUN1D2
prerank,chemokine binding (GO:0019956),-0.34758392360083873,-1.0969227846178495,0.327710843373494,0.6666436373272441,1.0,24/30,63.13%,PDPN;CCR9;ACKR3;ITGA4;CX3CR1;ITGB3;HMGB1;ZFP36;ITGAV;CCR5;ACKR1;CCR2;CXCR4;PLP2;CCRL2;CXCR6;CCR1;CCR10;ACKR4;CXCR5;CCR6;FGF2;CXCR2;ITGB1
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.3845294304957173,-1.0944870869475993,0.3261390887290168,0.6688864119548793,1.0,3/21,3.98%,PDE1A;PDE5A;PDE1C
prerank,metallocarboxypeptidase activity (GO:0004181),-0.3594087297068623,-1.0942471632739448,0.314214463840399,0.6653063126517355,1.0,5/26,11.69%,AEBP1;AGBL4;PEPD;AGBL3;CPM
prerank,GTPase binding (GO:0051020),0.28679259696632453,1.0940128105086366,0.2771392081736909,1.0,1.0,58/194,16.99%,LCP1;SOD1;CHML;CHM;EVI5L;EXOC8;TBC1D30;MYO5A;CYRIB;CIB1;GNB1;IARS1;USP6NL;LAMTOR1;TRIP11;AP1G1;RABGAP1L;RAPGEF6;FGD5;XPO5;RASIP1;MYCBP2;RANBP1;PKN1;PAK1;GCC2;DOCK7;ATP6AP1;DMXL2;PICALM;MYO9B;PDE6D;ERC1;RRAGC;RABGAP1;KIF3B;USP33;AP3M1;YBX1;ANKRD27;RCC1;ATG16L1;BICD2;RUSC2;PPP6R1;WHAMM;ATG14;TMEM127;RAB3GAP1;CDKL5;BRAF;ABI2;DOCK4;EXOC2;DNM1L;BNIP3;CYFIP1;BECN1
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.27219431844818726,1.0910607574807292,0.2678787878787879,1.0,1.0,59/269,16.38%,PRKAR1A;RAD18;PRR5L;TRIB3;RALB;ARIH1;TRIM28;SLF1;MAP1LC3B;HSPA8;RPL23;SPOP;CCT2;RFFL;TUBB;YOD1;TNFRSF1B;WFS1;RALA;CDKN1A;TPI1;BAG1;RPL5;TRAF5;SMAD7;AXIN1;NDUFS2;MAGEC2;TRAF3;RELA;MDM2;AUP1;FBXO7;MFHAS1;NAE1;ERLIN2;GPI;NLK;SPOPL;PA2G4;ELOB;MID1;NEK6;CUL3;CHEK2;FAF1;NFKBIA;PSMD1;APC;RNF20;FANCL;UBE2G1;GABARAPL1;TUBA1B;TCP1;LAPTM4B;ABI2;DNM1L;SLF2
prerank,ribosomal large subunit binding (GO:0043023),-0.45540895213241805,-1.0908464255238932,0.37336244541484714,0.6698205045776234,1.0,4/11,13.90%,CPEB2;LTN1;RBM3;MRRF
prerank,endodeoxyribonuclease activity (GO:0004520),0.4137617928185476,1.0906598713047249,0.33213644524236985,1.0,1.0,6/20,17.17%,ZRANB3;ERCC4;APLF;RPS3;ENDOV;DCLRE1C
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.464490927745156,-1.090039629237449,0.3653061224489796,0.6678177450382032,1.0,6/10,22.96%,CFLAR;CASP12;CASP7;CASP2;CASP3;CASP9
prerank,protein phosphorylated amino acid binding (GO:0045309),0.35822057523329814,1.0895974972058655,0.3225806451612903,1.0,1.0,14/42,19.55%,PIN1;BCAR3;PFN1;SAMSN1;YWHAB;SYK;YES1;CRKL;LDLRAP1;SHC1;PTPN11;IRS1;YWHAE;FBXW7
prerank,voltage-gated sodium channel activity (GO:0005248),-0.36697043698425436,-1.088222464261321,0.30892448512585813,0.6683631572496629,1.0,5/22,12.92%,HCN1;SCN8A;SCN3A;SCN1A;CACNA1G
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.3532330318503022,1.0881839741803865,0.35071090047393366,1.0,1.0,10/44,12.79%,MECOM;EZH2;EED;TTLL12;SMYD3;SETD5;SETD3;SETD1B;KMT5B;DOT1L
prerank,3'-5' DNA helicase activity (GO:0043138),0.43997363915702065,1.0874147612602247,0.37163375224416517,1.0,1.0,6/16,21.43%,ERCC3;ASCC3;FBH1;MCM2;NAV2;DHX9
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.44237471039736187,-1.0865682495172908,0.358974358974359,0.6683624309298133,1.0,9/12,51.86%,B3GALT5;B3GALNT1;B3GALT1;B3GALT2;B3GNT9;B3GNT3;B3GNT8;B3GNT6;B4GAT1
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),-0.32283246678435656,-1.083703525947136,0.3094059405940594,0.6717743871434009,1.0,3/38,2.65%,SPOCK1;TFPI;ANXA2
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.43322770553081813,-1.0797524654825224,0.3673913043478261,0.6781292669957552,1.0,4/12,20.68%,IGF1;SOCS2;IGF2;PIK3R1
prerank,nucleoside monophosphate kinase activity (GO:0050145),-0.3740556949261297,-1.07932322801383,0.36,0.6752970856614073,1.0,1/20,0.02%,DLG2
prerank,fibroblast growth factor binding (GO:0017134),-0.36856225641334794,-1.0792947033876277,0.34382566585956414,0.6714107010411016,1.0,4/21,10.70%,FGFR2;CEP57;THBS1;KL
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.44450590555481284,-1.0780631248833519,0.3785557986870897,0.6705691766111511,1.0,8/11,35.95%,UBR5;UBE4A;UBE2K;STUB1;UBOX5;UBE4B;PRPF19;RBX1
prerank,nuclease activity (GO:0004518),0.3357647393218784,1.0769409932285052,0.34728682170542635,1.0,1.0,7/52,9.37%,AEN;PNKP;NME1;MAP1S;RNASE6;XRN2;RNASE12
prerank,carboxy-lyase activity (GO:0016831),0.3993547719241263,1.076304559116097,0.3481349911190053,1.0,1.0,7/23,16.15%,MLYCD;DDC;AMD1;ODC1;UXS1;ECHDC1;CSAD
prerank,vitamin D receptor binding (GO:0042809),-0.4247633501282403,-1.0743580746616916,0.40130151843817785,0.6762145286609714,1.0,11/14,32.57%,MED13;MED1;MED17;SNW1;RXRA;THRAP3;MED24;TAF11;MED16;MED30;TAF7
prerank,actinin binding (GO:0042805),-0.37559502341375234,-1.0728483424016668,0.37115839243498816,0.6758657084413775,1.0,7/21,12.02%,CACNA1C;PDLIM5;CACNA1D;SYNPO2;NFKB1;RARA;CSRP2
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.3837022744938481,-1.071743489288776,0.36607142857142855,0.6744783987035707,1.0,12/19,24.41%,GRID2;GABRA2;GRID1;GABRG2;GRIK4;GABRA5;GABRG3;GABRA4;GRIK1;GRIK3;GABRG1;GABRA1
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.44464485777844154,1.0705907754139183,0.3974121996303142,1.0,1.0,5/14,14.40%,MAL;BCL2L13;BAD;NOD1;APAF1
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.3599248131731503,-1.070156320325051,0.38405797101449274,0.6745953867076722,1.0,14/23,39.90%,WIPI1;CLVS2;HIP1R;COMMD1;SNX3;SH3PXD2B;HIP1;JPH2;GBF1;MAPKAP1;PLA2G4E;PHLDA3;ATP13A2;WDR45
prerank,amino acid binding (GO:0016597),-0.3305776989054671,-1.068838027346528,0.3594936708860759,0.6740173595248973,1.0,7/31,10.84%,GRIN2B;GLRB;SRR;GLRA3;CASTOR2;GLRA1;DDAH1
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.34253611085031993,-1.0682417309550283,0.32867132867132864,0.671751118913065,1.0,13/28,26.53%,GRID2;GABRA2;GRID1;GABRG2;GRIK4;GABRA5;GABRG3;GABRA4;GRIK1;GRIK3;GABRG1;GABRA1;CHRNA7
prerank,calcium-activated potassium channel activity (GO:0015269),0.4714962939478697,1.0680276626944942,0.3879781420765027,1.0,1.0,4/11,9.53%,KCNN2;KCNU1;KCNMB2;KCNMB3
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.43978340975561264,-1.066727369064242,0.37782340862423,0.6716529190935119,1.0,6/11,22.96%,CFLAR;CASP12;CASP7;CASP2;CASP3;CASP9
prerank,G protein-coupled receptor activity (GO:0004930),0.2707886799540908,1.0666303322362376,0.30062111801242236,1.0,1.0,13/239,6.38%,MTNR1A;GPR176;GPR52;GPR63;ADGRE1;NPFFR1;ADGRL4;ADGRL3;PAX8;TSHR;HCRTR1;XPR1;RXFP1
prerank,amino acid transmembrane transporter activity (GO:0015171),-0.3049942953989816,-1.0657123964725457,0.3315508021390374,0.670536089736022,1.0,8/47,5.65%,SLC7A11;SLC6A13;SLC7A2;SLC47A1;PDPN;SLC6A1;SLC7A14;SLC1A5
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.39104838789891044,1.0646645854133259,0.35335689045936397,1.0,1.0,5/22,9.15%,ZRANB3;TNFAIP3;TAB2;TAB3;SPRTN
prerank,hydro-lyase activity (GO:0016836),0.34932835346670954,1.0639038082701877,0.355877616747182,1.0,1.0,11/41,16.03%,ENO4;CA2;CA4;CDYL;PARK7;HACD2;HSD17B4;ACO1;ECHDC1;ECHS1;NAXD
prerank,hormone receptor binding (GO:0051427),-0.41941016346244275,-1.0614954809039332,0.3882863340563991,0.6770466977227034,1.0,3/14,10.49%,NCOA6;JAK1;SOCS2
prerank,transforming growth factor beta binding (GO:0050431),-0.3587208111138579,-1.0611143580360929,0.35180722891566263,0.6742038084751654,1.0,11/23,24.83%,TGFBR3;TGFBR1;TGFBR2;THBS1;ACVR1;LTBP1;CD109;TWSG1;NRROS;TGFB3;VASN
prerank,MAP kinase phosphatase activity (GO:0033549),0.45570263603991296,1.0572057856225583,0.39,1.0,1.0,1/12,1.30%,DUSP7
prerank,syntaxin binding (GO:0019905),-0.28726574026132173,-1.0562479510747445,0.32344213649851633,0.6821807526990902,1.0,22/61,18.87%,SNAP25;STX16;STX8;SYT9;GOLGA2;STXBP5;TMED9;STXBP4;UNC13C;SYT12;RAB11A;UNC13B;ABCA1;SNPH;VAMP2;STXBP1;VPS54;PTPN2;VAMP1;SYT2;DAPK1;SNAP29
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",-0.41358363439986756,-1.0560187507800793,0.39651416122004357,0.6791122097848035,1.0,5/13,23.80%,FAN1;DNASE1L1;DICER1;ZGRF1;SLX4
prerank,kinase binding (GO:0019900),-0.21715744597175396,-1.0550571745145672,0.28,0.6776882040989464,1.0,116/434,19.50%,DLG2;ANK2;PRKAG2;BICD1;MAPK4;NBEAL1;SASH1;EGFR;GSN;SMAD3;IQGAP1;WWC2;PDGFRB;PKD1;DNAJC3;SNAP91;ERRFI1;TNS2;CYLD;UFL1;TOM1L2;DLG4;MAPT;IFNAR2;CTNNB1;WNK1;RHOA;AP2A2;MAML1;FLNA;PRKAG1;UNC5C;GHR;VDAC1;SLC12A2;CIT;PIP5K1A;PRKCD;CAB39;SKI;IRAK1;IL31RA;HTT;SRCIN1;TAX1BP1;CDKN1B;AP2A1;GOLGA2;IRAK3;SYN1;CEP152;SIK1;CNOT9;DLG3;RND3;PRKACA;RHOBTB2;CCND3;STRADA;GSK3B;CAMK2N1;EEF2;VRK2;DCX;TP53;ILK;PER1;PRKAB2;HSF1;RHOB;RPS7;RHOBTB1;TPRKB;RPS6;GRB2;PIK3IP1;TOLLIP;MSH2;GYS1;DLG1;CSPG4;SHC3;POLR2A;RELB;DNM1;CAV2;MAP3K12;PTK2;PTPN22;CCNK;DCTN1;TOM1L1;CEP250;TRAF2;STX1A;PTPN23;PTPN2;NR3C1;GPRC5B;IRAK4;MAP3K1;MAVS;SV2A;SLC12A4;DVL1;CDC42;TCF7L2;ADD2;JTB;PARP1;TRIM5;MSN;HNRNPA0;ATF5;STUB1;IRGM
prerank,protein kinase C activity (GO:0004697),0.44019943276535306,1.0549979404507166,0.4187380497131931,1.0,1.0,4/14,12.19%,PRKCH;SMG1;PKN1;PRKCI
prerank,peptide hormone receptor binding (GO:0051428),0.4556437506087719,1.0539502941649235,0.41935483870967744,1.0,1.0,1/11,3.34%,GNRH1
prerank,Toll-like receptor binding (GO:0035325),0.4718931125615299,1.0527958461752336,0.38104448742746616,1.0,1.0,1/11,2.97%,TIRAP
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.2765009808083166,1.0525604345872515,0.36,1.0,1.0,22/173,10.59%,SOX30;LRRFIP1;ATF3;IRX1;DACH1;KLF8;GTF2IRD1;ELK3;ZBTB33;BCL6B;HEY1;YY1;NFX1;PPARD;ZNF3;HEY2;ZBTB14;RELA;SOX13;TRPS1;ZKSCAN3;HIC2
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.45403594047796464,1.050906484010536,0.39147286821705424,1.0,1.0,2/11,3.80%,NUDT11;NUDT5
prerank,ubiquitin binding (GO:0043130),-0.2717458100679894,-1.0499426499372297,0.35135135135135137,0.6864460834118908,1.0,30/73,20.61%,SMAD3;UBXN7;UBE2N;SIRT2;UBXN2A;USP13;ILRUN;UBXN2B;USPL1;RNF168;NPLOC4;NSFL1C;BUB3;TOLLIP;IKBKG;DDI2;RNFT1;TSG101;RNF19B;TOM1L1;UCHL3;USP16;GGA3;RNF31;USP5;OTULINL;RAE1;DNAJB2;NEDD4;HSPB1
prerank,cardiolipin binding (GO:1901612),0.46457635557747107,1.049497092213144,0.4142857142857143,1.0,1.0,2/10,5.26%,MME;UQCC3
prerank,ribosomal small subunit binding (GO:0043024),0.41298934012677,1.0491431254166772,0.3960573476702509,1.0,1.0,9/17,20.06%,NME1;PIM1;EIF4H;DDX3X;EIF4B;NPM1;MTIF2;LARP1;EIF1
prerank,ubiquitin-protein transferase activity (GO:0004842),0.2584356300858392,1.0469736926728572,0.347926267281106,1.0,1.0,74/346,16.62%,FBXL6;RNF7;CBL;ARIH1;TRIM28;RNF149;TNFAIP3;RNF38;RFFL;BIRC2;RSPRY1;NEURL2;NEDD4L;VPS11;ANKRD39;NHLRC1;RBBP6;FBXL5;UBE3A;TRIM14;FBXW2;IRF2BPL;RNF130;NFX1;COP1;TRAF5;RNF187;LMO7;PPP1R11;TTC3;TRIM25;AKTIP;TRAF3;FBXO11;RBCK1;MDM2;PJA2;MYCBP2;RFWD3;UBE3D;FBXO7;RNF6;ZNRF1;UBE2M;RNF13;RNF25;CHFR;ANAPC11;DTX4;ANAPC4;RNF11;CUL3;UBE2R2;RNF146;RNF216;TSPAN17;TRIM27;RNF180;RNF20;FANCL;TRIM3;NHLRC3;FBXO22;UBE2G1;RMND5A;RNF114;TAF1;PELI1;KLHL13;KLHL42;RNF128;RNF125;UBE2H;VPS18
prerank,double-stranded RNA binding (GO:0003725),0.3160726681311434,1.045785493779852,0.38924050632911394,1.0,1.0,26/70,21.43%,LRRFIP1;ILF3;SLC3A2;FXR1;ADAR;ZFR;EIF4H;DDX3X;ADARB2;APTX;AGO4;EIF4B;ILF2;ADARB1;PRKRIP1;TUBA1B;STAU2;DDX60;RC3H1;DHX36;TFRC;AGO1;DHX30;HSP90AB1;DGCR8;DHX9
prerank,histone methyltransferase activity (GO:0042054),0.36337954743124357,1.044075465090375,0.3996627318718381,1.0,1.0,8/32,14.46%,EZH2;EED;TTLL12;SMYD3;CARM1;KMT5B;DOT1L;NTMT1
prerank,protein kinase activator activity (GO:0030295),-0.28048292100105865,-1.0440299164688436,0.3674698795180723,0.6976152734946703,1.0,15/60,14.66%,PRKAG2;GRM5;IQGAP1;ABI1;WNK1;ERCC6;CAB39;MAP2K2;STRADA;STK11;FAM20A;IGF2;TAOK1;MADD;RPLP1
prerank,growth factor receptor binding (GO:0070851),-0.26104688388546954,-1.043917631478036,0.35737704918032787,0.6940759893912755,1.0,18/95,15.59%,ERBB4;PDGFRB;SNX2;FGF1;SNX4;FER;IL6R;PIBF1;EFEMP1;ITGA5;PDGFRA;CNOT9;PLSCR1;KL;GRB2;IL6ST;PDGFD;ARF4
prerank,microtubule minus-end binding (GO:0051011),0.4406749322793882,1.042914056838518,0.412573673870334,1.0,1.0,3/13,7.22%,HAUS4;TUBGCP5;CAMSAP2
prerank,nuclear receptor coactivator activity (GO:0030374),0.32265168820856155,1.0410808131872262,0.3972179289026275,1.0,1.0,16/52,14.37%,CCDC62;DCAF6;CALCOCO1;MED12;ACTN4;ATXN7L3;PKN1;BUD31;TACC1;CCAR2;CARM1;USP22;MED4;SS18;CNOT6;NCOA7
prerank,snRNA binding (GO:0017069),0.33891958668282507,1.040427494059403,0.39834710743801655,1.0,1.0,14/42,18.82%,EIF5A;RBM22;PRPF31;GEMIN5;SF3B3;COIL;SNU13;EFTUD2;SNRPA;RBM41;SNRPA1;HEXIM1;SNRPB2;SNRPD3
prerank,myosin binding (GO:0017022),-0.2849950837276037,-1.0398439530330867,0.36962750716332377,0.7008560810108656,1.0,10/55,9.58%,CALD1;KIRREL1;GSN;RAB3C;MOBP;RHOA;SPATA6;TRAK1;RAB27B;STXBP5
prerank,UDP-glycosyltransferase activity (GO:0008194),-0.2745352041443039,-1.039249624453735,0.40588235294117647,0.6985671363812068,1.0,14/70,17.44%,MGAT4C;GXYLT2;OGT;B4GALT1;CHSY1;HEXA;CSGALNACT2;HEXB;XXYLT1;LARGE1;B3GALT5;B3GALNT1;B3GALT1;POGLUT3
prerank,ion gated channel activity (GO:0022839),-0.34353122409895803,-1.0392255654294746,0.39712918660287083,0.6949627703396547,1.0,10/24,29.03%,ANO3;ANO1;TMEM63A;ANO6;TMEM63B;ANO10;KCNT1;TTYH3;TTYH1;TMEM63C
prerank,mRNA 5'-UTR binding (GO:0048027),0.37662200880829566,1.0392038230330456,0.4143356643356643,1.0,1.0,8/24,19.41%,CCT5;RPS14;RPL5;DDX3X;RSL1D1;RPL26;DHX36;LARP1
prerank,Hsp90 protein binding (GO:0051879),-0.32099215476216675,-1.0385378530369647,0.3853658536585366,0.6931731347203445,1.0,13/33,28.23%,PACRG;MAPT;SLC12A2;PPID;HSF1;USP19;NPAS2;NR3C1;TSC2;STUB1;TELO2;PPEF2;HDAC6
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.342745183092719,-1.037325081331416,0.4107981220657277,0.6927944375338413,1.0,8/24,21.16%,PLA2G4A;PLEKHA8;OSBP;OSBPL5;SNX3;ARFIP2;GSDMD;OSBPL8
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.3818787586198923,1.034820415863888,0.4114583333333333,1.0,1.0,4/21,9.24%,POLK;POLE;POLD3;POLA1
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.434616752273984,1.0330697791127268,0.44061302681992337,1.0,1.0,4/13,13.98%,THUMPD2;TRMT11;TRMT10B;WDR4
prerank,sulfuric ester hydrolase activity (GO:0008484),-0.42596196503408834,-1.0301821484266902,0.4458077709611452,0.7067629266671352,1.0,7/12,19.33%,SULF1;SULF2;ARSB;ARSG;ARSK;ARSI;GNS
prerank,protein homodimerization activity (GO:0042803),0.2463459586378708,1.028301095534654,0.40216216216216216,1.0,1.0,110/589,16.21%,CIDEA;MIGA1;LRRFIP1;ATF3;CADM1;MAP3K11;SYNE1;BANF1;TMEM266;ABCB10;GLB1;GYG1;PECAM1;ABCG2;BCL2L2;GREM1;ZHX3;TRIM8;NUDT5;GBP3;EXT2;APOE;MAP3K9;MME;SLK;PHB2;TOX3;TRIM14;B2M;USF2;TPI1;SMIM1;TDG;FXR1;TBX1;KCNN2;YARS2;GBP4;PRPS1L1;PRPS1;SSBP1;PEX7;PTPRT;CHMP1A;SFPQ;ACTN4;SPPL3;F11R;HARS1;TXN;DCLRE1B;AXIN1;GALM;SNX1;RELA;CARNMT1;RASIP1;RAB11FIP2;CSF1R;RABEP1;NRBP1;FZD9;EXD2;CACYBP;PARK7;MSH3;TFAP4;TERT;S100A16;NQO2;GTF2A2;CISD2;NOD1;ATG7;HSD17B4;BNIP3L;CRPPA;MYO9B;MID1;MZF1;SP1;IKBKB;STARD3NL;TENM4;CHUK;PAPSS1;TPM2;GSS;DSCAML1;DDIT3;PLEK;CHEK2;HES1;TRIM27;PTPA;GRHL1;GCH1;MAP3K10;IMPA1;S100A13;ODC1;UXS1;MYH9;CAMK2G;TPD52L1;ANG;TCF3;STARD3;KLHL7;DNM1L
prerank,sequence-specific DNA binding (GO:0043565),0.24588983340837675,1.0281374349397006,0.3871319520174482,1.0,1.0,65/590,10.73%,SOX30;ATF3;IRX1;CTCFL;FOXQ1;CHCHD2;ARID5A;ONECUT1;FOXN2;TFCP2;NR4A2;ATF6;CTC1;LEF1;HES6;KLF2;ELK3;PAX8;BCL11B;GABPA;ZBTB33;BACH2;BCL6B;HEY1;NR5A1;SIRT3;MMP12;IRF9;PRDM4;BBX;SOX2;MYBL2;YY1;FLI1;SMG1;GMEB2;KDM2A;ZNF740;USF2;CPSF4;RFX3;TBX1;CHTOP;CALCOCO1;CEBPG;FOXF2;PPARD;LONP1;CLOCK;TET3;HEY2;ZBTB14;ACD;SOX13;UPF2;JUND;HOXA7;TFAP4;ERG;KLF6;ZKSCAN3;TERT;RBPJ;ESR1;THRB
prerank,protein phosphatase binding (GO:0019903),-0.2474382916183019,-1.0264769583355022,0.40069686411149824,0.7124518203175739,1.0,39/117,22.22%,EGFR;IQGAP1;AP3B1;JAK1;MAPK14;DLG4;MAPT;CTNNB1;PXN;VCP;MYO16;ENSA;STAT6;CDKN1B;ARPP19;MAP3K5;TP53;IKBKE;KIF3A;VRK3;SIRPA;RACK1;PTK2;MTMR9;PPME1;MTMR4;TRAF2;FBXL2;SNX3;SHOC2;MET;PPP1R16A;PPP6R3;PIK3R1;ITGA1;PPP1R3B;SH3RF2;ADCY8;PDLIM4
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.3865425049315213,1.0259142154999557,0.41697416974169743,1.0,1.0,2/22,3.59%,DUSP7;DUSP12
prerank,disordered domain specific binding (GO:0097718),0.37657678642872383,1.0258530857536259,0.4359861591695502,1.0,1.0,4/23,9.25%,BCL2L2;FYN;CALM3;MDM2
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.46366549642630106,1.0252689721256765,0.429769392033543,1.0,1.0,1/10,1.30%,DUSP7
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.46366549642630106,1.0252689721256765,0.429769392033543,1.0,1.0,1/10,1.30%,DUSP7
prerank,cation:chloride symporter activity (GO:0015377),0.46150944426787716,1.0252142825448136,0.42524271844660194,1.0,1.0,1/10,0.15%,SLC12A1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",-0.43359186039772146,-1.0240283564884733,0.45,0.7147686199724742,1.0,3/11,29.05%,DDAH1;DDAH2;PADI2
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.34905783768308873,-1.0225651238711249,0.4117647058823529,0.7146663927491141,1.0,6/23,16.01%,PDE1A;PDE5A;PDE1C;PDE4B;PDE11A;ADPRM
prerank,amino acid:sodium symporter activity (GO:0005283),-0.4236061697248812,-1.0225647071227442,0.4505928853754941,0.7110201356432513,1.0,5/11,13.91%,SLC1A3;SLC6A13;SLC6A1;SLC6A12;SLC6A15
prerank,CCR chemokine receptor binding (GO:0048020),-0.3346476953656211,-1.0224799778472249,0.43341404358353514,0.7075928255098216,1.0,6/28,21.82%,CNIH4;CCL14;NARS1;NES;CX3CL1;CCL13
prerank,GTPase activator activity (GO:0005096),0.254203021328484,1.0223542829199472,0.42724097788125726,1.0,1.0,74/313,15.32%,THG1L;RGS2;TIAM1;VAV3;GNAQ;EEF1D;NUCB2;EVI5L;RGS5;CYTH4;CHN2;TBC1D30;TBC1D8;RALGAPA2;ITSN1;RGS8;TBC1D9;STXBP5L;RASGRP3;TBC1D10B;ARHGAP25;DENND5B;ARHGEF6;USP6NL;ARHGEF7;LAMTOR1;TBC1D4;CCDC88C;RALGAPB;RAPGEF3;DENND1A;RGS10;RABGAP1L;RAP1GDS1;ARHGEF18;RAPGEF5;EIF2B3;RGS3;RAPGEF6;FGD5;TBC1D12;DOCK9;MYCBP2;RANBP1;PLCB1;OPHN1;ACAP2;TBC1D25;ARHGAP39;NF1;SBF2;ADPRH;MYO9B;SMAP1;PREX2;TBC1D14;LARS1;RABGAP1;EEF1B2;ARHGAP15;EPS8L1;SYDE1;RGL2;DENND4C;ANKRD27;ASAP1;ELMO1;RCC1;ARHGEF10;RALGAPA1;DOCK8;DENND1B;RAB3GAP1;GAPVD1
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),-0.23126642141623316,-1.022178278898475,0.40611353711790393,0.7047490046119558,1.0,54/181,21.92%,ARNT2;SMAD3;MIER1;PRRX1;HDAC4;CHD4;MAPK14;CTNNB1;RBL2;GTF2I;HDAC1;MED1;TTC8;PPARGC1A;ANXA4;WWP2;LDB1;PPARA;MTA3;SPEN;SNW1;BHLHE40;PSMA6;RXRA;GSK3B;MTA1;SMARCD3;TP53;CRY1;DDRGK1;TBX3;NCOA1;PIAS3;ATN1;BBS2;DACT1;KDM1A;COMMD7;TEAD3;TAF6;JUN;CTDP1;TADA3;MTDH;TCF7L2;BBS5;STAT1;MTA2;PIAS4;BHLHE41;HSPB1;DTX3L;ATF4;ELK1
prerank,intracellular chloride channel activity (GO:0061778),-0.37387542457156175,-1.0216991236443822,0.415929203539823,0.6989385739888253,1.0,9/16,40.14%,ANO3;ANO1;ANO6;ANO10;TTYH3;TTYH1;ANO5;ANO8;ANO2
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.37387542457156175,-1.0216991236443822,0.415929203539823,0.6989385739888253,1.0,9/16,40.14%,ANO3;ANO1;ANO6;ANO10;TTYH3;TTYH1;ANO5;ANO8;ANO2
prerank,deubiquitinase activity (GO:0101005),-0.25472841590187517,-1.0212325674392073,0.3927392739273927,0.6966231498444805,1.0,34/88,22.41%,OTUD7A;USP40;USP29;CYLD;USP13;USP11;USP4;STAMBPL1;MINDY3;OTULIN;OTUD6B;USP50;USP38;USP34;USP19;USP20;UCHL3;USP7;USP10;USP16;USP1;TANK;USP42;USP5;USP45;EIF3F;COPS5;JOSD1;MYSM1;USP35;USP49;EIF3H;USP46;USP2
prerank,voltage-gated ion channel activity (GO:0005244),-0.3909503133326254,-1.0182328809287324,0.430062630480167,0.7005634521704973,1.0,3/14,5.66%,HCN1;KCND2;VDAC1
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),-0.3848174976430085,-1.0168905674536635,0.4270833333333333,0.7003131160989418,1.0,10/15,36.46%,KMT2A;RBBP5;KMT2B;KMT2D;SETD4;WDR5;WDR82;PRDM9;CXXC1;SETMAR
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.33705910489431123,1.0165490122993224,0.44107744107744107,1.0,1.0,10/34,13.25%,NDUFB6;NDUFB4;NDUFA10;NDUFA1;NDUFS2;NDUFB7;NDUFV3;NDUFA8;NDUFC2;NDUFA13
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.33705910489431123,1.0165490122993224,0.44107744107744107,1.0,1.0,10/34,13.25%,NDUFB6;NDUFB4;NDUFA10;NDUFA1;NDUFS2;NDUFB7;NDUFV3;NDUFA8;NDUFC2;NDUFA13
prerank,transferrin receptor binding (GO:1990459),-0.42959905763487866,-1.0162329738861193,0.45121951219512196,0.698472721484841,1.0,3/10,3.65%,SNX2;RGMA;SNX4
prerank,cadherin binding (GO:0045296),0.25335227869900884,1.015423128549389,0.4417249417249417,1.0,1.0,99/315,19.95%,LRRFIP1;EFHD2;PSMB6;CBL;PTPRJ;NUDC;VASP;BSG;HSPA8;EIF2A;GLOD4;PTPRM;EEF1D;PCBP1;SRC;EHD4;FLNB;PTPRB;MRTFB;SLC3A2;CDH2;PROM1;ESYT2;PFN1;HNRNPK;SLK;RAB11B;EPS15L1;YWHAB;PTPRT;CDH12;RPS26;F11R;RUVBL1;TRIM25;EIF4H;ITGA6;DOCK9;SNX1;TJP1;RAB1A;RANBP1;PARK7;EIF4G2;DDX3X;RPL24;RPL34;PI4KA;OLA1;AHSA1;PICALM;CRKL;UNC45A;CDH5;ERC1;RPL23A;GIPC1;EPS8L1;APC;HCFC1;ASAP1;ABCF3;TWF1;EIF5;GAPVD1;MYH9;FXYD5;RSL1D1;PACSIN2;CDH13;PFKP;CD2AP;BAIAP2;CAPZA1;LDHA;UBAP2;RANGAP1;PTPN11;GOLGA3;ARGLU1;EPN2;CD46;CNN3;RPL15;RDX;SH3GLB1;RPS2;FNBP1L;YWHAE;BZW2;EIF3E;LARP1;KIF5B;CCT8;RPL14;ADD1;SEPTIN9;PKN2;PAK2
prerank,omega peptidase activity (GO:0008242),-0.25299973329380854,-1.0150969150900035,0.41042345276872966,0.6975187895815425,1.0,34/89,22.41%,OTUD7A;USP40;USP29;CYLD;USP13;USP11;USP4;STAMBPL1;MINDY3;OTULIN;OTUD6B;USP50;USP38;USP34;USP19;USP20;GGT5;UCHL3;USP7;USP10;USP16;USP1;TANK;USP42;USP5;USP45;COPS5;JOSD1;MYSM1;USP35;USP49;GGH;USP46;USP2
prerank,ribosome binding (GO:0043022),-0.28260307558657616,-1.0142267739148774,0.4126984126984127,0.6961026873794596,1.0,12/46,14.31%,CPEB4;CPEB1;CPEB2;SEC61A1;EIF3C;YTHDF1;EEF2;TMCO1;SRP72;SRP19;RACK1;NOMO1
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",-0.3792342098188237,-1.0132519009608354,0.4410480349344978,0.6948175559056049,1.0,10/16,53.15%,PIR;CDO1;ETHE1;ALOX12;ADI1;BCO2;HGD;ALOXE3;HAAO;ALOX5
prerank,single-stranded RNA binding (GO:0003727),0.32795784290017566,1.0116165147294134,0.43769968051118213,1.0,1.0,17/43,20.73%,ILF3;FXR1;LONP1;ZFR;EIF4H;DDX3X;ADARB2;AGO4;EIF4B;PTBP1;ENDOV;U2AF2;HNRNPF;DDX60;AGO1;AQR;CNBP
prerank,ion channel inhibitor activity (GO:0008200),0.33718751817724135,1.01126659664448,0.4376012965964344,1.0,1.0,3/35,4.26%,RSC1A1;PHPT1;NEDD4L
prerank,glutamate receptor binding (GO:0035254),-0.3645840692788559,-1.0082064077489066,0.4326086956521739,0.7032384893807391,1.0,8/17,26.16%,DLG4;SYNDIG1;SHISA6;IGSF11;SHANK2;SHANK1;CAMK2A;HIP1
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.45245126434350086,1.006672281920114,0.46421663442940037,1.0,1.0,2/10,7.87%,MECOM;SETD5
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.4205975594704433,1.0062987061016764,0.45849802371541504,1.0,1.0,2/13,1.45%,PTPRJ;IL1R1
prerank,organic anion transmembrane transporter activity (GO:0008514),0.269949340473138,1.0061623514073845,0.4574175824175824,1.0,1.0,29/134,16.69%,SLC7A8;SLC1A1;SLC36A4;ABCC4;SLC25A1;SLC25A24;ABCG2;SLC3A2;SLC52A2;SLC52A3;SLC6A6;SLC17A6;SLC1A2;SLC35A1;SLC35B1;SLC25A2;SFXN5;SFXN1;SLC35A3;SLC25A12;MPC2;SLC38A5;SLC66A1;SLC25A21;SLCO1C1;SLC25A42;SLC16A1;SLC25A38;SLC25A25
prerank,thiol-dependent deubiquitinase (GO:0004843),-0.25145974137341537,-1.0038985137219074,0.4444444444444444,0.7102401625687914,1.0,32/83,22.41%,OTUD7A;USP40;USP29;CYLD;USP13;USP11;USP4;STAMBPL1;MINDY3;OTULIN;OTUD6B;USP50;USP38;USP34;USP19;USP20;UCHL3;USP7;USP10;USP16;USP1;TANK;USP42;USP5;USP45;COPS5;JOSD1;MYSM1;USP35;USP49;USP46;USP2
prerank,chemokine receptor activity (GO:0004950),-0.33607793454796,-1.002467923988621,0.44575471698113206,0.7102163498143398,1.0,18/24,63.03%,CCR9;ACKR3;CMKLR1;CX3CR1;CCR5;GPR35;CCR2;CXCR4;GPR75;GPR17;CCRL2;CXCR6;CCR1;CCR10;ACKR4;CXCR5;CCR6;CXCR2
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.23812212425575657,1.0001463244738795,0.49023861171366595,1.0,1.0,80/597,14.21%,SOX30;ATF3;IRX1;CTCFL;FOXQ1;ARID5A;ONECUT1;FOXN2;TFCP2;MTERF3;NR4A2;TAL1;ATF6;LEF1;HES6;KLF2;ELK3;PAX8;BCL11B;GABPA;ZBTB33;BACH2;BCL6B;ORC3;HEY1;NR5A1;IRF9;PRDM4;BBX;SOX2;MYBL2;SMARCA2;YY1;FLI1;GMEB2;ZNF740;USF2;CPSF4;BEND3;RFX3;TBX1;CALCOCO1;CEBPG;PPARD;SFPQ;CDC45;CLOCK;ORC4;HEY2;ZBTB14;RELA;SOX13;POLA1;CENPC;JUND;HOXA7;TFAP4;ERG;KLF6;ESR1;THRB;CARM1;ORC2;NFIC;ZBED4;E2F3;MZF1;SP1;IRF2;CHD3;TBP;HDAC5;ZBTB45;DDIT3;TGIF1;THRA;YBX1;HES1;SP8;GRHL1
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.374600071911463,0.9999511623210565,0.4679376083188908,1.0,1.0,8/22,18.18%,ATP6V1D;ATP2A2;ATP6V0D1;ATP6V0E1;ATP2C1;ATP6V1B2;ATP5F1B;ATP6V1A
prerank,potassium ion antiporter activity (GO:0022821),0.40018130303262656,0.9936289357372551,0.4780114722753346,1.0,1.0,3/15,6.87%,SLC9A7;SLC9A6;SLC9A8
prerank,chemoattractant activity (GO:0042056),-0.3240150349031998,-0.9922913147103518,0.4731934731934732,0.7311894040846861,1.0,14/26,44.59%,BMP4;SCG2;CX3CL1;VEGFA;VEGFB;PGF;FGF10;FGF7;HMGB1;HMGB2;HGF;MIF;NTF3;GDNF
prerank,1-phosphatidylinositol binding (GO:0005545),-0.3841267742371256,-0.9914510100628798,0.46881720430107526,0.7299435891689614,1.0,4/15,8.92%,WDFY3;SNAP91;EEA1;ZFYVE16
prerank,mRNA binding (GO:0003729),0.2506032428827519,0.9899625425898159,0.49818181818181817,1.0,1.0,76/249,19.41%,ZC3H12D;NCBP1;KHDRBS3;EIF2A;PCBP1;LARP4B;ZFP36L1;HNRNPAB;SF1;QKI;CCT5;HNRNPK;MYEF2;RPS14;FXR1;RPL5;SLC4A1AP;RBM20;RPS26;HNRNPC;GEMIN5;FYTTD1;YTHDC1;SRSF4;SECISBP2L;XPO5;NOVA2;DXO;MARF1;PARK7;TARDBP;CPSF6;EIF4G2;NCBP3;DDX3X;NANOS3;RPS3;PTBP1;ACO1;PCBP3;G3BP2;RPL35;RNF20;DCP1A;SCAF8;RBM4B;SSB;SF3B6;HNRNPL;TRA2B;SLBP;PPP1R8;NOCT;ADARB1;RSL1D1;TDRD7;UPF3B;PURB;PARN;N4BP1;LARP4;CALR;EIF2S2;EIF3A;LUC7L2;RPL26;RPS2;RC3H1;NSRP1;EIF4G1;CLUH;MRPL13;DHX36;HNRNPM;DCP1B;LARP1
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.3960386472221387,0.9866449461298163,0.473491773308958,1.0,1.0,1/15,0.29%,CISH
prerank,vinculin binding (GO:0017166),-0.4128266045962335,-0.9863438559048215,0.4893162393162393,0.7384470202220929,1.0,3/11,5.06%,CTNNA1;TLN1;PXN
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.36352024244842274,-0.986333103844994,0.47030878859857483,0.7350125406458473,1.0,3/17,1.54%,GRIA4;GRIA2;GRIN2B
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.4440386411877255,0.9861252174270697,0.47572815533980584,1.0,1.0,4/10,14.65%,PIK3CG;PIK3C2G;PIK3CD;PIK3C2A
prerank,kinase inhibitor activity (GO:0019210),-0.3029966793808554,-0.9849056621245899,0.49504950495049505,0.7349385895161283,1.0,17/33,33.13%,PARVA;DNAJC3;GMFB;TAOK3;CDKN1B;DUS2;LRP6;SH3BP5;SH3BP5L;RHOH;TRIB1;QARS1;SNCA;CDKN1C;NCK1;MAPK8IP1;SMCR8
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.42460620958537904,-0.9847305488419689,0.4906832298136646,0.7319214728134326,1.0,5/10,19.61%,DLG4;SHISA6;IGSF11;SHANK2;SHANK1
prerank,myosin V binding (GO:0031489),0.39954688797046867,0.983053154829489,0.4954296160877514,1.0,1.0,4/15,8.27%,RAB11B;RAB6B;RAB6A;RAB14
prerank,small GTPase binding (GO:0031267),0.2610431974799107,0.9817140937147971,0.5157068062827225,1.0,1.0,46/169,16.21%,SOD1;CHML;CHM;EVI5L;EXOC8;TBC1D30;MYO5A;CYRIB;CIB1;USP6NL;TRIP11;AP1G1;RABGAP1L;RAPGEF6;FGD5;XPO5;MYCBP2;RANBP1;PKN1;PAK1;GCC2;DOCK7;ATP6AP1;DMXL2;PICALM;MYO9B;PDE6D;ERC1;RABGAP1;KIF3B;USP33;AP3M1;ANKRD27;RCC1;BICD2;RUSC2;PPP6R1;WHAMM;TMEM127;RAB3GAP1;CDKL5;BRAF;ABI2;DOCK4;EXOC2;DNM1L
prerank,pyridoxal phosphate binding (GO:0030170),-0.34253731049261316,-0.9807934278960891,0.4642082429501085,0.7378668664776624,1.0,3/20,4.22%,PYGB;ABAT;SRR
prerank,microtubule plus-end binding (GO:0051010),0.36920386501466407,0.9807842692027672,0.4842105263157895,1.0,1.0,9/20,19.53%,KIF18A;CLASP2;DST;CLIP2;APC;CLIP1;CLASP1;PAFAH1B1;MAPRE3
prerank,thyroid hormone receptor binding (GO:0046966),0.3519262642167742,0.979984107876953,0.5155709342560554,1.0,1.0,7/28,11.71%,ARID5A;GAS2L1;MED12;GTF2H1;TACC1;MED4;JMJD1C
prerank,calcium channel regulator activity (GO:0005246),-0.2913795821830576,-0.9799182025858626,0.4884910485933504,0.7366141027844038,1.0,8/37,12.06%,ITPR1;STIM2;NRXN1;STIM1;SGK1;CACNG7;NRXN2;SRI
prerank,G protein-coupled receptor binding (GO:0001664),0.2669453641876716,0.979857429538667,0.4924965893587995,1.0,1.0,14/132,11.37%,RTP3;REEP1;SAG;HSPA8;CXCL12;GNAQ;INSL3;CCDC88C;WNT5A;GNA12;CCL25;GNA11;PPY;GNAI1
prerank,LRR domain binding (GO:0030275),0.4015126106511225,0.9793472535181721,0.5020408163265306,1.0,1.0,5/14,13.25%,POLR2J;MRTFA;ZXDC;ERC1;DDIT3
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.42208596433962964,0.9792779097110247,0.48084291187739464,1.0,1.0,2/12,1.95%,PIK3CG;PIK3C2G
prerank,nucleosomal DNA binding (GO:0031492),0.367591749783898,0.9775940600108839,0.4762773722627737,1.0,1.0,8/21,19.00%,ACTL6A;ACTB;HNRNPC;RCC1;SMARCA4;RBBP4;HDAC2;SMARCB1
prerank,phosphatidylglycerol binding (GO:1901611),0.399924655311199,0.9772147438698837,0.4912959381044487,1.0,1.0,3/13,10.14%,MME;UQCC3;PITPNA
prerank,C-C chemokine binding (GO:0019957),-0.3324125484673721,-0.9766700723254156,0.49213483146067416,0.7406307971187162,1.0,16/22,63.03%,CCR9;ACKR3;CX3CR1;ZFP36;CCR5;ACKR1;CCR2;CXCR4;CCRL2;CXCR6;CCR1;CCR10;ACKR4;CXCR5;CCR6;CXCR2
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.23065157672079037,0.9761776381988182,0.56,1.0,1.0,75/732,10.73%,TBX4;SOX30;LRRFIP1;ATF3;IRX1;MAZ;ZBTB42;CTCFL;FOXQ1;DACH1;MECOM;ONECUT1;KLF8;FOXN2;TFCP2;NR4A2;TAL1;ATF6;ZFAT;LEF1;HES6;RUVBL2;GTF2IRD1;KLF2;ELK3;PAX8;BCL11B;GABPA;ZBTB24;ZBTB33;BACH2;BCL6B;ZKSCAN1;SMAD1;PRDM15;HEY1;NR5A1;ZBTB41;IRF9;PRDM4;MEIS1;SOX2;MYBL2;YY1;GMEB2;ZNF83;ZNF740;USF2;RFX3;ZNF260;CARF;TBX1;CALCOCO1;CEBPG;FOXF2;PPARD;ZNF205;CLOCK;KDM6A;HEY2;ZBTB14;RELA;SOX13;JUND;HOXA7;TFAP4;ERG;KLF6;ZKSCAN3;WBP2;MGA;HIC2;RBPJ;ESR1;THRB
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.2954401357557398,0.9755623301346558,0.5016129032258064,1.0,1.0,10/54,13.02%,AMDHD2;ACER2;GLS2;GLS;HDAC9;HDAC3;SIRT1;NADSYN1;ACER3;HDAC5
prerank,phospholipase activity (GO:0004620),0.29118101960245435,0.975267149671003,0.4962178517397882,1.0,1.0,10/67,14.31%,FAM83B;SMPD4;PLAAT3;PNPLA7;SEC23IP;DDHD1;PNPLA8;ABHD12;ABHD4;PNPLA6
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.25909393463140395,0.9751806604612251,0.503242542153048,1.0,1.0,35/147,15.32%,THG1L;TIAM1;VAV3;EEF1D;NUCB2;CYTH4;ITSN1;DENND5B;ARHGEF6;ARHGEF7;LAMTOR1;CCDC88C;RAPGEF3;DENND1A;ARHGEF18;RAPGEF5;EIF2B3;RAPGEF6;FGD5;DOCK9;MYCBP2;SBF2;PREX2;EEF1B2;EPS8L1;RGL2;DENND4C;ANKRD27;ELMO1;RCC1;ARHGEF10;DOCK8;DENND1B;RAB3GAP1;GAPVD1
prerank,protein kinase binding (GO:0019901),0.23537248419260862,0.9741593517893123,0.5562987736900781,1.0,1.0,75/479,13.97%,FAM83B;RAC2;FRMD5;PRKAR1A;MAP2K7;MAP3K11;PTPRR;GSK3A;TRIB3;CKS2;DUSP7;PTPRJ;EEF1A1;PTPRC;OXSR1;PIN1;MTCP1;RPTOR;ACTB;TIRAP;HDAC9;HDAC7;RFFL;PRKD2;NEK9;SMAD1;CDK5RAP1;LRBA;SPRED1;RBBP6;DCTN2;TRIM14;CDKN1A;ARHGEF7;CALM3;RGCC;FBXO5;SIRT1;CADPS;AXIN1;PRAM1;TRPV4;PLCG1;ACVRL1;RELA;POLA1;RAB11FIP2;PJA2;PKN1;FBXO7;PPP1R12A;CIR1;RNF13;BAD;ESR1;RHOG;ADIPOR1;USP37;RPS3;NBR1;TNIP2;IKBKB;KIZ;TBC1D14;NEK6;CDH5;HDAC5;ACTA2;PLEK;CHEK2;CTBP2;MAP2K6;FAF1;TRIM27;APC
prerank,kinase activator activity (GO:0019209),-0.3006967658252768,-0.973445023406963,0.4868421052631579,0.7448789880745111,1.0,9/30,16.88%,PRKAG2;WNK1;MALT1;CAB39;STRADA;STK11;MADD;RPLP1;GPRC5B
prerank,ATPase regulator activity (GO:0060590),-0.2945892577052809,-0.9699313876205349,0.4934725848563969,0.7499466767117237,1.0,11/38,17.65%,TOR1AIP2;ATP1B1;DNAJC24;ATP1B3;BAG3;DNAJC19;TOR1AIP1;ATP1B2;FNIP1;ATP5IF1;DNAJB4
prerank,glycerophospholipid flippase activity (GO:0140333),0.4275144715834179,0.9697623511319645,0.49906890130353815,1.0,1.0,4/11,14.35%,ATP8A1;ATP11A;ATP11C;ATP10A
prerank,double-stranded DNA binding (GO:0003690),0.23172230439758065,0.9682424355815265,0.5630530973451328,1.0,1.0,59/531,11.87%,SOX30;ATF3;IRX1;FOXQ1;ONECUT1;FOXN2;TFCP2;NR4A2;ATF6;LEF1;HES6;PNKP;KLF2;ELK3;PAX8;BCL11B;GABPA;ZBTB33;BACH2;BCL6B;HEY1;NR5A1;IRF9;PRDM4;BBX;MYBL2;YY1;FLI1;GMEB2;ZNF740;USF2;CPSF4;RFX3;TDG;TBX1;CEBPG;PPARD;CLOCK;ZNF638;HEY2;ZBTB14;SPRTN;PCID2;JUND;HOXA7;RAD51B;PARK7;MSH3;TFAP4;ERG;TARDBP;KLF6;ESR1;THRB;APTX;RPS3;NFIC;POLR3F;HDGF
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.37905461960380543,-0.9675043720969195,0.511578947368421,0.7523700212142423,1.0,8/13,27.09%,ALDH1A1;ALDH1A2;ALDH4A1;ALDH3A2;ALDH2;ADH5;ALDH9A1;ALDH1L2
prerank,protein tyrosine kinase binding (GO:1990782),-0.2591652217188602,-0.9652160804720477,0.5274390243902439,0.7544501963547866,1.0,18/71,20.00%,GRM5;KHDRBS1;PTPN14;NEDD9;ACVR1;TP53;NOX4;PITPNM3;SIRPA;SHC3;DUSP22;RACK1;TOB1;PTPN2;SOCS5;ANGPT2;CPNE3;BMPR2
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.37261210603943096,0.9650571782447058,0.49471830985915494,1.0,1.0,1/18,0.29%,CISH
prerank,copper ion binding (GO:0005507),0.3105000026059058,0.9642907858978185,0.5088282504012841,1.0,1.0,9/42,15.84%,SNCG;RNF7;SOD1;PARK7;PAM;PRNP;CUTC;S100A13;ANG
prerank,voltage-gated chloride channel activity (GO:0005247),-0.40199710962614865,-0.9630018589413045,0.49586776859504134,0.7564756694310715,1.0,4/10,14.26%,CLCN6;ANO1;CLCN2;ANO6
prerank,triglyceride lipase activity (GO:0004806),-0.3417210474879502,-0.9622288300813331,0.5136986301369864,0.7548400432621538,1.0,7/20,38.40%,ABHD5;LIPE;PLA2G15;DDHD2;PNPLA2;LPL;PNPLA3
prerank,C-C chemokine receptor activity (GO:0016493),-0.328817539855893,-0.9602973250370104,0.5106837606837606,0.7560631768285078,1.0,15/21,63.03%,CCR9;ACKR3;CX3CR1;CCR5;CCR2;CXCR4;GPR75;CCRL2;CXCR6;CCR1;CCR10;ACKR4;CXCR5;CCR6;CXCR2
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.40334824636650934,-0.9581897229674725,0.5245901639344263,0.7575963982445731,1.0,5/11,36.69%,SLC2A10;SLC5A3;SLC17A5;SLC5A11;SLC2A9
prerank,lipoprotein particle binding (GO:0071813),-0.33392524958288017,-0.9553429953457854,0.5042735042735043,0.7608351535619455,1.0,6/20,18.43%,MAPT;SORL1;LDLR;THBS1;HSPD1;SCARF1
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.22538817889374574,0.9522500816524512,0.6483050847457628,1.0,1.0,74/731,10.73%,TBX4;SOX30;LRRFIP1;ATF3;IRX1;MAZ;ZBTB42;CTCFL;FOXQ1;DACH1;MECOM;ONECUT1;KLF8;TFCP2;NR4A2;TAL1;ATF6;ZFAT;LEF1;HES6;RUVBL2;GTF2IRD1;KLF2;ELK3;PAX8;BCL11B;GABPA;ZBTB24;ZBTB33;BACH2;BCL6B;ZKSCAN1;SMAD1;PRDM15;HEY1;NR5A1;ZBTB41;IRF9;PRDM4;MEIS1;SOX2;MYBL2;YY1;GMEB2;ZNF83;ZNF740;USF2;RFX3;ZNF260;CARF;TBX1;CALCOCO1;CEBPG;FOXF2;PPARD;ZNF205;CLOCK;KDM6A;HEY2;ZBTB14;RELA;SOX13;JUND;HOXA7;TFAP4;ERG;KLF6;ZKSCAN3;WBP2;MGA;HIC2;RBPJ;ESR1;THRB
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.32821696597691463,-0.9519733845945748,0.5336322869955157,0.7654440860975719,1.0,4/20,5.80%,LPGAT1;AGPAT4;ABHD5;AGPAT5
prerank,DNA replication origin binding (GO:0003688),0.34943015998785487,0.9518347078468288,0.5334538878842676,1.0,1.0,5/23,11.53%,ORC3;CDC45;ORC4;POLA1;ORC2
prerank,SH3 domain binding (GO:0017124),0.29053129926125776,0.951599619401024,0.5294985250737463,1.0,1.0,16/62,17.04%,CBL;VASP;CABYR;SHANK3;EVL;SGIP1;PTPN12;REPS1;SYNJ2;ELMO1;RUFY1;CYBA;ABI2;ADAM9;CD2AP;ARHGAP27
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.407073333397862,0.951587786579938,0.53125,1.0,1.0,6/12,20.20%,NCBP1;GEMIN5;NCBP3;CYFIP1;LARP1;EIF4E
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.34787645342804085,0.9511067571926817,0.5347222222222222,1.0,1.0,4/24,12.61%,PPIP5K2;NME1;IP6K2;DTYMK
prerank,sialyltransferase activity (GO:0008373),0.3562294929809101,0.9510164677954035,0.5350089766606823,1.0,1.0,6/20,14.80%,ST6GALNAC3;ST8SIA1;ST3GAL6;ST3GAL1;ST6GALNAC2;ST8SIA6
prerank,ATP hydrolysis activity (GO:0140603),0.3120062008458577,0.9505419135136525,0.5546218487394958,1.0,1.0,8/41,14.88%,ABCB10;RUVBL2;VWA8;RUVBL1;DDX3X;CHD3;MYO1E;TOR3A
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.30271755295142927,-0.9474645458581429,0.5310880829015544,0.7729183466740818,1.0,13/30,26.57%,ATP7A;SLC39A14;SLC30A10;SLC39A13;SLC30A4;SLC31A1;SLC39A8;SLC11A2;SLC39A7;SLC39A6;SLC25A28;SLC30A5;TTYH1
prerank,neuropeptide hormone activity (GO:0005184),0.3516331658291456,0.9468810262009768,0.5333333333333333,1.0,1.0,22/22,64.89%,PPY;AGRP;OXT;QRFP;CORT;HCRT;GHRH;NPPA;UCN;CALCB;GAL;CRH;VIP;NMB;PNOC;NPFF;NPY;GRP;SPX;CCK;PENK;ADCYAP1
prerank,protein heterodimerization activity (GO:0046982),0.24807881007927912,0.9461961009231625,0.5771276595744681,1.0,1.0,33/178,14.77%,MIGA1;ATF3;SIM1;NR4A2;ATF6;SAE1;BCL2L2;ZHX3;PPP2CA;RALGAPA2;EXT2;PHB2;USF2;FXR1;RALGAPB;UBA2;SNX1;FZD9;FBXO7;NAE1;GTF2A2;ITGA3;IKBKB;TENM4;RRAGC;CHUK;YWHAH;TPM2;DDIT3;EPAS1;RCC1;CYBA;RALGAPA1
prerank,androgen receptor binding (GO:0050681),-0.304040405539468,-0.9461362884861736,0.5427251732101617,0.7727254624467964,1.0,5/25,8.56%,DDX5;FOXP1;RNF14;WIPI1;SNW1
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.30753533704759,-0.9438219370590303,0.5375,0.7747916850953587,1.0,5/29,6.39%,SLC13A3;SLC26A7;SLC25A13;SLC1A5;SLC26A2
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.3541524560216842,-0.9434060820374738,0.5498938428874734,0.7725282524751975,1.0,6/16,20.67%,MTMR7;SACM1L;MTMR12;MTMR9;MTMR4;MTMR11
prerank,peptidase activator activity (GO:0016504),-0.3224305930359958,-0.9415209068444023,0.5292740046838408,0.7738513708942777,1.0,14/22,32.44%,CASP8AP2;VCP;PCOLCE2;PSME4;EBAG9;PCOLCE;TANK;PINK1;APH1B;CLPX;PSME2;CAV1;PSME3;PSME1
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.34972957327196713,-0.9415183435107554,0.5295315682281059,0.7705583863372808,1.0,4/15,12.08%,ALDH1A1;ALDH1A2;ALDH4A1;ALDH3A2
prerank,NAD binding (GO:0051287),-0.3113436127294943,-0.9408895346249825,0.5411471321695761,0.7685131238746774,1.0,5/26,6.88%,ALDH1A1;ME1;ZC3HAV1;SIRT2;GLUD1
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.3056033475024153,0.9401092190480315,0.5560897435897436,1.0,1.0,5/42,9.00%,CKS2;CCNC;CCNH;CDKN1A;CCNG2
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",-0.24717635212557176,-0.9392960451803516,0.5514018691588785,0.7690071436525224,1.0,24/74,22.80%,DGKI;NADK2;PIK3C2B;GK;NADK;DCAKD;PIK3C3;DGKH;PANK3;ADK;FAM20C;PKM;CHKA;AGK;FAM20A;PAPSS2;NT5C3A;IDNK;HYKK;NOL9;DGKQ;CHKB;RFK;HK2
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.2909225715278968,0.9392382125310698,0.5631825273010921,1.0,1.0,14/53,18.21%,SLC7A8;SLC1A1;SLC36A4;SLC3A2;SLC17A6;SLC1A2;SLC25A2;SFXN1;SLC25A12;SLC38A5;SLC66A1;SLC25A38;SLC7A5;SLC43A2
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.2206806089253736,0.9357828848807338,0.6986444212721585,1.0,1.0,83/831,10.73%,TBX4;SOX30;LRRFIP1;ATF3;IRX1;MAZ;ZBTB42;CTCFL;FOXQ1;DACH1;MECOM;SIM1;ONECUT1;KLF8;TFCP2;NR4A2;TAL1;ATF6;ZFAT;LEF1;HES6;RUVBL2;GTF2IRD1;KLF2;ELK3;PAX8;BCL11B;STOX1;GABPA;ZBTB24;ZBTB33;BACH2;BCL6B;ZKSCAN1;SMAD1;PRDM15;HEY1;NR5A1;ZBTB41;IRF9;PRDM4;BBX;MEIS1;SOX2;MYBL2;YY1;GMEB2;ZNF83;ZNF740;USF2;ZSCAN2;VEZF1;RFX3;ZNF260;NFX1;CARF;TBX1;CALCOCO1;CEBPG;FOXF2;PPARD;ZNF205;ACTN4;CLOCK;ZNF3;KDM6A;HEY2;ZBTB14;RELA;SOX13;TRPS1;JUND;HOXA7;TFAP4;ERG;KLF6;ZKSCAN3;WBP2;MGA;HIC2;RBPJ;ESR1;THRB
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.24010588139804623,0.9338752588215121,0.6195121951219512,1.0,1.0,49/232,17.28%,RNF7;CBL;ARIH1;RNF149;RNF38;RFFL;BIRC2;NEURL2;NEDD4L;VPS11;NHLRC1;RBBP6;UBE3A;TRIM14;IRF2BPL;RNF130;NFX1;COP1;RNF187;PPP1R11;TRIM25;MDM2;PIAS2;MYCBP2;RFWD3;UBE3D;RNF6;ZNRF1;RNF13;RNF25;ANAPC11;PIAS1;DTX4;RNF11;CUL3;RNF216;TRIM27;RNF180;FANCL;TRIM3;NHLRC3;RNF114;PELI1;RNF128;RNF125;VPS18;UBR3;MSL2;KCMF1
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.39866547103321875,-0.9337435995493613,0.5572815533980583,0.7785954660178721,1.0,3/10,4.57%,PRKAG2;PKIG;PRKAG1
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.36939229434340354,-0.9327947596974248,0.5306553911205074,0.7774613477605424,1.0,6/13,27.04%,GPSM1;GDI1;ARHGDIA;ARHGDIB;ITGB1BP1;SH3BP4
prerank,carboxylic acid binding (GO:0031406),0.31106769110869614,0.9322301147735449,0.5513245033112583,1.0,1.0,2/38,0.80%,PCK1;GCLC
prerank,secondary active transmembrane transporter activity (GO:0015291),-0.26160535867166296,-0.9316727508697357,0.5439093484419264,0.7770014554122594,1.0,14/51,17.88%,SLCO3A1;MCU;SLC22A8;ANKH;SLC25A3;SLC22A4;SLC20A1;TMEM241;SLC35D2;SLC22A6;SLC16A2;SLC16A10;SLC5A6;SLC5A5
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.3329110940467578,-0.92615777674342,0.5809312638580931,0.7863077246779993,1.0,4/18,12.08%,ALDH1A1;ALDH1A2;ALDH6A1;ALDH3A2
prerank,mannose binding (GO:0005537),0.3989130945021386,0.9259153900472423,0.5653846153846154,1.0,1.0,1/12,4.35%,LMAN2
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.40073480953632634,-0.9250935119233776,0.5700575815738963,0.7856000949090364,1.0,2/10,13.95%,SLCO3A1;SLC22A6
prerank,calmodulin-dependent protein kinase activity (GO:0004683),-0.3101968902609461,-0.9244489393782855,0.5763097949886105,0.783870617873968,1.0,10/24,27.86%,CAMK4;PHKA2;CAMK2D;CAMK1;DAPK1;PHKG2;MKNK2;CAMK2B;CAMK2A;MAPKAPK2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.3907070549103728,-0.9243955425919509,0.5483193277310925,0.7807764893480356,1.0,1/10,1.67%,DPYSL3
prerank,histone acetyltransferase binding (GO:0035035),-0.3235530290710843,-0.9240471753331533,0.565121412803532,0.7783729838001195,1.0,6/21,19.85%,GLI3;KANSL1L;SIRT2;TP53;EID1;STAT1
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.4012955369080915,-0.9237467963868234,0.6070686070686071,0.7759843192310405,1.0,8/10,38.20%,FAN1;DNAJC2;DNAJB2;ANKRD13D;ANKRD13B;LAPTM5;FAAP20;IDE
prerank,metalloaminopeptidase activity (GO:0070006),0.36753041879826226,0.9233127880640426,0.5769944341372912,1.0,1.0,1/16,0.21%,LVRN
prerank,anion transmembrane transporter activity (GO:0008509),-0.37431822374160534,-0.9230265906020868,0.567193675889328,0.774537091903275,1.0,5/12,15.61%,SLC39A8;SLC22A6;SLC26A11;SLC4A2;SLC19A1
prerank,lysine-acetylated histone binding (GO:0070577),-0.32242853638768776,-0.9222647982209546,0.5717391304347826,0.7699734948508938,1.0,6/20,12.86%,KMT2A;BRD9;BRD7;PSME4;BRD4;DPF2
prerank,acetylation-dependent protein binding (GO:0140033),-0.32242853638768776,-0.9222647982209546,0.5717391304347826,0.7699734948508938,1.0,6/20,12.86%,KMT2A;BRD9;BRD7;PSME4;BRD4;DPF2
prerank,nuclear localization sequence binding (GO:0008139),0.35480150888570255,0.9218436643108965,0.5614678899082569,1.0,1.0,7/18,20.66%,KPNA3;KPNA1;NFKBIA;KPNB1;POM121;BRAP;RANBP6
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.3053819448116855,0.9197702159674648,0.5566666666666666,1.0,1.0,6/35,10.48%,SRC;FYN;SYK;PEAK1;LYN;YES1
prerank,transcription cis-regulatory region binding (GO:0000976),0.2240660130203387,0.9190175215255282,0.6904761904761905,1.0,1.0,59/406,14.54%,ATF3;CTCFL;DACH1;SIM1;ARID5A;FOXN2;TFCP2;MTERF3;TAL1;ATF6;LEF1;ELK3;PAX8;STOX1;GABPA;NR5A1;MMP12;BBX;SOX2;SMARCA2;YY1;FLI1;ZSCAN2;VEZF1;RFX3;NFX1;CALCOCO1;FOXF2;SFPQ;LONP1;ACTN4;DRAP1;ZNF3;ZBTB14;RELA;SOX13;TRPS1;XRN2;JUND;PARK7;TFAP4;CARM1;RPS3;ZBED4;E2F3;MZF1;SP1;IRF2;CHD3;TBP;HDAC5;DDIT3;THRA;EPAS1;CREBRF;DR1;GRHL1;PURG;E2F6
prerank,palmitoyltransferase activity (GO:0016409),0.3200157178738655,0.9185106417703174,0.5786618444846293,1.0,1.0,6/28,14.14%,ZDHHC17;ZDHHC13;ZDHHC14;ZDHHC15;ZDHHC9;ZDHHC7
prerank,ubiquitin protein ligase activity (GO:0061630),0.23607434120622459,0.9180280812785737,0.6666666666666666,1.0,1.0,48/228,17.58%,RNF7;CBL;ARIH1;RNF149;RNF38;RFFL;BIRC2;NEURL2;NEDD4L;VPS11;NHLRC1;RBBP6;UBE3A;TRIM14;IRF2BPL;RNF130;NFX1;COP1;RNF187;PPP1R11;TRIM25;MDM2;MYCBP2;RFWD3;UBE3D;RNF6;ZNRF1;RNF13;RNF25;ANAPC11;DTX4;RNF11;CUL3;RNF216;TRIM27;RNF180;FANCL;TRIM3;NHLRC3;RNF114;PELI1;RNF128;RNF125;VPS18;UBR3;MSL2;KCMF1;RNF215
prerank,voltage-gated anion channel activity (GO:0008308),0.37421430419797397,0.9147659980768409,0.5916515426497277,1.0,1.0,3/15,5.71%,CLCN3;GPR89A;GPR89B
prerank,exopeptidase activity (GO:0008238),-0.254227550388203,-0.9141803968494678,0.6214099216710183,0.7852205784165582,1.0,16/50,21.50%,DPP6;RNPEP;TRHDE;DPP4;ANPEP;DPP10;FAP;CPM;CTSA;NAALAD2;CTSZ;LAP3;ACE;ENPEP;DPP3;GGH
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.3248974931432271,0.9120234765506325,0.5795246800731262,1.0,1.0,5/24,14.14%,ZDHHC17;ZDHHC14;ZDHHC15;ZDHHC9;ZDHHC7
prerank,chemokine activity (GO:0008009),0.3155325900212367,0.9105502424695942,0.5983193277310924,1.0,1.0,2/31,8.53%,CXCL12;CCL25
prerank,histone deacetylase binding (GO:0042826),0.2632460071889327,0.9105480457955224,0.6419019316493314,1.0,1.0,16/88,13.89%,TAL1;LEF1;HDAC9;HDAC3;MAPK8;YWHAB;SFPQ;HEY2;RELA;PKN1;AKAP8L;TFAP4;CIR1;SP1;HDAC5;HES1
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.3542995881932354,-0.909571469726916,0.5894736842105263,0.7925019883917959,1.0,3/14,5.64%,SLC7A11;SLC1A3;SLC25A13
prerank,Notch binding (GO:0005112),-0.30727530031025424,-0.909072593905107,0.6069767441860465,0.7903985740669158,1.0,6/22,20.57%,SNED1;DNER;SNW1;CCN3;MEGF10;DTX1
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.3953392992763873,0.9080272583487249,0.5779467680608364,1.0,1.0,1/11,0.82%,MAP3K11
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.387669758310781,0.9067097786276842,0.5728744939271255,1.0,1.0,2/11,11.45%,APLF;RPS3
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),-0.37873049388559943,-0.9055597804945111,0.5945378151260504,0.7946088134361518,1.0,2/11,14.70%,SLC22A4;SLC25A47
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.3382459492806969,-0.9044282907337184,0.6059322033898306,0.7939064852371543,1.0,8/15,38.36%,PLA2G4A;SNX3;SAP30L;SH3PXD2B;PLEKHF1;JPH2;PLA2G4E;PHLDA3
prerank,calcium ion binding (GO:0005509),0.22473141884335518,0.9028652419736585,0.7157894736842105,1.0,1.0,43/323,12.86%,EFHD2;SPOCK2;LCP1;EML1;SLC25A24;CABYR;ASTN2;CETN3;PPP3CB;ADGRL3;NUCB2;MEX3B;LTBP4;ATP2A2;ITSN1;CDH2;EFHD1;MMP12;ESYT2;SDF4;RASGRP3;CIB1;RET;MCTP2;CALM3;SELP;CDH12;RCN2;AIF1L;S100A16;TRPM4;MCTP1;PAM;ACER3;PPP3CA;PRNP;PPP3R1;MICU3;IDS;AGRN;LETM1;SLC25A12;CDH5
prerank,serine-type endopeptidase activity (GO:0004252),0.259848088353022,0.9027953867640702,0.6189069423929099,1.0,1.0,2/80,0.59%,PCSK1;CELA1
prerank,protein phosphatase inhibitor activity (GO:0004864),0.3203143666695123,0.9022789809336412,0.6139130434782609,1.0,1.0,6/26,15.59%,SAG;BOD1;PPP1R11;MGAT5;CABIN1;PPP1R8
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.3713097768640885,0.902040708266633,0.6102661596958175,1.0,1.0,6/16,18.18%,ATP6V1D;ATP6V0D1;ATP6V0E1;ATP6V1B2;ATP5F1B;ATP6V1A
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.3713097768640885,0.902040708266633,0.6102661596958175,1.0,1.0,6/16,18.18%,ATP6V1D;ATP6V0D1;ATP6V0E1;ATP6V1B2;ATP5F1B;ATP6V1A
prerank,lipoprotein particle receptor binding (GO:0070325),-0.29240702226500964,-0.9010658514062304,0.619277108433735,0.7981107512056373,1.0,5/27,12.26%,LRP1;RELN;HSPG2;AP2A1;MESD
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",-0.2920358743893669,-0.9004743661258334,0.6057692307692307,0.7962621647353902,1.0,17/28,42.88%,PRORP;AGO3;DICER1;ELAC1;RPP30;RPP14;DROSHA;RPP21;EDC3;DBR1;ELAC2;RNASEH2A;POP4;RPP38;NUDT16;MRPL44;NUDT16L1
prerank,exoribonuclease activity (GO:0004532),0.3695817716389308,0.8969238288864486,0.5767097966728281,1.0,1.0,4/12,13.09%,CNOT7;EXOSC9;EXOSC1;CNOT6
prerank,manganese ion binding (GO:0030145),0.28722060462873983,0.8966277251783442,0.6273006134969326,1.0,1.0,7/48,11.55%,PCK1;GYG1;PIM1;SOD2;EXD2;PAPOLA;MGAT5
prerank,calcium:sodium antiporter activity (GO:0005432),-0.38139350679524986,-0.8960242258595877,0.6181818181818182,0.8025613633184563,1.0,2/10,9.44%,SLC24A3;SLC24A2
prerank,protein phosphatase activator activity (GO:0072542),0.3766766156921184,0.8957568445640087,0.6105476673427992,1.0,1.0,6/13,21.18%,CALM3;PTPA;PPP2R5A;CALM1;PPP2R5C;PHACTR4
prerank,protein kinase regulator activity (GO:0019887),-0.2230047264025848,-0.8956057720849531,0.7072368421052632,0.800199008268425,1.0,20/95,14.89%,PRKAG2;CCNL2;PARVA;DNAJC3;ELP4;WNK1;PRKAG1;GMFB;TAOK3;CAB39;CDKN1B;CCND3;STRADA;STK11;PRKAR1B;CCNT1;MADD;DUS2;RPLP1;CCNK
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.3895961837758289,0.8955472365527173,0.5834932821497121,1.0,1.0,4/12,14.40%,BCL2L13;BAD;NOD1;APAF1
prerank,aminopeptidase activity (GO:0004177),0.31477543910233585,0.895149758072364,0.6214285714285714,1.0,1.0,2/26,5.04%,LVRN;METAP2
prerank,single-stranded DNA binding (GO:0003697),0.2515519740327663,0.8936453635008913,0.6533523537803139,1.0,1.0,17/93,12.64%,CTC1;PCBP1;ERCC4;SSBP1;PMS2;CDC45;LONP1;MLH1;SPRTN;RAD23A;POLA1;RAD51B;PARK7;MSH3;APTX;TOP3A;NUP35
prerank,histone deacetylase activity (GO:0004407),0.33227339593790906,0.8912109393564462,0.5958254269449715,1.0,1.0,4/19,7.36%,HDAC9;HDAC3;SIRT3;SIRT1
prerank,diacylglycerol kinase activity (GO:0004143),-0.36483119322135676,-0.890999049557371,0.6207627118644068,0.8070459080509331,1.0,3/11,12.46%,DGKI;DGKH;AGK
prerank,N-methyltransferase activity (GO:0008170),0.3481903576346667,0.8909395799088794,0.6060070671378092,1.0,1.0,4/20,13.14%,TRMO;TRMT11;SETD3;RNMT
prerank,gamma-tubulin binding (GO:0043015),0.33772719235598564,0.8896341942321205,0.6184971098265896,1.0,1.0,5/21,10.75%,TUBGCP5;ARHGEF7;RAB11FIP5;PAK1;DDX3X
prerank,neuropeptide receptor activity (GO:0008188),0.30897732877274126,0.8887224776188108,0.6423728813559322,1.0,1.0,2/29,2.09%,NPFFR1;TACR1
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.33292059855502165,0.8885818795727328,0.6166077738515902,1.0,1.0,4/21,9.23%,CDK19;CDK11B;CDK4;CDKL4
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.33292059855502165,0.8885818795727328,0.6166077738515902,1.0,1.0,4/21,9.23%,CDK19;CDK11B;CDK4;CDKL4
prerank,ribonuclease activity (GO:0004540),0.27188428663900666,0.8884026907105962,0.6478658536585366,1.0,1.0,18/56,20.89%,ZC3H12D;RNASE6;CNOT7;EXOSC9;RNASE12;EXOSC1;CNOT6;PPP1R8;ANG;RNASE4;N4BP1;SMG6;TSNAX;DIS3L2;EXOSC7;AGO1;RNASE1;ERN1
prerank,sodium channel regulator activity (GO:0017080),0.29412846757833216,0.8879162817348911,0.6612641815235009,1.0,1.0,4/37,6.33%,RSC1A1;NEDD4L;FXYD6;FGF13
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",-0.3163777945239889,-0.8866717268202254,0.6414686825053996,0.8129063418220743,1.0,17/18,68.40%,DHRS11;HSD17B7;HSD17B8;HSD11B1;HSD17B10;HSD17B2;HSD3B7;HSD17B14;HSD17B1;SRD5A2;HSD3B2;AKR1C1;DHRS9;RDH16;HSD17B6;HSD17B3;RDH5
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.3759994161653522,-0.8862135127729929,0.6122004357298475,0.8108149998983477,1.0,5/11,10.86%,RAD50;STN1;HNRNPA2B1;RPA1;HNRNPA1
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.34249949071261,-0.8852521702560768,0.6455981941309256,0.8097324824088412,1.0,3/15,26.87%,CCR9;CMKLR1;CX3CR1
prerank,phosphotyrosine residue binding (GO:0001784),0.29783883873197664,0.8848055291938292,0.6558441558441559,1.0,1.0,10/37,18.07%,BCAR3;PFN1;SAMSN1;SYK;YES1;CRKL;LDLRAP1;SHC1;PTPN11;IRS1
prerank,translation initiation factor activity (GO:0003743),0.29681936160318434,0.883200643908704,0.6519607843137255,1.0,1.0,13/36,20.20%,EIF2S1;EIF2A;EIF3B;EIF2B3;EIF4G2;EIF5;EIF3M;EIF2S2;EIF3A;EIF4G1;EIF3E;EIF1;EIF4E
prerank,kinase activity (GO:0016301),0.2450045169258228,0.8829526928888867,0.6811188811188811,1.0,1.0,26/109,17.96%,PIK3CG;PPIP5K2;TRIB3;DGKB;PIK3C2G;PANK2;CERKL;LYN;ETNK1;PI4KA;PIK3CD;MAP4K4;IP6K2;PAPSS1;TRRAP;PIK3C2A;CDKL5;PGM2L1;TAF1;CERK;ITPKB;PANK1;PANK4;ADPGK;DGKK;SEPHS1
prerank,G protein-coupled peptide receptor activity (GO:0008528),-0.2315400226276755,-0.8826087742316435,0.7270114942528736,0.8120826285700083,1.0,6/73,6.33%,SORCS1;CALCRL;LGR4;SORCS3;NPR3;EDNRA
prerank,mannosyltransferase activity (GO:0000030),0.3348108331420596,0.8808639896788966,0.620253164556962,1.0,1.0,5/21,11.36%,TMTC2;DPY19L4;ALG8;DPY19L1;PIGB
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),-0.2850434371429161,-0.8803235958307245,0.6391509433962265,0.8136529756219113,1.0,6/28,19.85%,EDA;CASP8AP2;MADD;TRAF2;TMBIM1;STAT1
prerank,mechanosensitive ion channel activity (GO:0008381),-0.36123068332853525,-0.8802240683511166,0.6433566433566433,0.8107440090013335,1.0,5/12,28.43%,PIEZO2;TMEM63A;TMEM63B;TMC4;TMC6
prerank,MAP kinase activity (GO:0004707),0.3662677575664244,0.8794766055572427,0.6473988439306358,1.0,1.0,5/14,12.90%,MAPK3;MAPK8;NLK;MAPK6;MAPK12
prerank,NF-kappaB binding (GO:0051059),0.3240954810351696,0.8783277208250176,0.6449399656946827,1.0,1.0,9/24,18.47%,HDAC3;EP300;RELA;RNF25;TAF4B;FAF1;NFKBIA;NPM1;HDAC2
prerank,phosphoric ester hydrolase activity (GO:0042578),-0.24499129568128516,-0.8776856162696671,0.704,0.8126509433438818,1.0,13/49,20.52%,ATP1A2;MPPED2;PLCXD3;SACM1L;DUSP16;FRA10AC1;ENPP6;PTPN22;ACP2;PTPRO;GDPD3;LHPP;SBF1
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.2286798727531183,0.8773934217045735,0.7448186528497409,1.0,1.0,29/188,13.56%,ATF3;CTCFL;ARID5A;MTERF3;TAL1;ATF6;PAX8;GABPA;SOX2;SMARCA2;YY1;FLI1;RFX3;CALCOCO1;SFPQ;ZBTB14;RELA;SOX13;JUND;TFAP4;CARM1;ZBED4;MZF1;SP1;CHD3;TBP;HDAC5;DDIT3;THRA
prerank,tau-protein kinase activity (GO:0050321),0.3296080442981546,0.8765453025844582,0.6211849192100538,1.0,1.0,3/20,6.62%,GSK3A;FYN;SIK3
prerank,steroid hydroxylase activity (GO:0008395),-0.3316607114431568,-0.8751584840024934,0.6383442265795207,0.8148510289326731,1.0,2/16,6.72%,CYP27A1;CYP7B1
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.30083663754076634,0.8736428408367668,0.6420361247947455,1.0,1.0,9/32,18.09%,JMJD4;ALKBH2;KDM2A;TET3;EGLN2;PHF8;FTO;TET2;KDM4C
prerank,cytokine activity (GO:0005125),-0.20649717263304682,-0.8714840324182541,0.8074074074074075,0.8191614580574305,1.0,14/131,13.96%,BMP6;WNT5B;BMP5;BMP7;BMP4;IL34;WNT4;AIMP1;IL16;CCL14;IL18;WNT9A;IL33;TNFRSF11B
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.34991943392843783,0.871155683240024,0.6395563770794824,1.0,1.0,4/15,12.68%,SLC1A1;SLC17A6;SLC1A2;SLC25A12
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.3521327480094081,0.8677923337271901,0.6283018867924528,1.0,1.0,3/14,15.51%,RDH11;RDH10;AKR1A1
prerank,cytokine receptor binding (GO:0005126),-0.22556761332689346,-0.867103577032141,0.8225806451612904,0.8248366510849932,1.0,11/83,14.02%,TGFBR3;SMAD3;JAK1;OSMR;IL6R;PIBF1;IL34;IL13RA1;SOCS2;IL18;IL6ST
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.2640415753074842,0.8664306221558238,0.7009493670886076,1.0,1.0,14/57,14.53%,NDUFB6;NDUFB4;COX6B1;NDUFA10;NDUFA1;NDUFS2;COX5A;NDUFB7;COX15;NDUFV3;NDUFA8;NDUFC2;NDUFA13;COX10
prerank,RNA stem-loop binding (GO:0035613),0.3712266309112524,0.8649244576755171,0.662,1.0,1.0,6/12,23.89%,DDX3X;RC3H1;DHX9;RC3H2;FMR1;MYH10
prerank,phospholipid transfer activity (GO:0120014),0.3266586524655327,0.86359207097015,0.6560283687943262,1.0,1.0,8/21,18.75%,PRELID3B;PRELID2;PITPNA;OSBPL2;CERT1;PLEKHA3;PLTP;PITPNB
prerank,signal sequence binding (GO:0005048),0.2869655302487835,0.8610922956796527,0.6964586846543002,1.0,1.0,9/35,17.60%,TOMM20;KPNA3;KDELR2;KPNA1;SEC61A2;NFKBIA;AP2M1;KPNB1;POM121
prerank,mitogen-activated protein kinase binding (GO:0051019),0.2975922810921707,0.859934652798815,0.6348122866894198,1.0,1.0,5/29,14.38%,DUSP7;PTPRJ;SIRT1;NBR1;GCH1
prerank,transcription coactivator binding (GO:0001223),0.3267524377773193,0.8596448528619358,0.6440071556350626,1.0,1.0,6/20,10.73%,RPL23;PPARD;RELA;TERT;ESR1;THRB
prerank,cholesterol binding (GO:0015485),0.2750437175788658,0.8577328670489626,0.7129032258064516,1.0,1.0,11/47,13.86%,PROM1;OSBPL10;SOAT1;TSPO;OSBPL1A;ERLIN2;CD81;STARD3NL;NPC2;NPC1;OSBPL2
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.31966253740577183,0.8564134904045735,0.7098445595854922,1.0,1.0,5/22,14.61%,APOE;SNX17;PICALM;LDLRAP1;AP2M1
prerank,tumor necrosis factor receptor binding (GO:0005164),0.3651775051879944,0.8562136340660578,0.6382978723404256,1.0,1.0,2/12,8.92%,TRAF5;TRAF3
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.3689984719399138,0.8556896448488542,0.6372007366482505,1.0,1.0,4/12,20.78%,PDE4D;PDE8B;PDE8A;PDE3A
prerank,methyl-CpG binding (GO:0008327),0.31150035492082234,0.851928911631948,0.6790780141843972,1.0,1.0,4/22,11.18%,ZBTB33;CHTOP;TET3;ERH
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.3058331855033642,0.851283854946691,0.6568144499178982,1.0,1.0,8/27,16.84%,ARIH1;DCUN1D4;AUP1;UBE3D;RNF180;RNF125;DCUN1D1;DCUN1D2
prerank,hexosyltransferase activity (GO:0016758),0.23794863636489352,0.85095768872575,0.7338935574229691,1.0,1.0,8/101,4.53%,CSGALNACT1;GYG1;TMTC2;CHSY3;EXT2;POMGNT2;ALG6;DPY19L4
prerank,heme binding (GO:0020037),0.25543946727051436,0.8491615050346013,0.695852534562212,1.0,1.0,9/65,11.65%,HMOX2;CYCS;PTGES2;SRC;THAP4;CYP1B1;CYB5R4;NOS3;COX15
prerank,phosphatidylinositol binding (GO:0035091),0.24368129511095632,0.8485739117782692,0.7346368715083799,1.0,1.0,23/91,16.77%,EXOC8;MCF2L;SNX8;ESYT2;PLEKHF2;DENND1A;SNX17;WDFY1;EPB41;SNX1;PITPNA;ING2;ZFYVE9;PICALM;SCARB1;MYO1E;SNX24;AIDA;PARD3;DENND1B;PIGU;ZFYVE1;SNX16
prerank,SUMO binding (GO:0032183),-0.33739301866696614,-0.8477830863726807,0.6659192825112108,0.8591589649881108,1.0,4/13,9.42%,CASP8AP2;PML;RNF4;USPL1
prerank,protein kinase C binding (GO:0005080),0.27338043300701903,0.8464960923940548,0.7006472491909385,1.0,1.0,8/43,13.32%,TIRAP;HDAC9;HDAC7;PRKD2;TRPV4;PKN1;HDAC5;PLEK
prerank,ankyrin binding (GO:0030506),0.3258987840447981,0.8429192883702198,0.6879699248120301,1.0,1.0,2/19,2.02%,SPTB;PTPRC
prerank,ubiquitin conjugating enzyme activity (GO:0061631),-0.26275724316887306,-0.8428691085562068,0.7039800995024875,0.8652974054075502,1.0,10/31,26.85%,UBE2N;UBE2E1;UBE2J2;UBE2J1;UBE2K;UBE2Q1;UBE2B;UBE2S;UBE2G2;UBE2E2
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.32330190672507797,0.8421077349017231,0.6726296958855098,1.0,1.0,2/18,3.90%,RPS6KA1;BIRC2
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.3312680748742362,-0.8409776453675968,0.7139830508474576,0.8654697929176941,1.0,5/14,20.67%,MTMR7;MTMR12;MTMR9;MTMR4;MTMR11
prerank,MHC protein binding (GO:0042287),0.3203542348420666,0.8390063550537771,0.6758147512864494,1.0,1.0,5/20,20.22%,TUBB;CD81;ATP5F1B;DERL1;TAP2
prerank,DNA-binding transcription factor binding (GO:0140297),0.21653228257488255,0.8379505740394624,0.8193384223918575,1.0,1.0,39/189,16.16%,CHCHD2;TAL1;HES6;DMAP1;HIPK2;GABPA;HDAC9;HDAC7;USF2;EP300;PPARD;SIRT1;HEY2;RELA;PIAS2;PARK7;LMO2;RBPJ;CREBBP;CTBP1;TLE4;PIAS1;IFI27;RERE;SP1;NBN;NEK6;TBP;HDAC5;DDIT3;HES1;HCFC1;CRTC3;MAP3K10;TCERG1;TAF1;TCF3;ID2;PURB
prerank,alpha-tubulin binding (GO:0043014),0.28729472128902184,0.837394337065799,0.7154605263157895,1.0,1.0,9/31,16.62%,FYN;DIP2B;DNAL1;TRPV4;TBCEL;TTLL7;EFHC2;INO80;SETD2
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.35958839149316507,-0.8360955100937678,0.6739562624254473,0.8712860519199908,1.0,5/10,15.30%,DPP6;DPP4;DPP10;FAP;NAALAD2
prerank,MAP kinase kinase kinase activity (GO:0004709),0.3564858148351031,0.8346776397518519,0.6834532374100719,1.0,1.0,2/11,5.23%,MAP3K7;MAP3K4
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.3401936418793913,0.8339826310820475,0.6883629191321499,1.0,1.0,3/15,8.77%,NDST3;HS6ST1;HS3ST2
prerank,telomerase RNA binding (GO:0070034),0.31049260144716206,0.8331061170060341,0.7011686143572621,1.0,1.0,9/22,19.61%,HNRNPC;TERT;DKC1;PARN;SMG6;SMG5;SNRPD3;DHX36;SMG7
prerank,H4 histone acetyltransferase activity (GO:0010485),0.35765254690578924,0.8318774280338807,0.6595744680851063,1.0,1.0,5/10,18.94%,EP300;USP22;NAA50;MSL3;HAT1
prerank,DNA polymerase binding (GO:0070182),0.31856118710483966,0.8318455330853911,0.6982142857142857,1.0,1.0,7/18,20.90%,LONP1;ACD;CDK2AP1;SMARCA4;SMG6;PTGES3;HSP90AB1
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.28218217285222746,0.8306454314511923,0.7135678391959799,1.0,1.0,11/35,17.30%,RUVBL2;MMP12;DRAP1;RELA;PARK7;TBP;DR1;BAZ2A;TAF1;SMARCA4;NPM1
prerank,chemokine receptor binding (GO:0042379),0.2809164392166545,0.8303895725855455,0.7257799671592775,0.9993624538771192,1.0,2/35,8.53%,CXCL12;CCL25
prerank,channel activity (GO:0015267),-0.2457536791747086,-0.8290510440200393,0.7385786802030457,0.8812075794212757,1.0,11/41,26.53%,PDPN;AQP4;MPV17;TMEM120B;MCUB;BCL2;TMEM120A;PANX1;AQP11;TRPV2;CHRNA7
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),-0.2906715427008384,-0.8288333065154696,0.7224770642201835,0.878373149919975,1.0,2/21,4.77%,GLRB;P2RX4
prerank,gated channel activity (GO:0022836),0.3517441035543295,0.8287693534975593,0.6719858156028369,0.9988934320196776,1.0,2/14,8.46%,TMEM266;TMC7
prerank,acetyltransferase activity (GO:0016407),0.27858382143622623,0.8287631912726756,0.7337770382695508,0.9951408281683262,1.0,8/31,18.45%,ACAT1;EP300;ESCO1;CREBBP;NAA80;NAA15;ELP3;NAA50
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.2565085966134727,-0.8279234446682399,0.7420212765957447,0.8768955118146728,1.0,12/34,21.42%,IQGAP1;CAB39;MAP2K2;STRADA;CCNT1;FAM20A;IGF2;TAOK1;CCNK;IRGM;PARP16;ETAA1
prerank,phosphatase inhibitor activity (GO:0019212),0.3080769631610534,0.8269978992101509,0.6838365896980462,0.9949858653720393,1.0,4/20,13.54%,SAG;BOD1;MGAT5;CABIN1
prerank,protein phosphatase regulator activity (GO:0019888),0.25709012016651744,0.8230088118701954,0.7520259319286872,0.9992054134285739,1.0,18/53,20.32%,SAG;PPP2R2D;BOD1;PPP1R16B;CALM3;RCAN2;ANKLE2;MGAT5;CABIN1;PTPA;PPP6R1;PPP2R3A;PPP2R5A;CALM1;IGBP1;PPP2R5C;PPP1R2;RCAN3
prerank,protein phosphatase 2A binding (GO:0051721),0.3014892407549075,0.8184656980620879,0.718978102189781,1.0,1.0,10/23,20.30%,BOD1;MFHAS1;ANKLE2;CTTNBP2NL;STRN4;PTPA;SMG5;IGBP1;SMG7;STRN3
prerank,iron ion binding (GO:0005506),-0.23092300174021102,-0.8152612403362982,0.8038147138964578,0.8965101821241727,1.0,20/48,31.19%,AGMO;AOX1;DNAJC24;TET1;KDM7A;FTL;NFU1;PHYH;FDX1;EGLN3;PHF2;CDO1;JMJD6;EGLN1;ABCE1;HIF1AN;SNCA;ETHE1;SCD;FXN
prerank,ligand-gated cation channel activity (GO:0099094),-0.21118621478820923,-0.8145564118872488,0.8772455089820359,0.8943291696192893,1.0,19/75,29.46%,GRIA4;GRIA2;GRIN2B;P2RX4;KCNJ2;KCNJ6;GRIK4;KCNJ13;KCNJ10;GRIK1;GRIK3;GRIN2D;GRIN1;MCOLN1;CHRNA7;GRIA1;KCNK1;KCNJ12;CCDC51
prerank,nucleotide diphosphatase activity (GO:0004551),0.32869528852986674,0.8144403502691827,0.7070524412296564,1.0,1.0,2/14,3.92%,NUDT11;NUDT12
prerank,pentosyltransferase activity (GO:0016763),0.26982799425738085,0.8128732017762446,0.7602862254025045,1.0,1.0,7/36,11.75%,UPP1;SIRT3;SIRT1;PARP11;UPP2;PNP;TNKS
prerank,ADP binding (GO:0043531),-0.2680049475509537,-0.8120745913558135,0.7355769230769231,0.8955700249751148,1.0,4/25,6.88%,PRKAG2;ME1;PRKAG1;GLUD1
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.32367425478050005,-0.8114648325856254,0.7252525252525253,0.8933955617247074,1.0,6/12,19.70%,CDK6;BRD4;CDK7;CCNK;CDK9;CDK12
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.3159065915167134,-0.8112848379886332,0.7230769230769231,0.8904713073367735,1.0,7/14,45.65%,KCNJ2;KCNQ1;KCNJ3;KCNJ8;KCNE4;KCNIP2;KCNH2
prerank,bHLH transcription factor binding (GO:0043425),0.30940225496637286,0.8095916354226008,0.6822429906542056,1.0,1.0,7/19,15.90%,USF2;SIRT1;LMO2;CREBBP;SP1;MAP3K10;TCF3
prerank,O-methyltransferase activity (GO:0008171),0.3603829203919149,0.8091538412255946,0.7063655030800822,1.0,1.0,1/10,2.20%,BCDIN3D
prerank,protein phosphatase 1 binding (GO:0008157),0.3027021595512674,0.8076464813686188,0.7596491228070176,1.0,1.0,3/21,12.28%,PPP1R16B;PPP1R11;AKAP11
prerank,lysine N-methyltransferase activity (GO:0016278),-0.2851820363837752,-0.80715878621344,0.7314814814814815,0.8944840753885981,1.0,7/20,23.23%,SETD7;EHMT2;ATPSCKMT;EEF1AKMT1;SMYD2;SETD4;METTL21A
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.3455848237878153,0.8064952873056973,0.6897196261682244,1.0,1.0,6/12,19.34%,KDM3A;KDM4D;JMJD1C;PHF8;KDM4C;KDM3B
prerank,acetylglucosaminyltransferase activity (GO:0008375),-0.22737270880978083,-0.8055580777688203,0.8388888888888889,0.8938357929159996,1.0,9/46,19.28%,MGAT4C;OGT;HEXA;HEXB;LARGE1;B3GALT5;B3GALNT1;B3GALT1;PIGA
prerank,histone demethylase activity (GO:0032452),0.2898754495049174,0.8048800956891471,0.7252173913043478,1.0,1.0,7/27,14.40%,KDM3A;KDM2A;KDM6A;KDM4D;JMJD1C;KDM5C;PHF8
prerank,RNA cap binding (GO:0000339),0.3209003274589837,0.8044339284439334,0.7255985267034991,1.0,1.0,7/16,20.20%,NCBP1;GEMIN5;NCBP3;CYFIP1;LSM1;LARP1;EIF4E
prerank,sulfotransferase activity (GO:0008146),-0.2472814520668865,-0.8031147357416625,0.7668269230769231,0.8948448536388235,1.0,4/33,10.57%,UST;HS3ST3A1;CHST15;CHST11
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.33124097671207076,-0.8029435960087622,0.7319587628865979,0.8920092919511062,1.0,9/11,66.89%,CHRNA7;CHRNB1;CHRNA4;CHRNB2;CHRNA9;CHRNA5;CHRNA3;CHRNB4;CHRNA1
prerank,methyltransferase activity (GO:0008168),0.2540323642060009,0.8003154183177802,0.7929883138564274,1.0,1.0,12/46,19.67%,BCDIN3D;PRMT3;TRMT11;METTL27;CARNMT1;RRP8;NTMT1;COQ5;LCMT1;COQ3;NSUN2;FTSJ1
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.27192061654218946,0.7980543908858853,0.7648026315789473,1.0,1.0,3/30,6.13%,RPS6KA1;BIRC2;CARD16
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.32766303305499367,0.797463573635994,0.7124773960216998,1.0,1.0,3/14,14.60%,CYB5R4;AIFM1;CYBA
prerank,serine-type peptidase activity (GO:0008236),0.22257371176123208,0.7965714322613996,0.8553008595988538,1.0,1.0,2/96,0.59%,PCSK1;CELA1
prerank,calcium activated cation channel activity (GO:0005227),-0.292229842878473,-0.7930564807788351,0.7455357142857143,0.9052500263555541,1.0,6/17,18.97%,KCNMA1;ANO1;TMEM63A;ANO6;TMEM63B;ANO10
prerank,telomeric DNA binding (GO:0042162),0.27167980000872294,0.7920228194334824,0.7809364548494984,1.0,1.0,5/32,10.31%,CTC1;SMG1;ACD;UPF2;TERT
prerank,cytokine receptor activity (GO:0004896),0.22822208478606631,0.7886559667311498,0.8563049853372434,1.0,1.0,4/83,3.23%,GFRA3;IL1R1;IFNLR1;CRLF1
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.268664631073076,0.7876501781535886,0.8090614886731392,1.0,1.0,7/34,14.16%,EZH2;TTLL12;SMYD3;SETD3;KMT5B;DOT1L;ETFBKMT
prerank,nuclear export signal receptor activity (GO:0005049),0.33827832339631997,0.7872309931077585,0.7215686274509804,1.0,1.0,4/11,18.34%,RANBP17;XPO5;XPO1;NUP42
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.33439788345194893,0.7871604945199213,0.752851711026616,1.0,1.0,4/12,15.76%,RUVBL2;RELA;TBP;TAF1
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.27670105986772847,-0.7869360716984907,0.8162790697674419,0.9116752104373136,1.0,8/20,24.91%,SLC39A14;SLC30A10;SLC39A13;SLC30A4;SLC39A8;SLC39A7;SLC39A6;SLC30A5
prerank,sterol binding (GO:0032934),0.24401123804357797,0.7822778253133744,0.8414442700156985,1.0,1.0,12/56,13.86%,INSIG1;PROM1;OSBPL10;SOAT1;TSPO;OSBPL1A;ERLIN2;CD81;STARD3NL;NPC2;NPC1;OSBPL2
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.26736454815392147,0.7767342751870243,0.7923875432525952,1.0,1.0,4/29,11.69%,ACER2;ENGASE;MGAM;ACER3
prerank,aspartic-type endopeptidase activity (GO:0004190),-0.3097805438078686,-0.7765449325699091,0.7607758620689655,0.9240612298087172,1.0,4/12,16.73%,BACE2;BACE1;DDI2;HM13
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.3039733877521805,-0.7731835136710737,0.7729257641921398,0.9259243564593846,1.0,3/13,5.80%,AGPAT4;ABHD5;AGPAT5
prerank,phosphatase activity (GO:0016791),0.22493841715072266,0.7638476198837056,0.875968992248062,1.0,1.0,12/73,13.44%,PTPRJ;ENOPH1;DUSP12;PLPP6;PXYLP1;PLPP1;PRUNE1;DUSP11;APTX;PGP;PTPMT1;PPP5C
prerank,phosphate ion binding (GO:0042301),0.34415580846646965,0.7635907153390338,0.745136186770428,1.0,1.0,2/10,10.66%,RELA;PNP
prerank,MHC class II protein complex binding (GO:0023026),-0.3169411482292248,-0.7634228644956983,0.7949260042283298,0.936652917347771,1.0,3/11,10.59%,ATP1B1;ANXA11;PKM
prerank,sodium channel activity (GO:0005272),0.24970689003541513,0.7631721343240773,0.8325281803542673,1.0,1.0,3/37,4.70%,GRIK5;GRIK2;SCN2A
prerank,phosphatidic acid binding (GO:0070300),-0.270276466174705,-0.7612382791388014,0.838012958963283,0.9365092470257471,1.0,13/19,40.77%,GRAMD1B;SMPD3;PITPNC1;COMMD1;RAPGEF2;GSDMD;PLEKHN1;MICALL1;JPH2;MAPKAP1;ATP13A2;OPA1;PITPNM1
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.2878056647012496,0.761013686090199,0.8035714285714286,1.0,1.0,3/22,8.82%,ILF3;ZFP36L1;EXOSC9
prerank,chloride transmembrane transporter activity (GO:0015108),0.3051381872225485,0.7606914834394136,0.8018518518518518,1.0,1.0,2/16,9.03%,SLC1A1;CLCN7
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.3380721022630369,0.7578541214525278,0.7650375939849624,1.0,1.0,4/10,16.62%,SETD5;SETD3;NSD2;SETD2
prerank,myosin II binding (GO:0045159),-0.3288071601680952,-0.7568459538645992,0.7697095435684648,0.939541959726788,1.0,3/10,14.18%,GSN;STXBP5;TRIOBP
prerank,E-box binding (GO:0070888),0.24972232225161248,0.7527679436776464,0.8316498316498316,1.0,1.0,5/34,15.90%,TAL1;CLOCK;TFAP4;HES1;TCF3
prerank,inward rectifier potassium channel activity (GO:0005242),-0.2534687703066161,-0.7525041030556054,0.828978622327791,0.9424790004102951,1.0,11/24,39.15%,KCNJ2;KCNJ6;ABCC9;KCNJ13;KCNJ10;KCNK1;KCNJ12;KCNJ3;KCNK6;KCNJ8;KCNJ15
prerank,Hsp70 protein binding (GO:0030544),-0.23451188781827387,-0.752276539691262,0.8416289592760181,0.9395367613960579,1.0,11/31,28.99%,PACRG;PPID;SACS;GPR37;DNAJC2;STUB1;DNAJB2;METTL21A;DNAJA1;PPEF2;SNCA
prerank,RNA methyltransferase activity (GO:0008173),0.29042293211184667,0.7513030272036776,0.7984790874524715,1.0,1.0,1/19,2.20%,BCDIN3D
prerank,histone methyltransferase binding (GO:1990226),0.3251847018168943,0.7511545218778235,0.7640232108317214,1.0,1.0,3/11,15.93%,PRDM4;LCORL;WIZ
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.33004575576964434,0.7501902265389401,0.7706611570247934,1.0,1.0,3/11,16.69%,SLC25A24;SLC25A42;SLC25A25
prerank,NADPH binding (GO:0070402),0.3139156165989193,0.7482540232041875,0.7946257197696737,1.0,1.0,2/13,8.73%,HMGCR;KCNAB1
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.2802622297962148,-0.7478543698551474,0.8199566160520607,0.9423402540734965,1.0,3/16,5.65%,SLC13A3;SLC25A13;SLC1A5
prerank,C2H2 zinc finger domain binding (GO:0070742),0.32619334113994547,0.7472338829108672,0.7822736030828517,1.0,1.0,2/11,8.78%,LEF1;ZXDC
prerank,leucine zipper domain binding (GO:0043522),-0.3254621524339003,-0.7453021345292862,0.8079847908745247,0.9427344267168388,1.0,2/10,5.22%,PAWR;AATF
prerank,NADP binding (GO:0050661),0.25162287763213625,0.7447008451445415,0.8441780821917808,1.0,1.0,5/32,11.33%,SPR;ME3;HMGCR;KCNAB1;NOS3
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.3317269536937393,0.7442845789116054,0.7745098039215687,1.0,1.0,3/10,17.17%,DCLRE1B;EXD2;DCLRE1C
prerank,SH2 domain binding (GO:0042169),0.2582028488034934,0.7435672537595652,0.8293515358361775,1.0,1.0,6/31,14.50%,SRC;DAG1;TRPV4;NLK;RUFY1;PAG1
prerank,ferrous iron binding (GO:0008198),0.2814798510633091,0.7426921013364493,0.8142361111111112,1.0,1.0,6/21,17.79%,ALKBH2;ISCU;EGLN2;FTO;TET2;FECH
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.32007890418998247,-0.7419890424954225,0.7946058091286307,0.9437293126648997,1.0,2/10,12.92%,CXADR;SIRPA
prerank,snoRNA binding (GO:0030515),-0.23014275104370954,-0.7417426027349984,0.8544600938967136,0.9408766859594825,1.0,20/30,42.88%,NUDT4;BMS1;UTP6;DDX21;NOP56;NUFIP1;WDR3;NOP14;NUDT7;IMP3;BYSL;GAR1;IMP4;TSR1;DHX37;NOP10;NUDT1;TBL3;NUDT16;NUDT16L1
prerank,acyl-CoA hydrolase activity (GO:0047617),0.28725412801952327,0.7413923849197503,0.800718132854578,1.0,1.0,4/17,18.10%,PPT1;ACOT8;ACAA2;ACOT13
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.3097144202855873,0.738255057317341,0.8095238095238095,1.0,1.0,2/14,12.61%,NME1;DTYMK
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.3168920172743883,0.7308440525553827,0.8198874296435272,1.0,1.0,3/12,15.02%,GREM1;CDH5;VEGFC
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.2890184253423703,0.7291648538371569,0.8426103646833013,1.0,1.0,4/16,12.04%,TDG;SMUG1;RPS3;ADPRH
prerank,thioesterase binding (GO:0031996),0.31873074383634836,0.7290929455439445,0.8362919132149902,1.0,1.0,3/11,15.68%,TRAF5;TRAF3;ARF6
prerank,N-acetyltransferase activity (GO:0008080),0.2799526097831183,0.7290290176120581,0.8439201451905626,1.0,1.0,3/19,12.94%,EP300;ESCO1;NAA80
prerank,methylation-dependent protein binding (GO:0140034),-0.19871236262419922,-0.7286196123321528,0.9470588235294117,0.9540858983036425,1.0,25/57,31.85%,MBTD1;KDM4A;KDM7A;MPHOSPH8;ZCWPW2;PYGO1;RBBP5;GLYR1;MTF2;SGF29;CBX5;BPTF;SUZ12;KAT8;PHF2;L3MBTL2;PHF1;ZMYND8;NCAPG2;WDR5;KDM8;MSH6;ING1;PHF13;LRWD1
prerank,NAD+ binding (GO:0070403),-0.2976211830144303,-0.7283364850471016,0.8217391304347826,0.9511946445514284,1.0,3/12,6.88%,ZC3HAV1;SIRT2;GLUD1
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.3055694690264859,0.7252478178132165,0.7962616822429907,1.0,1.0,5/12,21.55%,TENT4A;PAPOLA;PAPOLG;MTPAP;TENT2
prerank,cAMP binding (GO:0030552),-0.29952232628193154,-0.7245564086741025,0.8128898128898129,0.9525399807624887,1.0,3/11,15.76%,HCN1;PDE4B;RAPGEF2
prerank,"DNA binding, bending (GO:0008301)",-0.2748706635834912,-0.7242077309790368,0.83640081799591,0.9498031536834826,1.0,9/14,35.72%,FOXD1;FOXC1;SAP30L;FOXL1;HMGA2;TERF1;HMGB1;HHEX;HMGB2
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.268431716699597,-0.7238923680748017,0.8565022421524664,0.947042419742554,1.0,9/17,35.52%,PITPNC1;ABCA1;ATP8B2;ATP8B1;MTTP;ABCA7;ABCB4;ATP10B;PCTP
prerank,BMP binding (GO:0036122),0.3121032824448953,0.7233406863668763,0.8174757281553398,1.0,1.0,1/11,3.13%,GREM1
prerank,receptor antagonist activity (GO:0048019),-0.2644794138477916,-0.7231732141220689,0.844097995545657,0.9447181851473043,1.0,1/17,7.25%,DKK3
prerank,protein kinase inhibitor activity (GO:0004860),0.23601424076760127,0.72155780483142,0.8881685575364667,1.0,1.0,5/42,6.44%,RPTOR;SPRED1;CDKN1A;CIB1;YWHAB
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.3058413885872948,0.7199754429638124,0.796812749003984,1.0,1.0,1/12,1.84%,SLC25A24
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.31245008971879895,0.7179262258164655,0.8089668615984406,1.0,1.0,3/12,10.97%,CIAPIN1;ISCU;CISD2
prerank,proton transmembrane transporter activity (GO:0015078),-0.2115201772441678,-0.71641866164986,0.9168831168831169,0.9489176364454394,1.0,16/39,31.92%,CYB5A;UQCRH;COX8A;CTNS;UQCRC1;NDUFA4;COX7A2L;COX6A1;SLC11A2;DMAC2L;UQCR10;UQCRQ;UQCR11;NNT;COX5B;SLC9A1
prerank,MHC class I protein binding (GO:0042288),0.3023031495205336,0.7138979110355952,0.859073359073359,1.0,1.0,4/13,20.22%,TUBB;ATP5F1B;DERL1;TAP2
prerank,receptor ligand activity (GO:0048018),0.18158539754716205,0.7114104234784688,0.9877750611246944,1.0,1.0,15/245,9.12%,GDF1;JAG2;SEMA6A;SEMA6D;SEMA7A;GREM1;CRLF1;GNRH1;SEMA3C;SEMA6B;BDNF;WNT5A;CCL25;NPPC;SEMA4C
prerank,methylated histone binding (GO:0035064),0.22046389390660548,0.7110641913506592,0.9301972685887708,1.0,1.0,18/62,19.21%,TTLL12;ING4;SPIN1;CDYL;ING3;ING2;CHD1;MORC4;TDRD3;RRP8;ING5;PHF8;TAF1;CHD8;MORC3;ATRX;MSL3;ZMYND11
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.24044561617933663,0.7051389545508026,0.9066666666666666,1.0,1.0,8/34,16.50%,UFC1;UBE2I;AKTIP;UBE2R2;UBE2F;UBE2G1;TAF1;UBE2H
prerank,fatty acid synthase activity (GO:0004312),0.3086584171673411,0.7023566762731456,0.8401639344262295,1.0,1.0,1/10,5.29%,ELOVL6
prerank,cytochrome-c oxidase activity (GO:0004129),0.2843630764812309,0.6998086358984904,0.8301158301158301,1.0,1.0,4/15,14.53%,COX6B1;COX5A;COX15;COX10
prerank,nuclear import signal receptor activity (GO:0061608),-0.2676747263278033,-0.6977468371985599,0.8728813559322034,0.965176113668576,1.0,3/15,12.80%,IPO9;TNPO3;TNPO2
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.2661514962090484,0.6972262924667086,0.8618181818181818,1.0,1.0,5/20,13.91%,YOD1;DESI2;USP47;OTUD5;USP9X
prerank,hormone activity (GO:0005179),0.2139521717151113,0.6949211515838619,0.9264475743348983,1.0,1.0,4/54,10.67%,GNRH1;CCL25;NPPC;PPY
prerank,low-density lipoprotein particle binding (GO:0030169),-0.2603186528175794,-0.693711285646747,0.8818565400843882,0.9658997934937894,1.0,3/16,9.17%,SORL1;LDLR;THBS1
prerank,carbohydrate kinase activity (GO:0019200),-0.2902213487762364,-0.6921451607939085,0.8747390396659708,0.9642276864296051,1.0,7/11,49.43%,NAGK;HK2;GALK1;POMK;HK1;KHK;XYLB
prerank,endoribonuclease activity (GO:0004521),-0.21340833899876577,-0.6893980633723539,0.945273631840796,0.9636888586686119,1.0,13/32,31.88%,AGO3;SND1;DICER1;INTS11;ZC3H12B;RCL1;NOB1;CPSF3;LACTB2;RIDA;ZC3H12A;EXOG;RNASEL
prerank,lipid phosphatase activity (GO:0042577),0.2817204110629241,0.6880381098823645,0.8867562380038387,1.0,1.0,4/14,13.99%,PLPP6;PLPP1;SGPP2;SGPP1
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.2989204934608515,0.6866599113833013,0.8465909090909091,1.0,1.0,4/11,21.10%,SGMS1;PIGN;SAMD8;SGMS2
prerank,phosphatase activator activity (GO:0019211),0.2852388950908435,0.6862752732032132,0.8568627450980392,1.0,1.0,6/14,21.18%,CALM3;PPP2R5A;FRS2;CALM1;PPP2R5C;PHACTR4
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.2913301283022043,-0.6796552509112431,0.8778004073319755,0.9692325149319799,1.0,2/10,16.78%,CDADC1;LACC1
prerank,carboxylic ester hydrolase activity (GO:0052689),0.1972345130044033,0.6780810115500191,0.9687964338781575,1.0,1.0,9/85,15.21%,NDST3;CA2;PLAAT3;PNPLA7;PGLS;ABHD12;ABHD4;PNPLA6;DAGLB
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.266581872213545,-0.6773932126429191,0.8828282828282829,0.9682721389195883,1.0,3/13,20.18%,SLC7A2;SLC38A7;SLC15A4
prerank,actin monomer binding (GO:0003785),0.2472107761310867,0.6758683536466554,0.9121265377855887,1.0,1.0,4/22,14.48%,MRTFA;PFN1;NOS3;TWF1
prerank,5'-3' exonuclease activity (GO:0008409),0.2805371256309848,0.6710361261323234,0.8768939393939394,1.0,1.0,3/14,9.38%,DCLRE1B;XRN2;DXO
prerank,mRNA methyltransferase activity (GO:0008174),0.28675632138835305,0.6653900247141565,0.8809523809523809,1.0,1.0,4/12,20.08%,TRMT61B;RNMT;NSUN2;METTL14
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.25454393102474626,-0.6627635815402598,0.9100642398286938,0.9770338603543087,1.0,4/15,29.68%,P2RX4;P2RY14;P2RY12;P2RY1
prerank,endopeptidase activator activity (GO:0061133),0.2983378570523244,0.6622818725843659,0.865530303030303,1.0,1.0,3/10,15.87%,VSIR;PSMD14;APH1A
prerank,phospholipase A2 activity (GO:0004623),-0.21829154394230552,-0.6553624063033947,0.9297820823244553,0.9795784930146836,1.0,10/26,38.70%,PLA2G4A;ABHD3;PLA2G6;PLA2G7;PLA2G12A;PLA2G15;PRDX6;PLA2G4E;PNPLA3;PLA2G4C
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.2714476969321029,0.6534341196724596,0.9127272727272727,1.0,1.0,4/15,13.93%,LPCAT2;GPAT4;AGPAT3;ABHD4
prerank,lysophospholipase activity (GO:0004622),0.24477208150022786,0.6445437998197354,0.9105839416058394,1.0,1.0,6/20,20.37%,PNPLA7;ABHD12;ABHD4;PNPLA6;LYPLA1;ENPP2
prerank,P-type ion transporter activity (GO:0015662),-0.26094202442780434,-0.6385307291351576,0.9096509240246407,0.9879207068257416,1.0,2/12,5.68%,ATP6V1E1;ATP7A
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.20772649526871384,0.6375099680750396,0.975767366720517,1.0,1.0,7/40,13.04%,THUMPD2;CARNMT1;ICMT;SETD3;METTL2B;METTL2A;RRP8
prerank,DNA secondary structure binding (GO:0000217),0.2192455000345131,0.6362102416873131,0.9581151832460733,1.0,1.0,3/31,9.56%,RAD18;YY1;RAD51B
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.27388293002203545,-0.6346210456606027,0.899009900990099,0.987430704415629,1.0,2/10,5.39%,KDM4A;KDM7A
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.1935107727241362,0.6327504123937014,0.9687034277198212,1.0,1.0,10/60,16.39%,CTDSP1;PPP3CB;PPP2CA;PPP2CB;PHLPP1;PPP3CA;PPP3R1;PPP5C;CAMK2G;PPM1L
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.2532812383808001,-0.6319902149606897,0.9147121535181236,0.9858462112278663,1.0,6/12,38.29%,GAB2;PIK3R1;SH2B1;BLNK;SH2B2;TRADD
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.21334619262969762,-0.628589709708122,0.9432314410480349,0.9848333680491315,1.0,2/21,10.70%,FGF1;KL
prerank,transaminase activity (GO:0008483),-0.2568544396047416,-0.627899275004345,0.9257731958762887,0.9821872258773748,1.0,4/11,24.67%,ABAT;BCAT1;GOT1;OAT
prerank,sequence-specific mRNA binding (GO:1990825),0.2746045694200352,0.6171937528619156,0.9192913385826772,1.0,1.0,10/10,72.56%,SSB;DHX9;FMR1;LIN28A;LARP6;ETF1;RBM24;TYMS;DHFR;SHFL
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.2546502623885362,0.6159995424179258,0.9197761194029851,1.0,1.0,2/14,11.99%,ISCU;ACO1
prerank,four-way junction DNA binding (GO:0000400),0.23680685161983878,0.6141548401372967,0.9420289855072463,1.0,1.0,2/17,9.56%,YY1;RAD51B
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.2720482078965539,0.6086201977272194,0.9209039548022598,1.0,1.0,11/11,72.81%,KCND3;KCNE1;KCNE3;KCNE2;KCNJ5;KCNE5;KCNH2;KCNE4;KCNJ8;KCNJ3;KCNQ1
prerank,enoyl-CoA hydratase activity (GO:0004300),0.27455462854687984,0.6048961169774033,0.9449901768172888,1.0,1.0,5/10,22.38%,HSD17B4;ECHDC1;ECHS1;HADHA;AUH
prerank,RNA polymerase binding (GO:0070063),0.23893608699497706,0.6037664299937237,0.9517625231910947,1.0,1.0,7/18,21.43%,PPIB;STOM;SCAF8;TCERG1;YTHDC2;PKN2;DHX9
prerank,single-stranded DNA helicase activity (GO:0017116),-0.2174658923476514,-0.603475610653912,0.9699570815450643,0.992119265243507,1.0,14/19,54.06%,WRNIP1;MCM6;RFC2;POLQ;HELQ;DNA2;RFC3;RAD51;RFC4;MCM7;MCM5;DSCC1;CHTF18;PIF1
prerank,endopeptidase regulator activity (GO:0061135),-0.17831462261218436,-0.6008124565222922,0.9835616438356164,0.9902364422637664,1.0,13/40,36.21%,TFPI;PSMF1;ITIH2;RENBP;CAST;SERPIND1;APH1B;PSME2;PSME3;ABCA2;PSME1;PSENEN;SPINT2
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.26708105511434105,0.5910730653385438,0.9352941176470588,1.0,1.0,1/10,5.58%,CDKN1A
prerank,nucleoside-diphosphatase activity (GO:0017110),0.24565392997549615,0.5843380394768893,0.9644268774703557,1.0,1.0,1/12,3.80%,NUDT5
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.24704939585007912,-0.5835383198578419,0.9516806722689075,0.9941387984735564,1.0,2/11,11.72%,PPP1R1A;PPP1R14C
prerank,histone acetyltransferase activity (GO:0004402),0.19695717011769132,0.5718442706361068,0.9799666110183639,1.0,1.0,8/30,18.94%,EP300;CLOCK;CREBBP;USP22;TAF1;TADA2A;NAA50;HAT1
prerank,CARD domain binding (GO:0050700),0.2342908964773024,0.5657537540230031,0.9653284671532847,1.0,1.0,2/14,11.12%,CARD16;NOD1
prerank,receptor tyrosine kinase binding (GO:0030971),0.1720066972538522,0.5631779510765484,0.9954682779456193,1.0,1.0,2/56,2.13%,CBL;MAP3K7
prerank,FMN binding (GO:0010181),-0.23915140371886154,-0.56217963208891,0.9423076923076923,0.9988642666051449,1.0,5/11,36.11%,DUS2;MTRR;NOS1;POR;NDOR1
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.17415612243243123,-0.5603543825730206,0.9927184466019418,0.9963480830509472,1.0,21/35,44.86%,DUS2;ELAC1;TARS2;NT5C3A;MTFMT;QTRT2;DUS4L;QRSL1;PTRH2;QTRT1;TRMT5;LCMT2;DTWD1;DUS3L;ELAC2;DUS1L;MRPL58;GATC;TYW3;TRMT12;TRPT1
prerank,antiporter activity (GO:0015297),0.2132642078424541,0.5558927685970823,0.9665551839464883,1.0,1.0,2/20,8.42%,CLCN3;SLC35A1
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.1830564997807201,0.5548569923579189,0.9866220735785953,1.0,1.0,13/38,21.18%,DENND1A;TECPR1;LANCL2;PARD3;PLEKHA5;ZFYVE1;KIF16B;SNX27;ZFYVE19;ZFYVE26;WDR45B;ATG2B;SNX12
prerank,titin binding (GO:0031432),-0.22243172420864907,-0.5547276776879981,0.9723991507430998,0.9949643104584478,1.0,2/13,11.26%,ACTN2;CAMK2D
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.2176106049835579,0.5514888082729467,0.9779816513761468,1.0,1.0,2/17,12.61%,NME1;DTYMK
prerank,glucose transmembrane transporter activity (GO:0005355),0.21237048665620084,0.5412225253915045,0.9652014652014652,1.0,1.0,17/17,78.79%,SLC2A1;SLC2A7;SLC5A9;SLC5A2;SLC5A1;SLC5A10;SLC2A6;SLC2A5;PPBP;SLC2A2;SLC2A4;SLC5A11;SLC2A8;SLC5A3;SLC2A10;SLC2A3;MFSD4A
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.2271186440677966,0.5329070424737385,0.9737827715355806,1.0,1.0,12/12,77.31%,NQO2;CRYZL1;ADH4;AKR1C1;DCXR;NQO1;CBR1;CRYZ;NDUFS7;CBR4;AIFM2;DHRS4
prerank,death domain binding (GO:0070513),0.2327702024528196,0.5305064224505991,0.9553398058252427,1.0,1.0,3/11,17.44%,CRADD;DAPL1;BAX
prerank,ribonuclease P activity (GO:0004526),-0.21383973871780732,-0.5140523757361275,0.9782608695652174,1.0,1.0,6/11,40.79%,PRORP;RPP30;RPP14;RPP21;POP4;RPP38
prerank,5'-nucleotidase activity (GO:0008253),0.21198624914177955,0.5098076981443787,0.9807321772639692,1.0,1.0,3/13,18.63%,NT5C3B;NT5C2;NT5DC1
prerank,lipase activity (GO:0016298),0.16244429423855872,0.501364640999475,0.9919093851132686,1.0,1.0,5/43,15.21%,SEC23IP;DDHD1;PNPLA8;ABHD12;DAGLB
prerank,hexose transmembrane transporter activity (GO:0015149),0.21230382925298166,0.500430343396883,0.9748549323017408,1.0,1.0,12/12,78.79%,SLC2A1;SLC2A7;SLC5A1;SLC2A6;SLC2A5;PPBP;SLC2A2;SLC2A4;SLC2A8;SLC5A3;SLC2A3;MFSD4A
prerank,hyaluronic acid binding (GO:0005540),-0.21411969900689767,-0.49946487149065316,0.9865384615384616,1.0,1.0,1/10,5.02%,CEMIP
prerank,neuropeptide receptor binding (GO:0071855),0.19646298571919796,0.48083223725638824,0.9873873873873874,1.0,1.0,1/14,10.67%,PPY
prerank,ribonuclease P RNA binding (GO:0033204),0.20869947275922676,0.45955780904637944,0.9897330595482546,1.0,1.0,10/10,79.14%,POP5;POP1;RPP25;RPP40;POP7;RPP38;POP4;RPP21;RPP14;RPP30
prerank,peptidoglycan binding (GO:0042834),0.20053979412503145,0.4534695499141951,0.9867674858223062,1.0,1.0,10/10,79.96%,NOD1;PGLYRP2;PGLYRP3;TLR2;NLRP3;JCHAIN;NOD2;HK1;PGLYRP1;RNASE7
prerank,growth factor activity (GO:0008083),0.12531462485993275,0.42570823497049914,1.0,1.0,1.0,1/74,0.86%,JAG2
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.16280732380428167,-0.42121133230233604,0.9958932238193019,1.0,1.0,7/14,40.79%,PRORP;RPP30;RPP14;RPP21;ELAC2;POP4;RPP38
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.17883672778433937,-0.4179971210828227,0.9957894736842106,1.0,1.0,1/10,11.45%,NOX4
prerank,nucleotidase activity (GO:0008252),0.15631585719817154,0.3855559342319102,0.998109640831758,1.0,1.0,2/15,12.10%,NT5C3B;NT5C2
prerank,CoA hydrolase activity (GO:0016289),-0.14145904213781435,-0.3792458179764998,0.9978070175438597,0.9995958815054292,1.0,3/16,24.33%,ACOT11;ACOT7;NUDT7
prerank,acylglycerol lipase activity (GO:0047372),0.16113238340342745,0.36586124298224765,1.0,1.0,1.0,11/11,83.90%,ABHD12;ABHD16A;ABHD12B;PNLIPRP2;ABHD6;ABHD2;ABHD15;MGLL;FAAH;LIPE;ABHD3
prerank,pseudouridine synthase activity (GO:0009982),0.1493455743865581,0.3557076974175082,0.9964093357271095,0.9997687178603941,1.0,2/13,16.27%,PUS10;DKC1
